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SUMMARY 
 
To manipulate recombinant microorganisms for industrial processes, controllable genetic 
systems are needed that can coordinate expression of recombinant metabolic pathways. All 
components are sensitive to change and thus putative targets for modification and genetic 
elements and regulatory systems need to be understood and determined. Central in gene 
regulation is the transcription activators that mediate gene transcription mechanisms by 
binding to promoters in response to environmental signals. Promoter engineering entails the 
modification of transcription factors and their target promoters. 
 
In this study, a metabolic control system in Saccharomyces cerevisiae was constructed that 
would allow induction in response to physiological environment, specifically hypoxia and 
low temperature conditions. Two approaches were undertaken to find such a system. Firstly, 
a bi-directional reporter gene cloning vector was designed to search for novel hypoxia-
inducible promoters. Secondly, a transcription regulatory circuit was built, consisting of an 
inducible transcription regulator and promoter with a reporter gene through which it mediates 
transcription. Advantage was taken of the modular nature of proteins and functional domains 
originating from different transcriptional proteins were combined.    
 
A search for promoter elements sensitive to hypoxia from a S. cerevisiae genomic DNA 
(gDNA) library, using a bi-directional cloning vector, did not yield highly inducible 
promoters. It was concluded that a multitude of signals overlap, rendering genetic induction 
difficult to control. A synthetic regulatory system would minimize the impact of these 
multiple interactions.  Such a genetic circuit was constructed, consisting of a chimeric 
transcription activator and a target fusion promoter. The chimeric transcription activator 
consisted of the GAL4 DNA binding domain, ADR1 TADIII transactivation domain and three 
domains of the MGA2 regulatory protein. The functional domains of Mga2p responsible for 
unregulated expression (at high basal levels) under both aerobic and hypoxia conditions were 
located, as well as a further upregulation under low temperature, and were mapped to the N-
terminal and mid-Mga2p regions.  
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 A target fusion promoter consisting of a partial GAL10/1 promoter sequence and a 
Trichoderma reesei core xyn2 promoter were constructed as target for this chimeric 
transactivator. This synthetic promoter was fused to the T. reesei xyn2 open reading frame 
encoding for a readily assayable β-xylanase activity. Both the chimeric transactivator and 
fusion promoter-reporter gene cassettes were expressed from the same episomal plasmid, 
named pAR.  
 
Transformed into S. cerevisiae Y294, this regulatory system induced transcription under 
aerobic and hypoxia conditions. Furthermore, the reporter gene expression was upregulated 
by the chimeric transactivator at low temperatures. The chimeric transactivator mediated a 
seven-fold induction of the reporter gene under aerobic conditions in S. cerevisiae Y294 
when transformed with plasmid AR.  A two- to three-fold induction at 23ºC was reported 
under anaerobic conditions, relative to a reference strain expressing a transcription activator 
without the Mga2p domains. At 30ºC, a two- to three-fold induction under aerobic conditions 
and similar induction under oxygen-limited conditions were observed.  
 
Replacing the reporter gene with your favorite gene (for example a recombinant enzyme) and 
incorporating such a pAR system into a recombinant yeast should induce expression of the 
chosen gene under low temperatures, both aerobic and anaerobically (thus creating a 
controllable system). The system also has wider application in identifying other transcription 
factors’ signal-sensitive domains. The design of this system provides the ability to add a 
linker to a transactivator and to either create specific signal sensitivity or relieve the regulator 
of its signal dependence. It creates an easy system for assessing other transactivators and 
their domains with unknown functions and thus provides a ”workhorse and prospector in 
one”.  
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OPSOMMING 
 
 
Vir die manipulering van rekombinante mikroörganismes vir industriële prosesse word 
beheerbare genetiese stelsels benodig om gekoördineerde uitdrukking van rekombinante 
metaboliese weë teweeg te bring. Alle komponente van sulke stelsels is sensitief vir 
verandering en genetiese elemente en reguleerbare sisteme moet dus deeglik verstaan of 
bepaal word. Sentraal tot geenregulering is die transkripsie-aktiveerders wat geentranskripsie 
beheer deur aan promoters te bind in reaksie op eksterne omgewingsfaktore. Promotor-
ingenieurswese behels wysigings van transkripsiefaktore en hul teikenpromotors. 
 
In hierdie studie is 'n genetiese beheerstelsel vir Saccaromyces cerevisiae ontwikkel wat 
induksie in reaksie tot spesifieke fisiologiese omgewingreaksies, naamlik hipoksie- en lae 
temperatuur, toelaat. Twee benaderings is gevolg: eerstens is ‘n tweerigting verklikker-geen 
vektor ontwikkel en gebruik om vir unieke induseerbare hipoksie-promoters te soek. 
Tweedens is ‘n transkripsie reguleringstelsel gebou wat uit ‘n induseerbare transkripsie-
reguleerder and promotor met ‘n verklikkergeen bestaan, waardeur transkripsie bemiddel kan 
word. Hierdie benadering benut die modulêre onderbou van proteïene en funksionele 
domeine afkomstig vanaf verskillende transkripsiefaktore is gekombineer. 
 
'n Soektog na hipoksie-sensitiewe promotors vanuit 'n Saccharomyces cerevisiae-genoom-
DNA (gDNA), deur van ‘n tweerigting verklikker-vektor gebruik te maak, het ongelukkig nie 
hoogs-induseerbare promotors opgelewer nie. Die gevolgtrekking was dat ‘n veelvoud van 
seine met mekaar oorvleuel en die beheer van genetiese induksie dus bemoeilik. Die 
ontwikkeling van ‘n sintetiese regulering-sisteem kan die impak van die veelvuldige 
interaksies verminder. Vir dié doel is ‘n sintetiese reguleringstelsel ontwerp, bestaande uit ‘n 
chimeriese transkripsie-aktiveerder met ‘n teiken fusie-promotor. Die chimeriese 
transaktiveerder bestaan uit die GAL4 DNA bindingsdomein, die ADR1 TAD III 
transaktiveringsdomein en drie domeine van die Mga2 reguleringsproteïen. In die studie is 
die funksionele domeins van Mga2p betrokke by lae temperatuur-respons en ongereguleerde 
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uitdrukking (teen hoë basale vlakke) onder beide aërobiese en anaërobiese toestande 
aangedui en is tot die N-terminaal en middel-Mga2p areas gekarteer. 
 
‘n Teiken-fusie-promoter, bestaande uit 'n gedeeltelike GAL1/10 DNA promotor-
opeenvolging en ‘n Trichoderma reesei kern xyn2-promoter, is as teiken vir hierdie 
chimeriese transaktiveerder saamgestel. Hierdie sintetiese promotor is aan die T. reesei xyn2 
oopleesraam, wat vir ‘n maklik meetbare β-xylanase aktiwiteit kodeer, gekoppel. Beide die 
chimeriese transaktiveerder and fusie-promoter-verklikker-geenkaset word vanaf dieselfde 
episomale plasmied, bekend as pAR, uitgedruk. 
 
Hierdie reguleringsisteem induseer transkripsie onder aërobiese en hipoksie toestande in  
S. cerevisiae Y294. Verder word die verklikkergeen se uitdrukking deur die chimeriese 
transaktiveerder by lae temperature verhoog. Die chimeriese transaktiveerder induseer ‘n 
sewe-voudige induksie van die verklikkergeen onder aërobiese toestande by 23ºC vanaf die 
pAR-stelsel in S. cerevisiae Y294. ‘n Twee- tot drie-voudige induksie teen 23ºC is onder 
hipoksie toestande gevind, relatief tot induksievlakke van ‘n verwysingstam met ‘n 
transaktiveerder sonder die Mga2 domeine. By 30ºC is ‘n twee- tot drie-voudige induksie 
onder aërobiese en lae suurstofvlakke waargeneem.  
  
Deur die verklikker geen met ‘n jou-gunsteling-geen te vervang (bv. ‘n rekombinante 
ensiem) en so 'n pAR-sisteem in ‘n rekombinante gis te inkorporeer, word uitdrukking onder 
lae temperature onder beide aërobiese- en anaërobiese toestande geïnduseer (en sodoende 
word ‘n reguleerbare sisteem geskep). Die sisteem het wyer toepassing om sein-sensitiewe 
domeine van ander transkripsiefaktore te identifiseer. Die ontwerp van die stelsel maak dit 
moontlik om 'n skakel tot die transaktiveerder by te voeg wat óf sensitiwiteit tot 'n spesifieke 
sein skep, óf die reguleerder vanaf seinafhanklikheid verlos.  So word ‘n bruikbare stelsel vir 
die bestudering van ander transaktivators en hul domeine met onbekende funksie geskep – ‘n 
“werksesel en prospekteerder in een”. 
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 Introduction and Objectives   
 
 
Genes are not puppet masters or blueprints.  
They are active during life; they switch one another on and off. 
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INTRODUCTION  
METABOLIC CONTROL THROUGH GENE REGULATION 
 
“Genes are not puppet masters or blueprints, nor are they just the carriers of heredity. They 
are active during life; they switch one another on and off; they respond to the environment. 
To make grand changes in the bodyplan of animals, there is no need to invent new words to 
write an original novel. All you need to do is switch the same ones on and off in different 
patterns. Merely by adjusting the sequence of a promoter or adding a new one, you could 
alter the expression of a gene.” TIME (Matt Ridley June 2, 2003 What makes you who you 
are, p. 41-47) 
 
To make “grand changes” as stated by Matt Ridley (2003), one needs to take control of 
processing in the cells. Regulating genes implies a method of control. Processing can be 
either the synthesis of gene products, proteins, or the metabolism of proteins in cells. Control 
means the increase or decrease in the product(s) of a gene or a group of genes. Control also 
has a special function in temporal induction or repression in higher organisms, the switching 
on, or off, of protein production controls life. Cell cycles, cell death, cell maturation, 
differentiation, etc. respond to an increase or decrease in specific proteins. These proteins 
switch other proteins on or off, at any stage of their production or processing.  
 
When focusing on controlling protein production, the emphasis could easily be on the most 
obvious point of control, i.e. gene promoters. As the above quotation puts it so simply, 
however elegantly, “Merely by adjusting the sequence of a promoter or adding a new one, 
you could alter the expression of a gene”, was the specific focus of the first part of this study. 
By means of a designer bi-directional cloning vector, it was attempted to mine the genome 
sequence of Saccharomyces cerevisiae for activating sequences.  Promoter elements are 
present in introns, as well as within protein encoding regions, therefore all sequences were 
considered as putative promoters. In practical terms this means isolating putative promoters 
responsive to a specific signal, and then making deletions or insertions, or fusions, to enhance 
or repress their transcription. Promoter isolation, characterization and manipulation have 
been carried out by molecular biologist ever since the role of promoters in transcription 
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induction was discovered.  
 
Defining and providing a specific signal is the most complicated component to regulate in 
transcription regulation. An element found in promoter sequences is linked to a response or 
responses to a specific signal or signals. Overlapping of signals and elements in promoters 
provides a multi-layered control system. “Genes … switch one another on and off; they 
respond to the environment” (Matt Ridley, 2003). Identifying strong and controllable 
promoters preferably functional under specific conditions only, may not be that easy, due to 
the multi-functional and interconnected roles that genes play in the cell.  
 
Therefore, the simplified definition of gene control given by Matt Ridley (2003) should be 
rewritten as follows: “Merely by adjusting the sequence of a promoter or adding a new one” 
should be replaced by ‘by adjusting the transcription activators that bind the altered /non-
altered sequence of a promoter’. Moreover, to make the definition more complete the 
following could be added: ‘also adjusting the co-activator requirements of transactivators 
will enable the modified expression of a gene’. The signals to which these co-activators and 
transactivators respond also need to be defined. The last sentence of Matt Ridley’s quotation 
also needs some elaboration: “you could alter the expression of a gene” should be ‘you could 
alter the expression of a gene or genes effectively (effectively = controllable), only if all the 
induction signals, which it or they respond to, are taken into consideration’. 
 
AIMS OF THE STUDY 
 
The two main objectives of the present study were the following: 
1. To design a metabolic control regulatory circuit for bio-industrial processes. 
2. To identify hypoxia control mechanisms in S. cerevisiae to be used in metabolic 
control. 
 
At some stage, the discoveries made in laboratories have to meet the rigorous conditions of 
industrial processes. In this study, the response of the yeast cell to the impact of different 
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physiological conditions experienced during fermentations was investigated. The ultimate 
goal is control of those responses to accelerate the process of scale-up from laboratory-
controlled to industrial fermentations. The ideal recombinant organism will be one in which 
whole recombinant metabolic pathways can be controlled with external signals. 
 
The first objective of this study was to mine the yeast, S. cerevisiae, for promoter 
elements/regions sensitive to hypoxia regulation. Results of this study led to the conclusion 
that multitudes of signals overlap with hypoxia. The alternative was to minimize the impact 
of a multitude of interactions by creating a synthetic regulatory system. The design of the 
synthetic regulatory system ensured the control of a specific gene (and in future the control of 
a set of genes). Long-term objectives of the synthetic regulatory design aimed at regulating 
all genes in a metabolic pathway and related pathways by means of incorporating a 
recombinant single synthetic transactivator/ target promoters system.  The conversion of an 
abundant substrate to a desired product often entails multi-step pathways that may have no 
shared ‘global’ regulation. Recently, a complete non-yeast metabolic pathway was 
engineered to function in the yeast host. An artificial and fully self-sufficient biosynthetic 
pathway involving thirteen engineered genes was assembled and expressed in a single 
recombinant S. cerevisiae strain (Szczebara et al., 2003) to produce mammalian steroids. The 
yeast’s endogenous sterol biosynthesis was re-routed to produce compatible sterols to serve 
as substrates for the heterologous part of the pathway. Biosynthesis involved eight 
mammalian proteins and optimization involved modulating mitochondrial systems and 
disrupting of unwanted side reactions associated with S. cerevisiae ATF2, GCY1, and YPR1 
gene products∞. Incorporating a regulatory system that regulates all the enzymes involved in 
this sterol production system could provide the ability to control the recombinant pathway 
and increase production. 
 
In vivo enzyme concentrations and regulatory mechanisms are determined by a variety of 
transcriptional and post-transcriptional mechanisms, and are responsive to a multitude of 
signals (Hofmeyr and Cornish-Bowden, 2000). The first step is to determine which 
transactivators are involved and to characterize these transactivators. 
4
                                                 
∞ ATF2 = alcohol acetyltransferase II, GCY1 = carbonyl reductase, YPR1 = 2-methylbutyraldehyde reductase. 
 
 
 The motivation for the specific design of a chimeric transcriptor and its target synthetic 
promoter regulatory system attempted in this study was to ‘simplify’ the factors that need to 
be taken into account. If the genes of engineered (e.g. optimized in terms of substrate 
specificity or for a specific temperature) enzymes are cloned, their ratios can be control by 
inserting the control mechanism designed. A combination of inserting the correct number of 
signal-regulated targets at the promoters for each enzyme and inserting the transactivator 
sensitive to known (identified) signals will enable the plant manager at an industrial 
operation to control the production flow. The plant manager should be able to use 
controllable fermentation conditions, e.g. oxygen supply or temperature and substrate 
concentrations, to increase production flow and reduce costs.  
 
The main objectives were reached by creating a chimeric regulator consisting of three 
domains that originated from three different yeast transactivators. It consists of a DNA 
binding domain, a transactivator domain (to assemble basal transcription machinery) and a 
putative signal sensor region to confer the ability for this transactivator to mediate up-
regulation under specific growth conditions. Additionally, a fusion target promoter was 
designed specifically for this chimeric regulator, providing the corresponding DNA binding 
site. The aim was the upregulation of all genes provided with this target promoter by means 
of the one chimeric transactivator. In this study, a reporter gene was supplied with the target 
promoter to evaluate the chimeric transactivator ability to upregulate under different 
conditions. The plasmid-based chimeric activation regulatory system design was found to be 
operational under hypoxia in the presence of glucose, sensitive to pressure under hypoxia and 
could be upregulated by lowering of temperatures. The system was design for yeast and, 
more specific, S. cerevisiae, but the concept could be applied to other recombinant 
organisms.  
 
This system aimed to exclude, or reduce, the response to a multitude of signals by using 
selective regions of a protein and to enable the identification of functional domains of 
transactivators responsible for transferring signals. The aim was a modular design that could 
be applied in future to map protein domains of transcription factors for signal “sensing”. This 
“ability” could have further applications in other organisms. Characterization of the hypoxia 
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inducible yeast transactivator Mga2p (the only known hypoxia response transactivator in 
yeast) was carried out to map domain functions. This led to the identification of Mga2p 
domains responsible for upregulation at low temperatures.  
 
Summary of chronological development of this research study 
 
Transcription activators and their target promoters can be manipulated if the motifs 
(transactivator) and elements (promoters) linking to a specific signal are known. At the outset 
of this study, the hypoxia promoter elements in several hypoxia-induced yeast genes were not 
yet identified. Elements already identified in literature were used for in silico searches. The 
computational studies were complimented with experimental work and a bi-directional 
reporter gene vector was built to search for promoters. The initial focus of the research was to 
find hypoxia inducible promoters and an extensive screening of a S. cerevisiae genome DNA 
library with the aid of a bi-directional reporter gene - promoter screening vector was done. 
The sequences obtained were tested for their ability to effect hypoxia induction, but none of 
them showed induction levels above that found for the reference ADH2φ promoter included 
in the study (Chapter III). When the hypoxia promoter element or low oxygen response 
(LOR) element present at the OLE1♠ and ATF1♠ genes was discovered (Vasconcelles et al., 
2001; Jiang et al., 2001), this element was also used in in silico searches. A 50-bp oxygen 
regulated element was identified by Jiang et al. (2001) and shortly thereafter, Vasconcelles et 
al. (2001) reported the shorter 20-bp LOR element included within the 50-bp region. The 
core consensus sequence was indicated as 5’- ACTCAACAA -3’. Jiang et al. (2001) and 
Jiang et al. (2002) found the transcription factor MGA2 to mediate complex formation at the 
LOR element of OLE1. 
 
The focus of the research was thus re-directed from screening for hypoxia-inducible 
promoters to the design of the AR regulatory system based on the ability of the Mga2 
transactivator to mediate transcription complex formation under hypoxia. The aim was to 
6
                                                 
 
♠ OLE1 = delta-9 fatty acid desaturase, ATF1 = alcohol acetyltransferase I 
φ The ADH2 (encoding alcohol dehydrogenase II) promoter mediated good aerobic induction of the reporter 
gene (xyn2) construct used in this study (personal communications Dr. D.C. la Grange). 
 
“talk” to the regulatory system by means of specific signals and to “respond” to the system 
by means of a chimeric transactivator.  
 
By comparing the putative mechanisms of Mga2p mediated regulation, and regulation 
mechanisms of the Mga2p, decisions were made to incorporate or exclude certain domains of 
the Mga2 protein when designing the AR regulatory system. Since the regulation pattern of 
Mga2p agrees with the type of control mediated by the hypoxia transcription activators in 
mammalian cells, HIF-1♦, alpha and NF-kappaB♦, their methods of control or the method 
whereby they are regulated in the cell were also compared to that of Mga2p. Data obtained 
was used as indicators of putative essential signal sensing or signal transducer domains or 
motifs (Chapter I). In silico comparative studies between Mga2p and its homologue Spt23p, 
(described in Introduction, Chapter II) were also used. 
 
This study was in part an attempt to provide an experimental  “tool” to confirm in silico 
predictions made concerning the signal sensing or signal transducer abilities of 
transactivators. Although the success rate of in silico predictions is high, all predictions need 
to be confirmed experimentally. Analysis of a genome-scale reconstructed metabolic network 
for the eukaryotic S. cerevisiae consisting of 1,175 metabolic reactions and 733 metabolites 
was done by Famili et al. (2003). This group calculated that the in silico results were 
consistent with observed phenotypic functions for approximately 70-80% of the conditions 
considered.  
 
Using this approach, a chimeric transactivator and corresponding promoter elements 
(collectively called the AR regulatory system) was developed that successfully responded to 
specific conditions, notably hypoxia and low temperatures, and induced gene expression of 
the reporter gene, xyn2 of Trichoderma reesei (Experimental results reported in Chapter II).  
This study confirmed that Mga2p is the low temperature sensor of S. cerevisiae (Nakagawa et 
al., 2002) and indicated specific domains of Mga2p to be responsible for this function. 
 
Note that the research results will not be presented in a strict chronological order.  
7
                                                 
 
♦ HIF = hypoxia inducible factor, NF = nuclear factor 
 
Layout of the Chapters to follow 
 
 
Chapter I  
An overview of transcription regulation in general (using examples of both yeast and higher 
eukaryotes relevant to proteins used in this study) will be given. As the regulation of a 
transcription regulator is subjected to control at both transcriptional and post-transcriptional 
levels, this discussion includes downstream regulation mechanisms. This will highlight the 
difficulty in identifying domains sensitive to specific signals, confirming the original 
problem encountered of an overlap of signal response, when a bi-directional cloning vector 
was used to screen for hypoxia inducible promoters. This chapter provides the literature 
background for cold or low temperature induction in yeast and higher eukaryotes.  
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Chapter II 
 
Introduction 
The introduction will include a detailed description of the components of the chimeric 
regulatory circuit constructed in this study as well a summary of the reasons for choosing 
specific domains and elements of the transactivator Mga2p. The silico methods used in this 
study to determine regions used and the further application of bioinformatic in silico searches 
will be discussed. It will serve as an introduction to the experimental work presented in the 
second part of this chapter, an article describing the engineering of a chimeric transcription 
regulator-reporter gene.  
 
Manuscript 
The engineering of a chimeric transcription regulator-reporter gene circuit (and the reference 
regulatory circuit) constructed for inducible gene expression using Mga2p domains. will be 
presented in the form of an manuscript prepared for publication (see cartoon below for a 
presentation of constructs). An appendix will provide details of a patent application.  
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Chapter III  
The design of a bi-directional promoter-screening vector that was built and evaluation of 
hypoxia inducible promoters will be presented. 
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Chapter IV 
This chapter will discuss the results obtained with the chimeric transcription regulator and the 
putative mechanisms involved in upregulated gene transcription. 
 
 
Chapter V 
Conclusions and suggestions will be made concerning improvements to and applications of 
the chimeric transcription regulator-reporter gene construction at a molecular level, as well as 
in the fermentation process itself.  
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Chapter I 
 
Literature overview of transactivators and gene regulation 
“Differential transcription of different genes” 
 
1. Introduction: general concepts of regulation 
 
WHERE DOES REGULATION OCCUR IN THE CELL? 
As implied in the introduction, regulation in the cell is self-imposed. The concentrations 
and type of proteins in the cells determine the actions of other (but not only) proteins in 
the cell. This is not a closed system, as the control system responds to signals from 
outside the cell. In the center of all of this lies the protein(s) responding to extracellular 
signals or to a fluctuation in the concentrations of intercellular proteins/metabolites. 
Metabolites can also be involved as, e.g. allosteric effectors or simply by changes in 
substrate and/or product concentrations. These proteins determine which genes are 
transcribed, and at what rate. These proteins are the transducers of signals and the 
transcription activators. 
 
WHAT IS TRANSCRIPTION REGULATION? 
Differential transcription of different genes determines actions and properties of cells 
(Lodish et al., 2000). Transactivators mediate actions to effect metabolic control of gene 
expression, and by responding to changes in the environment, to effect differential 
transcription and metabolic control. 
 
Regulation of transcription is complex, as there is neither a beginning nor an end! It is 
almost impossible to answer whether the chicken or the egg was first: 
- Does one start with the regulation mechanisms of the transactivators that can 
modulate changes in chromatin structure? 
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- Or does one rather go one step back, and start with the regulation system to control 
the activators or repressors of the transactivators? 
- Would it not be more appropriate to go one step forward, and explain how signal- 
specific or general transactivators bind to promoter DNA?  
- Or, rather, explain the multi-signal induced response of some transactivators, 
mediated by post-transcriptional modification by its activators or repressors?  
- Or, alternatively, stick to the analysis of one promoter and its response to different 
signals mediated by several transactivators?  
 
Basal level transcription can be define as follow: Initiation of transcription is the 
assembly of transcription complexes, consisting of RNA polymerases and co-factors 
bound at commonly found cis-elements at the promoter DNA of a gene, close to the start 
site. Regulation of transcription initiation is the most common method of gene control 
and occurs at all genes. Core promoters are defined as that region of the promoter 
necessary for basal level transcription. To enhance transcription above basal levels, 
transactivators bind other cis-acting control elements found in promoters in eukaryotes. 
Enhancers can bind to a multitude of upstream elements. These cis-element sequences 
can be the binding sites for both activators and/or repressors, allowing another control 
point in the cell for enhanced but differential transcription. Sequence-specific cis-
elements are located even thousands of kilobases away from the start site (Lodish et al., 
(2000); McKnight and Tijan (1986)). What then is transcription regulation? 
 
WHAT IS TRANSCRIPTION REGULATION? 
Global gene expression systems (also described as regulons) determine the binding 
pattern of transcription regulators. The network of regulator-gene interactions enables 
the cell to go through the cell cycle, responding to changes in the environment. In the 
present study, the focus will be on the building of a chimeric transactivator – promoter 
regulation system or regional regulon. The aim is to create a simple network of 
metabolic regulatory mechanisms for upregulated enzyme production, substrate 
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degradation and ethanol production. Before building a network, the characteristics of a 
transactivator first need to be defined. 
 
WHAT IS A TRANSCRIPTION ACTIVATOR AND ITS FUNCTION, AND HOW 
ARE ACTIVATORS CLASSIFIED? 
First, an attempt will be made to define a transactivator: It is a protein-binding or DNA-
binding protein, or adaptor (that bind DNA or other proteins) – binding protein. The 
activator protein often binds to a complex of co-factors or adaptors. This protein 
complex facilitates activation (Ptashne, 1988). The transactivator is the protein 
responding to a specific signal, and without which the activation would not take place 
under that specific signal. Transactivators are signal transducers. 
 
The formation of an optimal promoter conformation to line up the transcription initiation 
complex involved not only the formation of multi-protein complexes (enhancesomes) at 
the activating sequences at promoter DNA, but also need the basal transcription 
machinery proteins to interact with DNA and Pol II (Ptashne and Gann, 1997). 
Enhancesomes facilitate the binding and bending of the promoter region of a gene. In 
this complex with RNA polymerase, the gene can be transcribed at induced levels. The 
function of the transcription activator is to mediate induction of transcription of the 
targeted genes (Lodish et al., 2000).  
 
The classification of an activator remains complex, and in my opinion depends on the 
following:   
1. It first depends on whether a general transcription activator or a signal specific 
transcription activator is being described.   
2. A sub-classification defines the transcription activator based on the signal or signals 
it responds to.  
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3. It can also be classified in terms of how its level of induction will be affected by its 
binding affinity to promoter elements, either when binding DNA directly or via 
another protein or proteins. This classification will include the sequence- specificity 
of upstream activation elements involved, as well as the effect of flanking regions on 
the binding of a transactivator and the proteins it interacts with, if operating in a 
complex.  
4. It can also be classified in terms of the repressors that will affect its activation. 
5. The co-activators or adapters that will enhance its activation properties may also be 
used.  
6. To complicate a thorough classification system even further is the fact that the 
identified transactivators tend to operate in multi-protein complexes (enhancesomes). 
The requirements of this complex assembly and the co-activator proteins involved 
can also define a transactivator as well as its role in this complex. 
7. Another option is classification based on the transactivator structure, using the 
domain characteristics. Activators are modular proteins containing any of the 
following: a DNA-binding domain, activation domain(s) and flexible polypeptide 
regions linking domains. Many transactivators have not yet been adequately studied 
to determine their respective domains. 
8. It can also be classified in terms of how it will affect different gene groups 
differently, as some transcription activators of one group also function as repressors 
of another gene or group of genes. 
 
Due to the interactive nature of transcription control, a single classification of 
transactivators will not be sufficient. In short the classifications of an activator listed 
above are based upon the following factors: response to a signal, the binding affinity to a 
promoter element, the effect of other co-activators or repressor proteins, and the 
structure of the transactivator itself. Other factors that will determine new classifications 
of activators (see points 9) and 10) below) that have emerged in recent studies, and may 
well be the most important, include the control mechanism of transactivator proteins at a 
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post-transcriptional level and the post-transcriptional control mechanisms by which they 
are controlled.  
 
9. A transactivator can also be classified based on its profile of post-transcription 
regulation, e.g. in terms of its ability to mediate up-regulation post-transcription, by 
mediating mRNA stability, and/or playing a role in the export of transcripts. 
10. Classification of transactivators on the basis of their post-translational processing 
will be valid as it was found that the processing of a transactivator protein could be 
the main target for its control, mediating the same control on all genes activated by 
this transactivator. Examples of control through processing will be discussed in this 
chapter, under the heading: ‘Further downstream control: post-transcription and 
translational control’ (Section 6).  
 
 
A BRIEF OVERVIEW OF TRANSCRIPTION REPRESSION IN YEAST 
Repressor proteins also effect transcription. ‘Relief of repression’ or derepression can 
lead to an upregulation of gene transcription. It is important to keep this in mind when 
activation of gene transcription is studied. Derepression can easily be mistaken for 
activation through an activator. Derepression can occur at the secondary chromosomal 
structure of a nucleosome arrangement, or at the promoters themselves. Derepression 
can occur at DNA or protein level (Lodish et al., 2000). An example of derepression in 
yeast is the silencing of mating-type loci that determine the life cycle of yeast. 
Condensed chromatin structure is responsible for repression of mating-type HML and 
HMR loci. It sterically blocks transcription and the general transcription factors cannot 
bind to the TATA box or initiation region. Another example is when some repressor 
proteins mediate deacetylation of histone N-termini. When promoter DNA is assembled 
onto a nucleosome with unacetylated histones, it also prevents binding of general 
transcription factors (Lodish et al., 2000). 
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Of interest here is that the gene products of transcription activators MGA2ϕ (modulated 
in this study) and SPT23ϕ are modifiers of transcriptional silencing in yeast, possibly 
effecting both repression and activation. Both MGA2 and SPT23 gene products have also 
been implicated in acetylation to modify chromosomal configuration – and can therefore 
be considered activators in this respect (Zhang et al., 1997; Dula and Holmes, 2000). 
 
Repression of hypoxia/anaerobic genes in yeast results from co-operation of Mot3p⊕ 
and Rox1p, the hypoxic regulon-specific protein in aerobic cells. Mot3, a DNA binding 
protein augments repression at tightly controlled genes e.g. ergosterol biosynthetic genes 
(Sertil et al., 2003). Rox1p, a HMG (high-mobility group) protein (Lodish et al., 2000), 
binds a specific sequence, assisted by the Tup1p/Ssn6p general repression complex 
(Zitomer et al., 1997) in upstream regions of ANB1 (encoding protein synthesis initiation 
factor eIF-4D) and HEM1 (encoding coproporphyrinogen oxidase) to repress 
transcription under aerobic conditions (Deckert et al., 1998; Mennella et al., 2003). 
Lowry et al. (1990) have identified a consensus operator sequence, YYYATTGTTCTC, 
which mediates the repression imposed by the ROX1 encoded factor upon the members 
of the hypoxic gene regulon, which include ANB1, HEM13 and COX5b (encoding a 
cytochrome 5b oxidase). The Tup1p/Ssn6p⊕ general repression complex in S. cerevisiae 
represses a variety of metabolic pathways. Tup1p is capable of repression through the 
positioning of a nucleosome over the TATA box, or a chromatin-independent 
mechanism (Deckert et al., 1998). The SSN6 gene product, a general transcriptional co-
repressor, acts together with Tup1p and also acts as part of a transcriptional co-activator 
complex that recruits the SWI/SNF and SAGA (Spt/Ada/GCN5/acetyltransferases) 
complexes to promoters (Bhaumik and Green, 2001). 
 
Derepression of a subset of genes takes place under hypoxia. The system by which yeast 
hypoxia genes are derepressed is a regulatory network. The biosynthesis of heme is 
                                                 
ϕ MGA2 = multicopy suppressor of gam1[snf2], SPT23 = suppressor of Ty-induced mutations 
 
⊕ MOT = Modifier Of Transcription 
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oxygen-dependant and heme functions as an inducer of HAP1 transcription. The Hap1p 
induces expression of the repressor ROX1 (Zitomer et al., 1997; Kwast et al., 1998). The 
reduced production of heme under hypoxia effects derepression, as the repression 
complex formation cannot form due to insufficient levels of Rox1p. 
One of the classification criteria of transactivators, to define the transcription activator 
based on the signal or signals it responds to, will be highlighted in the following 
discussion. 
 
2. General concept of metabolic flux and transcription factors 
 
Transcription factors unfortunately (or fortunately, as it provides another point of 
control) often respond to more than one signal. It is not possible to explain 
transactivation of a set of genes, and the metabolic sphere in which it plays a role in the 
cell, without referring to the signal or signals responsible for this cascade of events. 
Multiple sensing mechanisms may also exist especially in multi-cellular organisms, 
affecting different genes in the same way in different cells. However, signal transduction 
pathway components activated by different receptors (a receptor can be considered in 
this instance as molecules specifically activated by a specific signal) may often elicit 
different cellular responses (Lodish et al., 2000). Attempting to regulating metabolic 
flux is a challenge due to the various interacting pathways, multiple enzyme isoforms, 
and different substrates that are involved (Ismond et al., 2003). All enzymes in a 
pathway (and interacting pathways) take part in the flux control although to different 
extents. This implies control is shared between all enzymes in different proportions Ξ. 
Metabolic control analysis is the study of the relative control exerted by each step 
(enzyme) on the system's variables (fluxes and metabolite concentrations). Cellular 
metabolism is a molecular economy that is functionally organized into supply and 
demand blocks linked by metabolic products and cofactor cycles (Hofmeyr and Cornish-
Bowden, 2000).  
                                                                                                                                                
 
Ξ http://dbk.ch.umist.ac.uk/metab/mca_cc.htm
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 In this study, a transcription activator that responds to a specific signal is described as 
the ‘transducer’ of that signal. The transducer of the hypoxia signal that switches on a 
specific set of genes to cope with low oxygen levels will be the hypoxia transducer. To 
complicate the study of gene control, a transducer often responds to more than one 
signal due to the fact that its post-transcriptional processing or transcription can be 
influenced by other signals. This may also be the cell’s survival system to cope with 
environmental signals that affect similar metabolic pathways or cell structures.  
 
Often a general response can occur in cells when major pathways are affected 
simultaneously. In higher, multi-cellular eukaryotes, this response is present in a much 
broader sense, affecting different cell types. When human cells are exposed to a low 
oxygen level (hypoxia), a wide range of elevated expressions of genes that help the cells 
and tissues to cope are found. This multi-tissue response may imply the existence of 
multiple oxygen-sensing mechanisms in response to one signal (Semenza, 2000). For 
example, hypoxic cells upregulate erythropoietin, which stimulates red blood cell 
production, thereby increasing the blood's oxygen-carrying capacity. Likewise, hypoxic 
cells increase the expression of vascular endothelial growth factor (VEGF), stimulating 
vascular branching to improve tissue vascularization and oxygenation. In hypoxia cells, 
upregulation of glycolytic enzymes occurs to help them cope with the transition from an 
aerobic to an anaerobic environment.  
 
It should be apparent that to define the concept of regulation and metabolic flow (flux) is 
difficult, since the properties of a cell are not fixed. A thorough definition should 
indicate the complexity of the control and emphasize it as a multi-faceted control 
system. Control of enzymes catalyzing the reactions in a pathway to be express at the 
right ratios at the right time will depend on (among other factors) on differential 
transcription, controlled by transcription activators. To ensure metabolic flow 
regulation of the “regulators of pathways that enable the cells to switch to other 
pathways is necessary”(Lodish et al., 2000).  
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 A list of possible in vivo regulation sites will be discussed next. This is to emphasize the 
original problem stated: “regulation of transcription is complex as there is neither a 
beginning nor an end!” The question is: As regulation of transcription is complex, at 
what level (‘place, or site in vivo’) does one start to control activators? 
 
2.1 Multi-layered inter-linked control systems, effected at DNA, mRNA and protein 
levels, and back again to DNA level, mediated by signals 
 
Some indication will be given of regulation mechanisms found at different regulation 
sites in the cell, including some of the most recent discoveries made. This will also 
include some of those found in higher eukaryotes. The multi-layered inter-linked control 
systems, operating at DNA, mRNA and protein levels, and back again to DNA level, are 
discussed, to indicate the wide scope of control mechanisms at different levels. This is 
by no means a complete list of possible sites or mechanisms involved in regulation. A 
detailed discussion in the second part of this chapter will highlight specific proteins and 
their control mechanisms at some of these ‘sites’ and for some, at all of these sites. The 
levels of involvement between levels of control and the sites where control takes place 
will be illustrated in Fig.1.  
 
To mediate a change in metabolic flow if signals are changed, components (transcription 
factors/signal transducers) getting the message to the site of control are needed. Finally, 
fixed points (sites) where the molecular biologist can effect a permanent change reacting 
on the regulated signals are needed. Such a site of control may be the promoters as 
transcription regulator targets or the transcription regulators/signal transducers 
themselves. Control at other levels is possible, such as mRNA transcripts or co-factors, 
but is often difficult to manipulate, as most mechanisms are still unknown or complex. 
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The choice of host organism will also influence the design of a recombinant regulatory 
circuit as the substrate(s) fermentation conditions and intermediate or endproduct(s) 
could also function as signals. The yeast S. cerevisiae was chosen as host primarily due 
to its ability to produce ethanol (bio-fuel) under all oxygen conditions and, secondly 
since it is possible to manipulate genetically for simultaneous saccharification and 
fermentation into ethanol (Lissens et al., 2004).  
 
2.2 Transcriptional machinery in eukaryotes with yeast as a model 
 
The yeast cell, as a single cell eukaryote, can be used as an in vivo model system to 
study the transcriptional machinery of higher multi-cellular eukaryotes (Zitomer et al., 
1997). It is an ideal organism for which to study the effect of changes in the environment 
due to the direct exposure of the yeast cells to the environment, and subsequent 
immediate response. A multi-signal response can be studied easily and at low cost in 
either batch or chemostat cultures. S. cerevisiae’s entire genome is sequenced. Protein-
protein interaction studies to identify protein complexes were recently carried out for S. 
cerevisiae. The company Cellzome® tried to establish how expressed proteins are 
organized into functional units. The aim of these studies was to determine the functional 
organization of the yeast proteome by cataloging proteins and their interactions.♦ A 
complete gene function map may soon be possible when combining these data sets with 
in silico metabolic control analysis. (Metabolic control imaging is a quantitative 
sensitivity analysis of fluxes and metabolite concentrations attempted by several 
research groupsο). Reporter genes and gene transfer systems are available for a wide 
range of plant, mammalian and other organisms to study gene induction in 
Saccharomyces. Comparisons of gene regulation patterns and protein-protein interaction 
profiles could indicate the evolutionary divergence between species, as well as  
                                                 
♦ Cellzome®: Gavin and 37 colleagues (2002) engineered affinity tags onto yeast proteins, which they 
used to pull a protein and its associated partners out of exponential phase haploid cells, grown in YPD 
(yeast extract, peptone, dextrose) at 30 ºC. Protein complexes ranging in size from 2 to 83 components 
were found. The putative functions of Mga2p will be discussed later in more detail, based on studies of 
this protein-protein complex. 
ο http://jjj.biochem.sun.ac.za/database/cronwright and http://dbk.ch.umist.ac.uk/metab/mca_cc.htm
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Figure 1 Schematic outlay of the inter-linked control systems in cells at DNA, mRNA and protein levels. 
Arrows indicate interaction between pathways and transactivators.  
 
           The symbol indicates interaction with a transcription activator directly or indirectly. The 
interactions depend on the role that the transactivator plays in the cell and with which proteins it interacts 
to mediate pathway or global changes.  
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 conserved pathways. S. cerevisiae is a facultative aerobic organism and it is possible to 
evaluate gene expression under different oxygen conditions. Data obtained using S. 
cerevisiae may have applications in both obligate aerobic and anaerobic organisms. The 
Crabtree-positive yeast, S. cerevisiae is a unique organism, with an anaerobic redox 
regulation system, making it capable of surviving without oxygen. This makes it even 
more interesting to determine its differential metabolic control, as high flexibility in 
gene expression profiles is needed to regulate cell growth under such diverse conditions. 
An example is the glycerol-associated genes that appeared to be differentially co-
regulated in response to different oxygen levels (Costenoble et al., 2000). During 
fermentation, both anaerobiosis and osmotic stress control the expression of glycerol 
phosphate dehydrogenase (GPD) genes in Saccharomyces. Especially GPD2 plays an 
important role in the anaerobic redox balance (Ansell et al., 1997).  
 
Oxygen depletion in mammalian cells is more complex and can mediate a multitude of 
responses in different cell types. The similarities and differences to the mammalian 
(vertebrate) hypoxia response system that exists in Saccharomyces spp. can be exploited. 
Another way to determine the pathway control in higher eukaryotes is to start from the 
other end, by looking at diseases of higher eukaryotes, and determining the nature of the 
agents causing these specific symptoms. This can be confirmed and compared to in vivo 
gene knockout/mutational studies in yeast if the mutation is known and a similar 
metabolic pathway exists in the yeast.  
 
Data obtained with yeast models may not always be similar in higher eukaryotes. Greco 
et al. (2003) stated that in general the hypoxic regulation system appears to be affected 
by the cellular (cell type of higher eukaryotes) background, since different cell lines of 
diverse origin are characterized by different responses. Some of the differences found 
may be due to the use of different reporter gene assays.  
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2.3 Cellular response, due to a particular signal 
 
To determine the agents responsible for a specific signal response, it is important to 
establish the possible extent of response due to a particular signal. Which system(s) in 
the cell will be affected? Data obtained from DNA array studies are reported by 
grouping genes in biological functional categories. When the focus is on transcriptional 
regulation, it is clear that a multitude of systems exists that can be divided into two main 
groups. This is described by Tsukagoshi et al. (2001), as either pathway-specific 
regulatory systems that control a set of genes, e.g. genes that must be expressed to 
catabolize particular substrates, or as a wide domain of regulatory systems that affect 
many individual genes in different pathways. The general conclusion was made that 
many genes are subject to more than one regulatory system. Due to the external 
influence on cells, highly flexible gene expression programs are required to allow cell 
growth in the presence of a wide variety of chemicals (Lucau-Danila et al., 2003). 
 
 
 
3. Hypoxia as the signal to induce a ‘switch’ 
 
3.1 Introduction 
Hypoxia was chosen as the signal to induce a ‘switch’, firstly because it is a well-studied 
signal in both yeast and higher eukaryotes. Secondly, the response of cells to a change in 
oxygen level is done by a system of checks and balances. This not only means that it is 
able use this signal to switch genes on and off but it is also able to modulate 
regulation to get differential gene transcription. Oxygen levels are critical under 
hypoxia conditions as oxygen serves as a reactant in sterol and desaturation 
reactions, apart from its function in the maintenance of a redox balance (electron 
transfer function). Brewers routinely aerate the fermentation wort at the beginning 
before pitching the yeast (James et al., 2003) to avoid the requirement for addition of 
unsaturated fatty acids (UFAs) in fermentations, which is essential as the yeast cell can 
not synthesize UFAs under anaerobic conditions needed for continued sterol 
biosynthesis. In wine fermentation, regular aeration is a known practice. In my opinion 
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further fine-tuning of oxygen supply can be achieved by the periodic flushing/bubbling 
through of oxygen at different time-points. Hypoxia, or exposure to different oxygen 
levels, can be ‘used’ in an industrial production system. Optimal ethanol production will 
be enhanced, as oxygen levels will be controlled to prevent stress or the cessation of cell 
maintenance and growth (Franzén, 2003).  
3.2 Definitions of hypoxia  
 
Before going into details of the intricate hypoxia control found in higher organisms or 
the use of hypoxia as a signal to regulate transcription of a subset of genes, the terms 
‘hypoxia’ and ‘anaerobic’ need to be defined. The term ‘anaerobic’ should be reserved 
for conditions where all traces of molecular oxygen are removed. However, often 
oxygen levels are not measured during fermentation and traces of oxygen are difficult to 
detect. In the literature, genome-wide gene induction studies in yeast of hypoxia 
induction often do not extend to include their response to anaerobic conditions, or vice 
versa. The term ‘hypoxia’ is frequently used in this study, where it will imply low 
oxygen levels and possibly anaerobic conditions, as the oxygen levels were not 
quantified. Hypoxia, even as in this study, can also unintentionally and incorrectly refer 
to fully anaerobic conditions. 
 
The amount of oxygen required to catalyze enzyme reactions operating under hypoxia is 
unknown. In human leukemia cell-line studies mild hypoxia is described as 8% O2 and 
severe hypoxia as 1% O2 (Wellmann et al., 2003). In yeast, a ‘true’ hypoxia response is 
considered the immediate response after the oxygen level is reduced to below 1%. Ter 
Linde et al. (1999) profiled hypoxia induction of a laboratory strain of S. cerevisiae in a 
chemostat culture grown in low glucose medium, at three hours after induction. The 
effect of the hypoxia signal was directly compared to aerobic values. Fermentation 
studies by Franzén (2003) investigated the effects of a range of oxygen levels. A certain 
time window was observed where the ethanol and glycerol produced could define 
oxygen levels. This may have practical applications when using oxygen as a 
signal/switch in large-scale production systems. 
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 Unique electron transport and redox balancing systems (or upregulation of systems 
already in place) need to take place under hypoxia and, even more so, under full 
anaerobic conditions. A supply of the redox ‘ready’ proteins formed under aerobic 
conditions may provide the anaerobic cells with sufficient potential to survive until the 
cells are re-supplied with molecular oxygen. Yeast genes can be separated in aerobically 
expressed genes, anaerobically expressed genes, and then those genes expressed under 
both conditions. Another sub-group is the hypoxia genes with a profile of being induced 
to high levels when oxygen levels drop. This induction can be transient. In the next 
paragraphs, these different groups will be discussed in detail. However, care should be 
taken in measuring oxygen levels. Catabolic activities of Escherchia coli (and 
specifically its respiratory activity) are affected by the actual oxygen availability per unit 
of biomass rather than by the residual dissolved oxygen concentration of the culture 
(Alexeeva et al., 2002). Another factor to consider will be the overlapping of signals 
with hypoxia such as population pressure. Population pressure (high cell densities) could 
induce a specific set of genes. In E. coli a 10-fold-elevated level of trehalose at higher 
densities was found due to the increased role of the RpoS sigma factor, which controls 
trehalose synthesis genes as well as the general stress response (Liu et al., 2000). 
 
3.3 Signal transduction under hypoxia  
 
Transactivators involved in low oxygen-induction of hypoxia genes  
Mga2p mediates hypoxia-induced complex formation at the promoters of OLE1 and 
ATF1 genes in S. cerevisiae (Jiang et al., 2001). Other hypoxia-induced genes (e.g. 
DAN/TIR℘) are involved in the cell membrane fluidity (Abramova et al., 2001, Cohen et 
al., 2001) but Mga2p does not seem to play a role in their hypoxia regulation. OLE1 
transcription (needed for nuclear membrane integrity) decreases more than 15-fold in the 
absence of wild type Mga2p and its homologue Spt23p (Zhang et al., 1999). In 
                                                 
℘ DAN/TIR genes encode nine cell wall mannoproteins in Saccharomyces cerevisiae which are expressed during anaerobiosis 
(DAN1, DAN2, DAN3, DAN4, TIR1, TIR2, TIR3, TIR4, and TIP1),  
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mammalian cells, the hypoxia-inducible factor 1 (HIF-1), NF-kappaB and AP-1℘ sense 
hypoxia and other signals such as reactive oxygen species. During hypoxia, an increase 
in intracellular Ca(2+) activates a pathway in mammalian cells that involves AP-1-
dependent transcription (Salnikow et al., 2002). Hypoxia-inducible factor 1 (HIF-1), is a 
transcription factor that accumulates during hypoxia, stimulates genes involved in 
glucose metabolism, angiogenesis, and cell survival (Semenza, 2000). The NF-kappaB 
family of transcription factors control inflammatory and immune responses, apotosis and 
developmental processes (Baldwin, 1996).  
 
Derepression of oxygen-repressed genes  
Rox1p is implicated in repressing hypoxia/anaerobic genes in the presence of oxygen. 
The repressing complex mediated by Rox1p assembles and binds promoter elements to 
repress hypoxia-induced genes in the presence of oxygen. This entire system is linked to 
heme production in the cell – heme is generally considered the sensor of O2 in cells 
(Amillet et al., 1996. See remarks on HEM13 below). 
 
Redox regulation, hypoxia and reactive oxygen species (ROS) – an internal signal  
ROS may be the upstream ‘universal’ intracellular signal, serving as an oxygen sensor in 
higher eukaryotes as well as yeast. Interestingly, Veal et al. (2003) indicated that the 
protein Ybp1 is required for H2O2-induced expression of TRX2 in yeast and that the 
effects of Ybp1 are mediated through the Yap1 transcription factor (YAP1 = Yeast AP-
like transcription activator). Veal et al. (2003) described TRX2 as the antioxidant-
encoding gene. ROS are considered internal signals as they are generated in the 
mitochondrial respiratory chain due to a redox imbalance (Otani, 2004). In mammalian 
cells, ROS mediate signal transduction in the early phase of ischemia preconditioning (a 
condition that includes hypoxia) through the post-translational modification of redox-
sensitive proteins. A mechanism involves redox-sensitive activation of transcription 
factors through protein kinase C and tyrosine kinase signal transduction pathways. 
Targets of protein kinase C is the mitochondrial ATP-sensitive potassium channel and 
                                                                                                                                                
AP-1 = eukaryotic transcription factor, AP-l-like proteins contain a bZip structural motif consisting of a leucine-rich zipper region 
and an adjacent basic region that are important for dimerization and DNA binding, respectively (Veal et al., 2003). 
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translocation (Otani, 2004). Mga2p as a redox sensitive protein may sense ROS 
generated under aerobic conditions and this may be one of the reasons why Mga2p (and 
its homologue Stp23p) are expressed under aerobic conditions in yeast cells. The theory 
of ROS as common oxygen sensors has supporters and detractors. This will be discussed 
in more detail in the following section when the role of TRX2 is highlighted and in 
section 4.2.2 ‘Intracellular oxygen sensing’.  
 
A classification of hypoxia-induced genes  
Over the past ten years, hypoxia-induced gene expression profiles have been studied by 
a number of research groups. Ter Linde et al. (1999) carried out a DNA micro-array 
study of gene expression adaptation to aerobiosis and anaerobiosis in chemostat cultures, 
grown in a low-glucose medium, supplied with Tween 80 and ergosterol at pH 5.0. The 
majority of the yeast genes showed similar transcript levels under aerobic and anaerobic 
conditions. Expression of many of the hypoxia (low oxygen) genes only marginal 
increased above normoxic (normal oxygen) levels under full anaerobic conditions, but is 
induced to high levels at low O2 conditions. This induction pattern put these genes in a 
class of “true” hypoxia inducible genes. 
 
Hypoxia-induced genes in S. cerevisiae can be broadly classified in three groups. It has 
become clear that most hypoxia-induced genes are not actively induced under low-
oxygen conditions, but are derepressed. HEM13 falls in this class as it was derepressed 
up to 20-fold under hypoxia conditions (Amillet et al., 1996). Deregulating repression 
complexes in normoxic conditions can induce aerobic expression, but little can be done 
to increase gene transcription levels above normal levels. The second group of genes are 
expressed under aerobic conditions however, induced at higher levels under hypoxia 
(and showing a marginal increase above normoxic levels under anaerobic conditions). 
This group is described as hypoxia-inducible genes and the activation mechanism(s) 
involved is worth looking at. The OLE1 gene encoding Δ9 fatty acid desaturase is an 
example. The mRNA levels of OLE1 increased 1.3-fold above the baseline of aerobic 
(normoxic) >1% O2 levels. A 6-fold induction was found at extremely low O2 conditions 
(that is <1% O2 or < 0.5 μmol), above aerobic levels (Vasconcelles et al., 2001). Mga2p 
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plays a critical role in controlling OLE1mRNA stability suggesting that there may be a 
functional linkage between OLE1 transcription and the regulation of OLE1 mRNA 
stability (Martin et al., 2001; Kandasamy et al., 2004). The third group is one that can be 
described as aerobic/anaerobic genes. Expression was found for these genes under both 
aerobic and hypoxia/anaerobic conditions. Hypoxia/anaerobic induction levels are for 
most genes often at a slightly reduced level compared to aerobic conditions (ter Linde et 
al., 1999, James et al., 2003). It does mean constitutive expression at different levels 
under both conditions. Most genes fall under this group and their expression levels can 
be far higher (even under hypoxia conditions) compared to the highest levels of 
expression of hypoxia genes. An example of this class is ENO1, encoding enolase I (ter 
Linde et al., 1999). However, few genes have been characterized under all oxygen 
conditions and strains may differ in response to different oxygen levels (James et al., 
2003). James et al. (2003) used DNA arrays studies to compare expression levels of an 
industrial brewery strain under anaerobic conditions at day one compared to expression 
levels at day three and eight. However, this group stated that absolute values for 
transcript levels cannot be extrapolated as laboratory and industrial strains have 
differences both in nucleotide sequence identity and copy number of various genes. 
Constitutively expressed genes, under all oxygen conditions, made the search for 
hypoxia promoters (see Chapter III) redundant when the emphasis shifted to control 
rather than overproduction.  
 
A fourth class of genes expressed only in the presence of >1% O2 does not fit under the 
description of hypoxia genes. These can be classified as non-hypoxic/non-anaerobic 
genes or true aerobic genes. Again, repression may be present under anaerobic 
conditions.  
 
3.4 Other signals overlapping with the hypoxia signal 
 
 
Screening in the fermentation/degradation ‘background’ to be used is essential before 
repression/induction by hypoxia can be considered as the only signal involved. This is 
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essential, before attempting large-scale fermentation studies. Other signals can mask the 
effect of oxygen levels on gene expression and can differ from gene to gene. 
Concentrations of the substrate, intermediates formed (especially glucose) and 
conditions (pH and temperature) under which fermentation will take place, as well as 
supplements added, such as unsaturated fatty acids, may influence hypoxia induction.  
 
3.4.1 Unsaturated fatty acids and hypoxia 
An overlap in unsaturated fatty acids and hypoxia signal response exists for the OLE1 
gene. OLE1 expression is repressed by unsaturated fatty acids and induced by oxygen-
limited conditions. The addition of unsaturated fatty acids to the culture medium 
moderately represses the processing of the hypoxia transcription activator Mga2p, 
thereby repressing its ability to upregulate OLE1 transcription under hypoxia (Hoppe et 
al., 2000). Kandasamy et al., (2004) found that UFA repression is also mediated by 
Mga2p. Mga2p appears to have two distinct functions with respect to the OLE1 mRNA 
stability, a stabilizing effect in cells grown in fatty acid free medium, and a destabilizing 
function with respect to OLE1 mRNA, in cells that are exposed to unsaturated fatty 
acids. 
 
The addition of an ergosterol/Tween 80 mixture (often used in laboratory-scale 
experiments) is considered an addition of UFAs as Tween 80 contains a mixture of 
different UFAs. Anti-foam agents also often contain unsaturated fatty acids. A hypoxia-
induced complex binds at a low-oxygen response (LOR) element, at the OLE1 promoter, 
to induce expression (Jiang et al., 2001; Vasconcelles et al., 2001). Inclusions of further 
upstream sequences, which include fatty acid response (FAR) elements of OLE1, also 
enhance hypoxia-induced expression (Martin et al., 2001). Exogenous saturated fatty 
acids induce OLE1 transcription 1.6-fold, but UFAs repress transcription 60-fold. The 
FAR element upstream sequences also contribute to OLE1 repression by UFAs (Choi et 
al., 1996; McDonough et al., 1992). The overlapping of hypoxia and UFA signals for 
OLE1 transcription is mediated by the transcription activator Mga2p and its homologue 
Spt23. UFAs repress the Mga2p-LOR element interaction. Hypoxia induction results in 
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a 5-fold increase of the soluble form of Mga2p above levels found at normoxic 
conditions, but only in the absence of UFAs (Chellappa et al., 2001).  
 
UFAs also prevent processing of the Mga2p’s homologue, Spt23p, into its active form. 
The effect of UFAs on Spt23p processing is more severe than in the case of Mga2p 
(Chellappa et al., 2001). If the processing of Mga2p can be modulated, and/or if it could 
be targeted to a chimeric promoter, it may be released from UFA repression if the 
regions that differ from Spt23p are used to build a chimeric transactivator. Avoiding 
regions conferring UFA repression may mean that hypoxia induction can also be 
eliminated, due to the overlapping of the downstream regulation sites at a singular or 
multiple domains (or motifs) of hypoxia and UFAs mediated by Mga2p.  
 
When a signal effects the transcription of an activator the question can be asked: What is 
the function of the effect of the specific signal in the cell? It was speculated that, due to 
differential repression control effected by UFAs (and especially different types of UFA, 
with different carbon lengths and levels of saturation), membrane fluidity is regulated 
(Nakagawa et al., 2003). Differences in the rates of fatty acid (FA) import or 
intracellular movements that could change concentrations of FA or UFA levels, a sensor 
or sensors could be triggered to mediate regulatory change to increase or decrease 
membrane fluidity. In S. cerevisiae, Ole1p, the delta-9 fatty acid desaturase is involved 
in the formation of unsaturated fatty acids from saturated acyl-CoA precursors (Choi et 
al., 1996, Gonzalez and Martin, 1996). In this regulation system (circuit) the sensing of 
membrane fluidity will determine the increase or decrease uptake of FA and/or increase 
or decrease of desaturase (Ole1p) activity. Utilizing fatty acids as energy supply may 
also be a function of an UFA signal response. Especially under hypoxia conditions, the 
yeast cell needs to redirect metabolic pathways, upregulate certain pathways and down 
regulate others, to survive.  
 
3.4.2 Role of the transactivator Mga2p 
It can be speculated that the main function of the yeast transactivator Mga2 protein is to 
sense membrane fluidity via a change in unsaturated fatty acid/fatty acids content in 
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membranes and to mediate the appropriate response by induction of a set of genes. With 
further investigation into the function of these genes, it seems as if they may also play a 
role in energy production. These gene products are involved, or may be involved, in 
redox balancing, electron transfer and acetyl group transfer. A putative link exists 
between the functions of genes affected by Mga2p and Mga2p’s involvement in zinc 
toxicity and sterol metabolism and will be discuss in detail in the next paragraphs. 
Unsaturated fatty acids and fatty acids ratios, ergosterol storage and sterol synthesis are 
linked via OLE1. It can be speculated that Ole1p may play a central role in using fatty 
acids as energy source, in addition to its role in the regulation of membrane fluidity. The 
genes upregulated by Mga2p and their respective functions or putative functions are 
summarized in Fig.2. Since the discovery of Mga2p as the yeast hypoxia transcription 
activator, experimental research done by Hitchcock et al. (2001), Chellappa et al. 
(2001), Rape et al. (2002), Jiang et al. (2002), Shcherbik et al. (2003), Nakagawa et al. 
(2002), Nakagawa et al. (2003), and Kandasamy et al. (2004) concentrated on 
elucidating the post-transcriptional processing of Mga2p and on the role that Mga2p 
might play in mediating other responses. The interplay between unsaturated fatty acid 
and hypoxia signals control seems to be mediated through the post-translational 
processing of Mga2p to regulate membrane fluidity. As mention earlier in this chapter, 
the Mga2p and its homologue Spt23 have been implicated in dose-dependent repression 
of Ty-induced mutations and Ty1 transcription (Zhang et al., 1997), membrane integrity 
(Zhang et al., 1999) and as modifiers of transcriptional silencing (Dula and Holmes, 
2000). Recently, Lyons et al. (2004) indicated the role that Mga2p plays in the 
metalloregulation of yeast membrane steroid receptor homologues, again indicating a 
role in regulating membrane fluidity.  
 
In yeast, different pathways and their products can affect cell wall integrity. This may 
depend on many factors, e.g. on the cell cycle stage or the carbon source. However, at all 
times the fluidity of all membranes, cell wall membranes or those of organelles and 
nuclear membranes, have to be regulated by means of UFA content. Mga2p (and its 
homologue Spt23p) stands central to this control mechanism as indicated by the genes 
under its control described in Fig.2. Signals that will effect changes in cell membrane 
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fluidity (and influence permeability of cell walls) mediated by Mga2p include a change 
in temperature, a reduction in oxygen availability and possibly a change in alcohol 
levels. Mga2p is regulated by a change in the FA/UFA ratio, indicating a controlled 
feedback regulation of the system. 
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Figure 2 The functions of Mga2p regulated genes. [Those indicated in brackets are putative Mga2p 
targets].  
*OLE1 has a desaturase function and a region similar in structure to the cytochrome b with putative 
electron transfer function. 
 
Mitchell and Martin (1995) eloquently describe the function of the integrity of the cell 
wall structure: “Membrane fluidity is of central importance for the function and integrity 
of the membrane system of the cell. It is essential for the mobility of embedded proteins 
and for forming membrane curvatures, which in turn are required for the formation of 
organelles, the vesicular system, and the nuclear envelope. A crucial parameter that 
determines membrane fluidity is the balance between saturated and unsaturated fatty 
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acids. Unsaturated fatty acids (UFAs) are formed at the surface of the endoplasmic 
reticulum (ER) by fatty acid desaturases, which convert coenzyme A (CoA)-bound 
saturated fatty acids to unsaturated fatty acids by introducing double bonds in the carbon 
chains”. UFA ratios in the cell membrane may be related to ethanol tolerance, heat 
shock response, and mitochondrial movement and inheritance, and determine the cell's 
ability to take up compounds or excrete metabolic end-products (Mitchell and Martin, 
1995). 
 
 
3.4.3 Other functions of transactivator Mga2p
 
Mga2p, linking cell wall integrity and carbon source metabolism 
Cell wall integrity is affected by carbon source metabolism (Palecek et al., 2002). The 
role of glucose should be highlighted, and it is not surprising to find a putative link for 
Mga2p in this regulation. The SNF1 gene product mediates glucose repression of 
multiple genes involved in invasive growth and the Snf1p can function as both activator 
and repressor. It was found that the high levels of Mga2p or Spt23p suppress defects 
caused by loss of Swi/Snf components (Zhang et al., 1997). Swi/Snf complexes 
comprise nine or more proteins, including both conserved (core) and nonconserved 
components; the Swi2/Snf2 ATPase is one of the core components (for more detail see 
section 3.4.4. ‘Glucose and hypoxia crosstalk’).  
 
Mga2p and regulation of sterol levels 
Mga2p may also regulate sterol levels in cells under hypoxia. Intracellular lipid particles 
in eukaryotic cells function as storage for components needed for membrane formation. 
If sterols are depleted and/or uptake from extracellular supplies is prevented, sterols are 
released from steryl esters of lipid particles to be incorporated into cell membranes 
(Leber et al., 1994). Even the enzymes involved in these rescue reactions are stored. 
Stored proteins of lipid particles identified are those involved in ergosterol synthesis: 
Erg1, Erg6p and Erg7p, (Erg = Ergosterol biosynthesis) as well as those involved in 
fatty acid metabolism: Faa1p, Faa4p, (Faa= Fatty Acid Activation) and Fat1p (Fat = 
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Fatty acid transporter). The upstream region of the OLE1 promoter contains FAR (Fatty 
Acid Response) promoter elements, the binding sites of proteins Faa1 and Faa4. These 
elements are involved in response to the unsaturated fatty acid depletion signal mediated 
by Faa1p and Faa4p (Choi et al., 1996; Nakagawa et al., 2003).  
  
A putative role of Mga2p in energy supply and redoxs sensing 
It is possible that Mga2p regulation will respond to changes in membrane lipid 
composition and internal free fatty acid or fatty acyl coenzyme A pools. Speculations of 
a putative role of Mga2p in energy supply control are based on the genes under its 
control and some homology to domains of proteins functioning in these pathways.  
 
The energy control function of Mga2p may indicate a possible link of OLE1 to the other 
hypoxia-induced Mga2-mediated gene ATF1, an acetyl transferase-releasing coenzyme 
A that transfers an acetyl group from acetyl-CoA to isoamyl alcohol. In Fig.3 the 
schematic outlay of the putative link of all genes under Mga2p control and their 
respective functions are illustrated. Mga2p and Stp23p are involved in hypoxia 
upregulation of a desaturase (encoded by OLE1), a thioreductase (encoded by TRX2) and 
an alcohol acetyl transferase coenzyme enzyme (encoded by ATF1), an enzyme that 
targets a thiol. The question can be asked: Can thiols and disulfides provide the redox 
function under hypoxia/anaerobic conditions normally provided by oxygen or in 
oxygen-independent reactions? The functions of Mga2p regulated genes are summarized 
in Fig.2.  
 
The Ole1p has a dual function in the cell. Its desaturase activity, located at the N-
terminal domain of the proteins, is responsible for the conversion of fatty acids to 
unsaturated fatty acids. Ole1p can catalyse the desaturation of a wide range of substrates, 
ranging from C12 to C19 carbon saturated fatty acids. Interestingly the C-terminal of 
Ole1p is similar to the cytochrome b5 enzyme (Cytb5) (Mitchell and Martin, 1995). 
Cytochrome b5 has been implicated as a component of the electron transfer cycle for 
some cytochrome P450’s. Cytochrome p450’s do not operate on their own, they require 
electron donors. Cytochrome b5 may enhance cytochrome p450 activity or may alter the 
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reaction undertaken by some cytochromes P450. Cytochrome c oxidase (COX), the 
terminal enzyme of the mitochondrial respiratory chain, catalyzes the transfer of 
electrons from reduced cytochrome c to molecular oxygen (Lodish et al., 2000).  
 
Cytochromes p450 that require electron donors in S. cerevisiae are sterol 14α-
demethylase, sterol 22-desaturase, squalene epoxidase (all three involved in the 
ergosterol/sterol biosynthetic pathway) and an enzyme involved in yeast sporulation. 
Interestingly, the cytochrome b5/NADPH cytochrome b5 reductase complex was shown 
to drive fungal C14-demethylation of lanasterol by a sterol 14α-demethylase (Lamb et 
al., 1999). The yeast cytochrome b5/NADPH cytochrome b5 reductase complex, 
donating both electrons, is needed, in contrast to the mammalian system where it donates 
the second but not the first electron. The yeast cytochrome b5/NADPH cytochrome b5 
reductase electron transport pathway is also involved in other non-cytochrome P450 
reactions of sterol biosynthesis and fatty acid metabolism. In these reactions, an 
involvement under hypoxia conditions is possible, by the Ole1p as electron carrier due 
to its cytochrome like C-terminal (Mitchell and Martin, 1995). Ole1p plays a role as 
electron donor in both P450 reactions and non-P450 reactions. Fah1p, another S. 
cerevisiae protein with a cytochrome b5-like region, functions in very long chain fatty 
acid hydroxylation, using an alternate electron transfer mechanism (Mitchell and Martin, 
1997). Cytochromes are proteins covalently linked to a heme molecule, an iron-
containing prosthetic group similar to that in hemoglobin or myogloblin. Electron 
transport occurs by oxidation and reduction of the iron (Fe) atom. Cytochrome b-type 
NAD(P)H oxidoreductases function in iron uptake in yeast. Zhu et al. (1999) identified a 
mammalian cytosolic cytochrome b-type NAD(P)H oxidoreductase, a flavohemoprotein, 
containing cytochrome b5 and b5 reductase domains, which they thought could play a 
role in oxygen sensing. 
 
Another Mga2p-regulated gene, ATF1, (Vasconcelles et al., 2001) can provide the cell 
with free CoA (Fig.3). This ability to transfer an acetyl group and then release CoA puts 
this enzyme in the central node of metabolic pathways in the cell. ATF1 effects the 
removal of an acetyl group and the production of free CoA by removing the acetyl-
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group from acetyl-CoA (a thiol) and transferring it to e.g. an alcohol, to form the volatile 
ester, isoamyl acetate. Normally ester synthesis (from medium-chain fatty acids and 
ethyl esters) is a consequence of the arrest of lipid biosynthesis resulting from a lack of 
oxygen. Bardi et al. (1998) proposed that under these conditions an excess of acyl 
coenzyme A will be produced. The acyl-esters are formed as secondary products of 
reactions aimed at recovering free coenzyme A. A similar role of ATF1 and ATF2, 
freeing CoA from acetyl-CoA by converting isoamyl alcohol into volatile esters, may be 
possible. 
 
Does Mga2p sense redox change via thiol disulfide oxidoreductases?  
This overview indicates which molecules the cell uses to sense and transfer a hypoxia 
signal, and why. How will the yeast cell sense hypoxia? Transcription of many genes 
that are upregulated by low oxygen levels encode genes that function in oxygen 
utilization pathways, e.g. oxidases involved in electron transport, reductases and 
desaturases involved in the biosynthesis of heme, sterol and unsaturated fatty acids. 
Heme A, a prosthetic group of cytochrome oxidase (COX) (Barros and Tzagoloff, 2002) 
that carries oxygen, has been called the oxygen sensor. The redox-state of a heme 
protein is most probably the sensor for changes in oxygen concentration. Kwast et al. 
(1999) suggested that cytochrome c oxidase is the oxygen sensor for hypoxic signal 
transduction in S. cerevisiae. Cytochrome c oxidase, the terminal enzyme of the 
mitochondrial respiratory chain, catalyzes the transfer of electrons from reduced 
cytochrome c to molecular oxygen. A di-iron moiety present in the Ole1p may be 
responsible for this sensing and electron transfer (Fig.3 - Please note that some of the 
links indicated are highly speculative). Driving of redox reactions by oxygen is the main 
function of oxygen but not the only function in the yeast cell and has an effect on the 
turnover of reducing equivalents. Franzén (2003) refers to the indirect effects of oxygen 
on growth and fermentation capabilities. The main function of oxygen can also be 
described as its involvement in energy production by aerobic oxidation of pyruvate in 
the mitochondria, producing the bulk of ATP (cell fuel). When driving redox reactions, 
oxygen is involved in transferring electrons and functions as the final electron acceptor.  
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R-(CH2)nCOOH (Fatty acid ) + (Coenzyme A) HS – CoA  ( a THIOL)
 ( R-  (CH2) n COO -)
ATP
Carnitine                                                             mitochondria
R-(CH2)nCOO - SCoA (Fatty acyl CoA ) + AMP + PP i ( inorganic pyrophosphate)
Ole1p encodes a desaturase but also has cytochrome b-like
domain
-domain.
- converting saturated fatty acids to unsaturated fatty acids and possibly
produces ATP                                                                         AMP ATP  ?
Fe Fe      catalytic center binds O2
Ole1p : N- desaturase - catalytic center e- transfer - cytochrome b -like domain -C
Trx2p   -   thioreductase may be involved in electron transfer
  -  ‘sensing’  reactive oxygen species
  R –  CH =CH - COOH
(
    ( unsaturated fatty acid)  + HS-CoA (THIOL)
The desaturase reaction will deliver a free thiol that can be recycle or acyl- or acetylated.
HS-CoA (THIOL)   & acetyl or acyl-groups
Cytosol
             Acetyl -S-CoA or Acyl –S-CoA
(Acetyl-CoA is the intermediate in numerous biosynthetic pathways and the precursor of
Steroids)
Atf1p converts isoamyl alcohol to a volatile ester
by transferring the acetyl group from acetyl-S-CoA, releasing free CoA.
Acetyl-S-CoA & isoamyl alcohol
Atf1p alcohol acetyl transferase
        Iso-amyl esterase (volatile) + HS-CoA Membrane fluidity & permeability is determine by FA/UFA ratio
Cell membrane
 
Figure 3 A schematic representation (based on published data available or my opinions/speculations 
discussed in text) indicating the functions (some putative) of gene products encoded under Mga2p control. 
A putative role for the Ole1p is indicated in ATP production with a broken black arrow. Broken gray 
arrows indicate the putative supply of thiols to enhance the conversion of fatty acids to unsaturated fatty 
acids. All other reactions (conversion of fatty acids to unsaturated fatty acids, desaturase of fatty acids and 
acetyl transferase reactions) are indicated with a solid black line. 
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Functions of oxygen need to be upregulate or replaced by other molecules under hypoxia 
conditions. Kwast et al. (1998) hypothesized that metabolic flux can be effected by 
increasing the efficiency of oxygen usage by e.g. hypoxia isoenzymes. This may involve 
different pathways and probably different sensors. Relevant to this study is the 
indication of cytochrome molecules (or its heme moiety) as possible oxygen sensors. 
Ole1p may be involved in the energy (ATP) production when oxygen levels are low. 
The type of genes regulated by Mga2p overlaps with sensing membrane fluidity as well 
as coping with the effects of hypoxia, as indicated in Fig.3. The Ole1p may function as 
an electron carrier itself – but its putative involvement with thio-esters may indicate the 
true carrier of electrons as iron-sulfur clusters. (Similar to NADH-CoQ reductase with a 
prosthetic FeS group of the electron transport chain (Lodish et al., 2000)). Trx2p, one of 
S. cerevisiae’s thioreductases, is essential for Yap1-dependent resistance to 
hydroperoxides and thus oxidative stress. Pre-existing Yap1 protein modification 
mediates an increase in Yap1-specific DNA-binding (Kuge and Jones, 1994). Northern 
blot analysis of several hypoxia and cobalt-induced genes was done by Vasconcelles et 
al. (2001). The TRX2 promoter was included in these studies as it contains exactly the 
same core LOR element as the OLE1 promoter. Elevated TRX2 mRNA levels were 
found under all conditions tested, normoxic (aerobic), hypoxia and cobalt. In vitro, 
electrophoretic mobility shift assay (EMSA) studies indicate that a hypoxia-induced 
complex is formed with the potential LOR elements from the ATF1, TRX2 and SUT1 
genes. Vasconcelles et al. (2001) indicated (using Northern blot analysis) hypoxia 
induction of not only ATF1 and TRX2 but also SUT1, encoding a hypoxia transactivator 
involved in sterol uptake (Ness et al., 2001). 
 
A study by Crow and co-workers (2004) showed the link between heme and thiol 
disulfide oxidoreductases, cytochrome c maturation systems and cellular disulfide-bond 
formation machinery for bacteria. This study indicated that thioreductases play an 
essential role in the oxygen-sensing system in bacteria. It can be hypothesized that as 
reductases can be regulated it may function as gauges. Reductases are possible targets in 
the cells that may affect metabolic processes under low oxygen conditions or oxidative 
stress caused by hydroperoxides (Kuge and Jones, 1994), also in higher eukaryotes 
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(similar to the putative role suggested for yeast thioreductase encoded by TRX2). Crow 
et al. (2004) stated that the post-translational maturation of cytochrome c involves the 
covalent attachment of heme to the Cys-X-X-Cys-His motif of the apo-cytochrome, if 
the two cysteines of the motif are in the reduced state. In bacteria this is mediated by the 
membrane-bound thiol disulfide oxidoreductases, with a high reducing power, which are 
essential components of cytochrome c maturation systems, linked to cellular disulfide-
bond formation machinery. This system resembles the overall function of the genes 
regulated by Mga2p, as illustrated in Fig.3.  
 
Depletion of the cellular pool of glutathione is detrimental to eukaryotic cells and in S. 
cerevisiae leads to sensitivity to oxidants and an eventual cell cycle arrest. Wheeler et al. 
(2003) indicated that Yap1p and Met4p transcription factors regulate the expression of 
gamma-glutamylcysteine synthetase (GSH1), encoding the rate-limiting enzyme in 
glutathione biosynthesis to prevent the damaging effects of glutathione depletion. They 
found that that glutathione depletion in S. cerevisiae appears to result in Yap1p 
activation via oxidation of thioredoxins, which normally act to down-regulate the Yap1-
mediated response. Transcriptional profiling of a gsh1 mutant (Wheeler et al., 2003) 
indicated that glutathione depletion leads to a general activation of Yap1 target genes. 
Since the oxidation of -SH groups is one of the earliest observable events during 
oxidant-mediated damage it shows the important role redoxins and specific –SH group 
as sensor and transducer of a change intra- or extracellular change plays in redox 
homeostasis in S. cerevisiae. Oxidation in response to changes in the environment of the 
-SH groups play a critical role in the function of many macromolecular structures 
including enzymes, transcription factors and membrane proteins. 
 
Is there an overlap of the regulation of intracellular zinc levels by Mga2p with lipid 
or sterol metabolism regulation? 
With toxic metal ion-exposure the Mga2p hypoxia sensor mediated the induction of 
YOL002c and YOL101c. This was found in a study of how the yeast cell regulates the 
zinc concentration to maintain cellular zinc within an optimal range (Lyons et al., 2004). 
Regulation of zinc intracellular levels is important, as zinc can be toxic to the cell. The 
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Zap1 protein is center to this intricate mechanism that senses zinc deficiency and 
responds by upregulating genes involved in zinc metabolism. Lyons et al. (2004) 
confirmed that YDR492w and YOL002c are direct Zap1p target genes. However, 
expression of YOL002c and a homologue, YOL101c, were induced by a high zinc 
content. In addition, YOL101c was induced by deletion of the Aft1p, an iron-responsive 
transcription factor. Interestingly, these high zinc induced genes are regulated by 
exogenous fatty acids, suggesting a dual role in lipid metabolism.  
 
It may be speculated that Mga2p plays a role linking hypoxia response to the 
overlapping signals of steroid and lipid (saturated and unsaturated) levels or a response 
to metals (cobalt and zinc) that overlaps with lipids (fatty acids). Mga2p does sense 
membrane fluidity and is involved in protecting the cell against toxic levels of zinc 
(Lyons et al., 2004). It may possibly be involved in a response to cobalt, and mediate an 
increase in electron transfer capabilities under hypoxia (that may be link to ATP 
production). In the peroxisome, oxidation of fatty acids produces heat. Fatty acyl groups 
transferred to carnitine can be moved across the mitochondrial membrane, and acyl - 
fatty acids in the mitochondria are converted to ATP (Lodish et al., 2000).  
 
The other possibility is cytosolic ATP production as suggested in Fig.3. Ole1p encodes a 
desaturase but also has a cytochrome b -like C terminal domain that might indicate that 
Ole1p plays a role in ATP production. The missing component is a proton-motive force 
unless this ATP production is similar to the glycolytic pathway ATP production in the 
cytosol. Atf1p may function by providing free coenzyme A (CoA). Acetyl or acyl 
groups, originating from proteins/fat/acetic acid or carbohydrates can be added to the 
thiol producing acetyl-CoA (Fig.3). 
 
 
3.4.4. Glucose and hypoxia crosstalk
 
Under full aerobic conditions in S. cerevisiae, the fermentative metabolism is active.  
S. cerevisiae is able to ferment under aerobic conditions and repress respiration (not 
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shutdown as substantial respiration are still present) when high glucose levels are sensed 
(Dejean et al., 2002). Under hypoxia, the availability of both carbon source and nutrient 
levels play a major role and overlap with hypoxia. Glucose, as the preferred carbon 
source of yeasts and the endproduct of most degradation pathways of complex carbon 
sources, is important when regulatory pathway manipulations are considered due to 
feedback regulation. Different sets of genes are activated (or repressed) at different 
glucose concentrations. A mammalian system identified in controlling pyruvate 
dehydrogenase expression by competition of hypoxia and glucose to mediate activation 
via a single element will be discussed and sharing of co-factors in repressor complexes 
by glucose and hypoxia. 
 
Glucose-mediated repression uses the same co-factors as hypoxia repression 
The same adapter proteins that are involved with the complex of the Rox1p-mediated 
hypoxia gene repression play a role in glucose repression. Rox1p complexes to 
Tup1p/Ssn6p, to repress aerobic expression of certain hypoxia-induced genes (e.g. 
ANB1, ORF YJR047c, encoding protein synthesis initiation factor eIF-4D and HEM13 
an essential gene in oxygen carrier-heme production) in yeast (Deckert et al., 1998; 
Mennella et al., 2003). In the presence of glucose, the Nrg1p repressor (a 25-kDa C2H2 
zinc finger protein) complexes with Tup1p/Ssn6p and represses the glucose- and Snf1p-
regulated STA1 (glucoamylase) gene. STA1 is involved in invasive growth. Nrg2 is a  
C(2)H(2) zinc-finger protein that is homologous to Nrg1p. Nrg2 also interacts with Snf1 
in the yeast two-hybrid system. The Snf1 protein kinase is essential for the transcription 
of glucose-repressed genes in S. cerevisiae and mediates glucose repression of multiple 
genes involved in invasive growth (Park et al., 1999). Cell wall integrity of yeast cells 
are affected by carbon source metabolism (Palecek et al., 2002) as well as hypoxia. An 
interesting link between the sensing energy supply and hypoxia is the ability of the yeast 
hypoxia transcription activator Mga2p to suppress snf2 mutations in some contexts. 
Snf2p is needed for raffinose, galactose and sucrose catabolism and required for the 
transcription of STA1 which encodes an extracellular glucoamylase in  
S. cerevisiae var. diastaticus (‘MGA’ stands for multicopy suppressor of gam1(snf2)) 
(Yoshimoto and Yamashita, 1991).  
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Passoth et al. (2003) found a hypoxia response element (AACATACGATCCGTT) at 
the yeast P. stipitis ADH2 promoter mediating hypoxia upregulation. This element 
sequence match four out of six with the relax consensus sequence bound by the HIF-1-α 
((C/G/T)ACGT(G/C)C(G/T) hypoxia transactivator protein found in mammalian cells. 
It is interesting that Krones et al. (2001) found that the HIF-1-α protein could replace 
under venous pO2 (hypoxia conditions) a glucose-dependent upstream stimulating factor 
at the liver L-type pyruvate kinase promoter, which binds normally under arterial pO2 
(aerobic conditions). This stimulation takes place under high glucose conditions. The 
HIF-1-α protein preferably bound glucose response E-box elements (consensus sequence 
CACGTG) when oxygen levels are low, even when glucose is present. In mammalian 
cells, an upregulation of glycolytic enzymes occurs to help cells to cope with the 
transition from an aerobic to an anaerobic environment. When the  
P. stipitis HIF-1-like element was cloned as a promoter element in S. cerevisiae, it did 
not effect a similar response. These findings indicate the possible differences between 
respiratory yeast and mammalian cells, compared to facultative yeast-like S. cerevisiae. 
The HIF-1 hypoxia-mediated induction system seems to be a system unique to ‘aerobic’ 
organisms and could probably be linked to glucose metabolism. It can be speculated that 
some differentiation had to take place during evolution for yeast to survive the different 
environments they encountered. It would be interesting to know if S. cerevisiae ‘lost’ 
this specific pathway or if P. stipitis acquired this pathway of control.  
 
3.4.5 Hypoxia, low temperature signal and pressure 
 
Mga2p also responds to low temperatures (Nakagawa et al., 2002) (For detail discussion 
see section 8 and Chapter II). Signals ‘available’ under fermentation conditions are low 
temperatures and osmo-pressure due to high sugar content in wort (relevant in beer 
production) or hydrostatic pressure, due to fermentation in an enclosed system, or any 
combination of these (Palhano et al., 2004). Pressure and release of pressure were also 
observed to affect hypoxia and anaerobic induction under experimental conditions in this 
study due to pressure created by the enclosed system used (see Chapter II for more 
detail). 
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4. Oxygen sensing and signal transduction in mammalian cells  
 
 
It is impossible to explain hypoxia induction in yeast without reference to the 
discoveries made in mammalian hypoxia responses. A link between thiol compounds 
(containing sulphydryl groups), hypoxia response and membrane fluidity, suggested for 
Mga2p in Section 3.4.3, was also indicated in mammalian cells (Haddad, 2002, Haddad 
et al., 2002). The mammalian HIF-1-α, activated by reducing, and the NF-kappaB, 
activated by oxidizing signals, are redox-sensitive transcription factors regulating the 
expression or suppression of O2-responsive genes in mammalian cells. Thiol redox 
balancing, facilitated by a shift in glutathione-SH / glutathione-SS-glutathione 
equilibrium, controls mammalian hypoxia transactivators (Haddad, 2002, Haddad et al., 
2002). In mammalian neuron cells, the overexpression of protein-disulfide isomerase in 
neurons protects them against active cell death induced by hypoxia/brain ischemia. 
Ubiquilin (ubiquilin contains multiple ubiquitin-related domains) was found to interact 
with protein-disulfide isomerase (Ko et al., 2002). More will be said about the role of 
ubiquilin later in this chapter (Section 7) to indicate another control pathway shared by 
yeast and mammalian cells. 
 
An example of modifiers of di-sulfide bonds and the membrane cholesterol balance 
playing a similar or overlapping role was indicated by Parker et al. (2002) in 
neuroreceptors. A reserve of neuroreceptors stored in the membrane compartment can be 
accessed by alteration of the sulphydryl balance or affecting the fluidity of the cell 
membrane.  
 
 
4.1 An introduction - Hypoxia as a signal in mammalian cells 
Mammalian hypoxia transactivators play an important role in diseases (Epstein et al., 
2001). Control mechanisms of these transactivators are intricate. Hypoxia is a major 
subject in mammalian systems as there is a whole subset of genes only expressed or 
upregulated under hypoxia conditions. Most of the hypoxia-response proteins in 
mammalian systems are controlled by an elegant system of post-transcriptional control 
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of the hypoxia transactivators. Two of the three mammalian hypoxia ‘transactivators’ 
(AP-1, HIF-1 and NF-kappaB) control mechanisms will be compared to Mga2p. A 
detailed description of hypoxia regulation will not be attempted. The focus will be on 
those mechanisms that may be relevant to systems found in yeast. 
 
4.1.1. The hypoxia induced factor (HIF) 1-α   
The hypoxia-induced factor (HIF) 1-α is called an infamous molecule as, when 
unchecked, it also turns on genes that enhance tumor growth. HIF-1-α protein was 
overexpressed in 68% of different clinical tumors (Zhong et al., 1998). In the 
mammalian system, the hypoxia-induced factor complex contains two proteins, HIF-α 
and HIF-ß. The α subunit mentioned above is rapidly degraded under normal oxygen 
concentrations, but it is stabilized under hypoxia. 
 
HIF-1-α suppressor pVHL 
The crystal structure of HIF-1-α indicates that it is bounded by the Von Hippel-Lindau 
protein (pVHL), a tumor suppressor (Min et al., 2002). pVHL ubiquinylates HIF-1-α 
and targets it for proteosomal degradation under normal cellular oxygen conditions. 
pVHL (a protein named after the Von Hippel Lindau disease) is the recognition 
component of the ubiquitin-E3 ligase complex that regulates HIF-1-α turnover (Jaakkola 
et al., 2001). The residues of HIF-1-α that interact with hydroxyproline 564 (Ivan et al, 
2001; Min et al., 2002) are highly conserved in pVHL orthologs of human, mouse, frog, 
fly, and worm. To facilitate this repression, pVHL has to recognize a hydroxylated 
proline residue on HIF-1-α (Perkel, 2001). pVHL can only interact with HIF-1-α 
subunits if they are post-translational modified by a prolyl hydroxylase (PH). Ubiquitin-
mediated proteolysis is involved in the regulated turnover of proteins (also required for 
controlling cell cycle progression (Glickman and Ciechanover, 2002)) and will be 
discussed in detail in section 6.1. 
 
Prolyl hydroxylase, oxygen sensor or a co-factor switch 
In the search for a mammalian oxygen sensor, it is possible that the prolyl hydroxylase 
activity of hydroxylation of a proline residue on HIF-1-α fulfils just that function. The 
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question is if there is a similar analogue in yeast. To date, no such activator has been 
found in S. cerevisiae, but Passoth et al. (2003) showed hypoxia-dependent P. stipitis 
ADH2 promoter regulation with a response cis element very similar to that of the HIF-1 
binding site at promoters in mammalian genes. A region of 15 bp contained the essential 
site for hypoxic induction, and this motif showed some similarity to the mammalian 
HIF-1 binding site. As mention before, this promoter was not induced by oxygen 
limitation when tested in S. cerevisiae. This was expected, as P. stipitis has a different 
regulation of its aerobic and fermentative metabolism from that of the Crabtree-positive 
yeast, S. cerevisiae. When tested in S. cerevisiae, the P. stipitis HIF-1 promoter was not 
induced by oxygen limitation. In Crabtree yeasts it seems unlikely that the hypoxia 
transcription factors are similar to the mammalian HIF-1 protein, but the possibility that 
control mechanisms may be similar cannot be excluded. A computer-aided promoter 
search (this study) did indicated HIF-1-like sequences in the promoters of many of the 
known hypoxia-induced Saccharomyces genes, but while the protein involved in binding 
these sequences remains unidentified, it is not be possible to establish whether it plays a 
role in Saccharomyces.  
 
Important to this study is the complexity of control of HIF-1. The pVHL-mediated 
degradation is a complex and controlled regulation of HIF-1-α subunits (Jaakkola et al., 
2001). If the system is summarized, it is a cascade of events happening in response to 
oxygen. An enzyme modifies (prolyl hydroxylation of) an activator subunit (HIF-1-α) 
that enable a repressor (pVHL) to bind the activation protein. Then the repressor 
(pVHL) targets the transactivator for degradation by the addition of ubiquitin molecules. 
This already provides different sites for control of transactivation in the cell. Prolyl 
hydroxylation of HIF-1-α indicated a unique post-transcriptional control method. Erez et 
al. (2003) found that the expression of prolyl-hydroxylase-1 suppresses hypoxia-
inducible factor-1- α activation and inhibits tumor growth. A further level of control is 
identified for HIF-1 by modifying its co-factors. Hydroxylation of the 803 asparagine 
residue of HIF-1- α subunits accounts for another oxygen-sensing switch (Lando et al., 
2002). This system, coined as the Asn-803 hypoxic co-factor switch (described in the 
next paragraphs), provides another level or site of control. 
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Asn-803 hypoxic co-factor switch control activation by general transcriptional co-
activators CBP/p300  
The co-factors involved in HIF regulation are believed to be the key to the cell’s ability 
to control transcription factor-mediated activation and the co-factors are considered the 
upstream factors in sensing signals. The HIF-1-α subunit heterodimerizes with subunit 
HIF-1-ß, and binds to the general transcriptional co-activators CBP or p300 (Dames et 
al., 2002; Freedman et al., 2002). CBP is the cyclic-AMP response element binding 
protein (CREB). These co-activators have a cysteine/histidine-rich binding domain 
called CH1 or TAZ1 (transcription activator zinc-finger domain). The TAZ1 motif 
interacts with the unfolded HIF-1, C-terminal transactivation of domain (CAD). HIF-1-α 
protein coils and folds as it interacts with the transcriptional co-activator. A conserved 
Asn-803 in HIF-1-α functions as a hypoxic switch. Hydroxylation of Asn-803 under 
normoxic conditions results in abrogation of binding of the HIF-1-α carboxy-terminal 
activation domain to CBP. This modification represses at normoxia by preventing 
recruitment of the p300/CBP (general acetyl transferases) co-activators (Hewitson et al., 
2002; McNeill et al., 2002).  
 
Co-factor control: chromatin remodeling effects transcription 
This activation is an example of how the three-dimensional structure determines 
transcription activation and the packing of helices that can account for differences in 
specificity. The unbound C-terminal transactivation domain of HIF-1 was discovered by 
Dames et al. (2002). They found it to be disordered and remaining relatively extended 
upon binding. Three short helices are formed upon binding, stabilized by intermolecular 
interactions. The Asn-803 side chain, which functions as a hypoxic switch, is buried in 
the molecular interface.  
 
Hydroxylation of the HIF-1-α subunits is performed by the novel asparaginyl 
hydroxylase factor inhibiting HIF-1 (FIH-1). Examining amino acids within the HIF-1a 
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substrate for their importance in recognition and catalysis by FIH-1, Linke et al. (2004) 
revealed the importance of the valine (Val-802) adjacent to the targeted asparagine. 
 
The transcriptional co-activators p300 and CBP are important regulators of the 
mammalian cell cycle, differentiation, and tumor growths, and are targeted by viral 
oncoproteins (Yu et al., 2004). They are phosphorylated in a cell cycle-dependent 
manner; they interact with transcription factors and complex with cyclins in vivo. Yeast 
homologues of general co-factors CBP or p300 that operate on the hypoxia transcription 
activators in a similar way have not yet been identified. These co-factor regulators may 
operate on more than one hypoxia (and those of other signals) transactivators. If such co-
factors are found it will answer the question of whether there are common upstream 
factors functioning as regulators in multiple pathways and, in addition, whether they are 
conserved across species. To date, the upregulation of all essential genes that are needed 
by mammalian cells to cope with low oxygen levels depends on more than one 
transducer or signaling pathway.  
 
Co-factor control of NF-kappaB 
The co-activators p300 and CBP affect the transcriptional activities of many other 
transcription factors, producing multiple downstream effects. Recent studies implicate 
the co-factors, the general acetyl transferases CBP and p300, as the common sensors that 
also interact with NF-kappaB (Greene and Chen, 2004; Darieva et al., 2004) the other 
hypoxia response factor in mammalian cells. The RelA subunit of the NF-kappaB 
heterodimer is subject to reversible acetylation. The p300/CBP acetyltransferases play a 
major role in the in vivo acetylation of RelA, targeting lys218, lys221 and lys310 for 
modification. Interestingly, both the yeast hypoxia transcription regulators’ MGA2 and 
SPT23 gene products have been implicated in acetylation to modify chromosomal 
configuration (Zhang et al., 1997; Dula and Holmes, 2000). A perfect solution will be if 
the alcohol acetyl transferase ATF1 upregulated under hypoxia by Mga2p and repressed 
by UFAs, could be implicated as histone acetyl transferases. 
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Yu et al. (2004) showed that an immediate early response transcription factor, Egr1, acts 
upstream of p300/CBP to induce or to repress transcription, depending on the stimulus. 
This indicates a further upstream factor in a signaling pathway as the stimulus (or signal) 
influences a transcription factor that controls the co-factors. This is why these co-
factors are considered general transcription factors. Unfortunately it brings one back to 
the dilemma “which is first, the chicken or the egg?” as was stated at the beginning of 
this overview, when trying to determine a beginning or and end of metabolic regulation. 
 
Acetylation of these distinct lysine residues regulates different functions of NF-kappaB, 
including transcriptional activation, DNA binding affinity, I-kappaB (the repressor of 
NF-kappaB) assembly and subcellular localization. Greene and Chen (2004) described 
the elegant system of regulation of NF-kappaB activity by reversible acetylation. They 
indicated that RelA serves as an intra-nuclear molecular switch, promoting both positive 
and negative regulatory effects on nuclear NF-kappaB action, affecting repressor 
binding and localization. The recent publication of Miao et al. (2004) indicates the link 
between diabetes and the NF-kappaB transcription factor. They have shown for the first 
time that diabetic conditions can increase in vivo recruitment of NF-kappaB. Histone 
acetyl transferases (such as CBP/p300) also mediate histone acetylation at the promoters 
of inflammatory genes, leading to chromatin remodeling and transcription. 
 
The question relevant to this study is if there is a common upstream factor in all 
response pathways, will it be possible to control this factor or to exclude a chimeric 
transcription factor from its control in yeast? 
 
The first question can be answered as co-factors for two mammalian hypoxia-induced 
transcription activators are shared. These co-factors facilitate a general response, but it 
needs to be controlled as many systems and cell types are affected, and differently 
affected. For the HIF-1 transcription factor the cofactor availability and regulated 
expression of the hydroxylase enzymes are essential (see section 4.2.1. “The hypoxia 
induced factor (HIF) 1-α”) For NF-kappaB it is the control of its RelA subunit via 
reversible acetylation by means of the same co-factors. Stability of the Rel homology 
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domain is critical for the generation of the NF-kappa B p50 subunit. (Lin and 
Kobayashi, 2003). 
 
The reason for this intricate control lies in the widespread effect hypoxia has as signal in 
mammalian cells. As mention before in mammalian cells a multicellular response is 
found in response to hypoxia. Hypoxic cells upregulate erythropoietin, which stimulates 
red blood cell production, thereby increasing the blood's oxygen-carrying capacity. 
Hypoxic cells increase expression of vascular endothelial growth factor (VEGF), 
stimulating vascular branching to improve tissue vascularization and oxygenation and 
glycolytic enzymes are upregulated to help them cope with the transition from an 
aerobic to an anaerobic environment. (Semenza and Wang, 1992; Semenza, 1999).  
 
 
Does a HIF-1-like control mechanism exist in yeast?  
The Spt23 and Mga2 proteins are not considered the yeast homologues of mammalian 
HIF-1 or its subunit HIF1-α, although they are also subjected to control through their 
post-transcriptional processing (See section 6). Hydroxylation as method of control 
(such as found for HIF-1) has not been identified for Mga2p and Spt23p. Due to their 
domain structure and redox-sensing abilities, Spt23p and Mga2p are described as NF-
kappaB-like proteins. The Mga2p and its yeast homologue Spt23p are the first and only 
hypoxia activators identified in yeast. However, another hypoxia-induced transcription 
factor may be present in yeast or a varied system of control may exist especially in 
Saccharomyces spp. that are not obligate oxygen users, as is indicated by the studies 
done with the obligate aerobic yeast, P. stipitis (Passoth et al., 2003).  
 
4.1.2 The hypoxia induced nuclear factor NF-kappaB  
The NF-kappaB family of transcription factors control inflammatory and immune 
responses, apotosis and developmental processes (Baldwin, 1996). A response to short-
term oxygen reductions (how mammalian cells sense a change in oxygen concentrations) 
has implications in mammalian embryogenesis. NF-kappaB p65, a telomerase, plays an 
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important role in regulating apoptosis (active cell death) and development processes. 
Sustained proliferation of cancer cells requires telomerase activity (reviewed by 
Akiyama et al., 2003).  
 
NF-kappaB prevents premature apoptosis (active cell death) in cells committed to 
undergoing physiological cell death. In stratified epithelium, such cell death normally 
proceeds via a distinct pathway that is resistant to NF-kappaB (Seitz et al., 2000). 
Molecular mechanisms leading to NF-kappaB activation by UV or by photosensitization 
are initiated by oxidative damage at the membrane level or by the induction of DNA 
alterations. NF-kappaB was identified among key factors that efficiently sensitize 
melanoma cells to UV and chemicals-induced programmed cell death in response to 
aberrant signal adaptor protein TRAF2 signaling. Expression levels of a TRAF2 
coincide with melanoma resistance to UV-irradiation (Ivanov et al., 2001).  
 
Following lipopolysaccharide stimulation, the nuclear localization of NF-kappaB is 
significantly increased in selenium-deficient macrophages, thereby leading to increased 
expression of COX-2, encoding a cyclooxygenase. An inverse relationship was 
demonstrated between selenium (Se) status and the expression of COX-2. Zamamiri-
Davis et al. (2002) showed that oxidant stress lowers the activation potential of the 
redox-sensitive transcription factor NF-kappaB, and that the activated NF-kappaB is 
required for the induced expression of COX-2. Inadequate Se nutrition has been linked 
to various diseases, including rheumatoid arthritis, cardiomyopathy, and cancer, and 
cyclooxygenase-2 (COX-2) is over-expressed in all these pathologies. Selenium was 
found to be an essential element, that through its modulation of glutathione peroxidase 
activity can inhibit NF-kappaB activation and can upregulate the repressor I kappaB-
alpha (Kretz-Remy and Arrigo, 2001). 
 
 
The NF-kappaB family 
 
The NF-kappaB family comprises a number of structurally related interacting proteins 
that bind DNA as dimers. This family includes many members (p50, p52, RelA, RelB, c-
 
51
Rel, etc.), the nuclear expression most of which can form DNA-binding homo- or 
hetero-dimers (Legrand-Poels et al., 1998). Their activities are regulated by subcellular 
location.  
 
Repression of NF-kappaB mediated by I kappaB-alpha 
The NF-kappaB transcription factor complex is tightly regulated through cytoplasmic 
retention by an ankyrin-rich inhibitory protein known as I kappaB-alpha. This repressor 
interacts with a p50 NF-kappaB/RelA heterodimer to retain the complex in the 
cytoplasm and inhibit its DNA-binding activity. To activate NF-kappaB the repressor I 
kappaB-alpha needs to undergo phosphorylation. This occurs while I kappaB is still 
bound to NF-kappaB and occurs in response to multiple signals. The complex is 
ubiquitinated at nearby lysine residues. The I kappaB-alpha protein is eventually 
degraded by the proteasome, while it still complexes with NF-kappaB. Removal of I 
kappaB-alpha uncovers the nuclear localization signals on subunits of NF-kappaB, 
allowing the complex to enter the nucleus, bind to DNA and mediate gene expression. 
Thus by a post-transcriptional modification method, NF-kappaB is controlled by 
localization (Lodish et al., 2000). 
 
Does a NF-kappaB mechanism exist in yeast? 
The Mga2p and Spt23 are described as NF-kappaB-like proteins (Hoppe et al., 2000). 
They belong to the same family of the redox-sensitive transcription factor NF-kappaB. 
This implies that they have some of the qualities, functions and modus operandi, or play 
a similar role in cell growth control as NF-kappaB. The activator proteins are both 
localized in the cytoplasm until activation takes place. The mechanism of control of the 
yeast hypoxia activators is similar to that of NF-kappaB as they are kept at the ER 
(control by localization) and activation involves an ubiquination processing. This will be 
discussed in detail in the following sections. Mga2p and the NF-kappa protein both 
contain immunoglobulin (Ig); hemoglobulin binding domains overlapping with ankyrin 
domains responsible for protein-membrane binding or protein-protein binding (Lodish et 
al., 2000, Huang et al., 2003). Their redox ‘response’ functions may be effected via one 
of the genes under their control. In yeast the Mga2 and Spt23 transactivator proteins are 
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responsible for altered expression of the desaturases enzyme encoded by OLE1, that 
contains a C-terminal COX b-like domain and with electron transfer abilities (See 
section 3.4.2, Role of the transactivator Mga2p and Fig.2).  
 
 
 
4.2 Hypoxia control occurs trough a multi-layered regulation system 
and is responsive to other signals in mammalian cells 
 
4.2.1 Overlapping response of hypoxia transactivators 
H2O2, VEGF and NF-kappaB and HIF-1  
The NF-kappaB plays a major role in cancer (Akiyama et al., 2003). Unchecked hypoxia 
inducible factor (HIF-1) also enhances genes that induce tumor growth (Erez et al., 
2003). During a stroke, the vascular endothelial growth factor (VEGF), a target of HIF-
1, stimulates vascular branching to improve tissue vascularization as well as improving 
oxygenation. Chua et al. (1998) found that hydrogen peroxide (H2O2), the ROS 
generated by several metabolic pathways in cells, increases the endothelial cell 
permeability in these cells. Using rat heart endothelial cell culture as a model, they 
indicated that VEGF mRNA responded to H2O2 in a dose- and time-dependent manner. 
An electrophoretic mobility shift assay revealed enhanced binding of transcription 
factors AP-1 and NF-kappaB. 
 
4.2.2 Response of hypoxia transactivators to other signals 
 
Cold-sensing and hypoxia transactivators 
Significant hypoxia upregulation of two related mammalian nuclear ribonucleoproteins, 
RNA-binding motif protein 3 (RBM3) and cold-inducible RNA-binding protein (CIRP), 
which are highly conserved cold stress proteins with RNA-binding properties, were 
found (Wellmann et al., 2004). Interestingly, Mga2p complexes with a single stranded 
RNA or DNA-binding protein (Cellzome).  
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 Response to other signals mediate by co-factor 
It is possible that co-activators (co-factors) can be controlled by other signals, via co-
activators, to provide a multi-layering regulation system. The complex proteins HIF-1-α 
and HIF-1-ß in mammalian systems can be regulated either directly, or by controlling 
their repressors. The factors HIF-1-α and HIF-1-ß can be controlled on their own as well 
as in their homo-dimerized state, although protein-protein interactions are difficult to 
disturb. Both cellular iron availability and oxygen levels influence HIF stability. Prolyl 
hydroxylase adds a hydroxyl (-OH) group to proline 564 of HIF in an iron- and oxygen-
dependent manner (Perkel, 2001). The HIF-1 complex binds general transcription co-
activators such as CBP/p300 (Freedman et al., 2002).  
 
Mitogen-activated protein kinases and phosphatidylinositol 3-kinase (PI-3K) cascades 
are indirectly involved in regulating mechanisms that mediate control of NF-kappaB. 
Darieva et al. (2004) found that the activation of PI-3K and c-Jun-N-terminal kinase 
cascades enhances NF-kappaB-dependent gene transcription in stimulated macrophages 
in mycobacterium through the promotion of p65/p300 binding. These studies indicated 
kinases as the upstream regulators. When the upstream co-factor regulation of Mga2p 
and Spt23 are elucidate it will be interesting to see if a similar role for kinases wil be  
found. This study emphasizes the inter-linked control system in the cell, as illustrated in 
Fig.1. 
 
4.2.3 Intracellular oxygen sensing  
 
ROS may be the upstream ‘universal’ intracellular signal, serving as an oxygen sensor in 
higher eukaryotes as well as yeast. The theory of ROS as common oxygen sensors has 
supporters and detractors. Those in favor are: 
i) Upon receiving a variety signals, many of which are probably mediated by the 
generation of ROS, repressor I kappaB-α undergoes phosphorylation, and is 
degraded by the proteasome (Lodish et al., 2000). This releases the NF-kappaB 
transcriptor to localize to the nucleus, and induce transcription. According to 
 
54
Legrand-Poels et al. (1998) ROS together with other signals may be responsible 
for NF-kappaB transactivator activation by sub-cellular location. 
ii) A second theory holds that a heme-containing protein undergoes a 
conformational change when bound to oxygen, thereby ‘sensing’ oxygen (Kwast 
et al., 1998). If ROS could function as an oxygen switch through the heme-
moiety of cytochromes, it functions as a transducer of a signal, mediating 
conformational changes. 
 
 
4.3 Conclusions: Signaling and sensing 
To conclude, it can be speculated that the findings that cells are able to regulate a factor 
critical to the hypoxic response depends on a specific post-translational modification, 
has ‘opened’ the presumably most common sensing mechanism of all. This may be an 
indication of the ‘beginning’ of control. It would be sensible to conclude that multiple 
oxygen sensing mechanisms exist in cells, as some may not involve post-translational 
modification. Cells are likely to have numerous oxygen-sensing mechanisms. The 
reason for this may be the different metabolic pathways that need upregulation at 
multiple sites, especially in higher eukaryotes with cell differentiation. NF-kappaB 
activation pathway appears to be crucial in transducing signals under stress conditions 
such as infection, inflammation, heat shock, apoptosis and tissue repair (Ali and Mann, 
2004) that will effect many different cell types.  
 
At this stage a definition for the oxygen sensor could be helpful, as co-factor or 
repressor modification enzymes are often described in the literature as the oxygen 
sensor. It is clear that many pathways exist for oxygen sensing as well as for signal 
transduction. As the role-players are identified it will become clear where in the 
signaling pathway they play a role or whether they play a role in signaling as well as 
sensing. Cells are able to regulate factors critical to the hypoxic response by a specific 
post-translational modification, signal transduction and sensing - that cannot always be 
separated. 
 
 
55
Three main mammalian proteins have been identified as being involved in the response 
to hypoxia and oxidative stress. Two of them, AP-1 (not discussed here) and NF-kappaB 
proteins (Legrand-Poels et al., 1998), are both found to be upregulated in response to 
ROS (Chua et al., 1998). NF-kappaB and HIF-1 proteins are upregulated in response to 
hypoxia.  
 
In yeast, there is only one hypoxia transactivator identified namely Mga2p. Spt23, the 
Mga2p homologue, does not mediate hypoxia-induced complex formation at the low 
oxygen response promoter elements identified at hypoxia upregulated genes. Spt23 
fulfils the essential functions of Mga2p as mga2 strains are viable, but a double mutant 
strain spt23 mga2 is not viable at 30ºC under aerobic conditions. Viability of the mga2 
strain was not checked under hypoxia conditions (Zhang et al., 1997). In S. cerevisiae, 
there is also a hypoxia-mediated derepression system functional at promoter level 
(Zitomer et al., 1997) as already discussed in the beginning of this chapter under the 
heading ‘A brief overview of transcription repression in yeast’. In yeast, some hypoxia 
genes will be repressed in the presence of oxygen by a Rox1p mediated complex at their 
promoters (Kwast et al., 1998; Kwast et al., 1999). By controlling the components of 
this complex, control of repressor complex formation and gene regulation of a certain 
group of genes can take place in yeast. 
 
A few questions need to be answered concerning the true oxygen sensor. It should be 
stated that sensing might be either the change in concentration itself that is sensed, or the 
actual intracellular oxygen concentrations. Oxygen is involved in redox reactions, 
transferring electrons. All molecules involved in electron transfer or oxygen carriers 
involve in redox reactions will be affected and will sense a change. It can be speculated 
that a change in oxygen levels reduces the number of electron transfer molecules per 
cell, and this mediates redox changes that ‘trigger’ co-factors to activate transcription 
activators. Activation may be a partial derepression action, where the activators of 
transducers are repressed by oxygen, or by an adaptor induced by oxygen. Such an 
“egg/chicken, which-was-first” system does exist, where control of a system that is 
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never ‘OFF’ is needed. In higher eukaryote cells more of these regulated systems are 
needed due to cell differentiation.  
 
 
Prior to a detailed discussion of the post-transcriptional regulation mechanisms of yeast 
transcription activators, a brief overview of what factors need to be considered when 
choosing or building a fusion promoter would be given. 
 
 
5. TARGET ELEMENTS IN PROMOTERS 
 
When building a transcription regulatory circuit, the chimeric activator needs to be 
provided with a docking site or synthetic target promoter fused to the gene that needs 
upregulation. In this study, the target promoter was fuse to a reporter gene to be able to 
evaluate induction levels mediated by the chimeric transactivator. In the application of 
the system, the target promoter will be provided in singular or multi-copies to the gene 
(or genes) that need/s to be upregulated in a pathway to mediate metabolic flow (see 
chapter V for more detail). The target promoter used in this study consisted of a core 
promoter with added upstream DNA binding elements. The T. reesei xyn2 reporter gene- 
target promoter construct (Chapter II) used in this study included a native core promoter 
of the xyn2 gene (la Grange et al., 1996). The core promoter was ‘fused’ to a ‘GAL10/1’ 
promoter fragment that contains multiple Gal4p binding sites. 
 
 
5.1 Core promoters 
 
Promoters responsible for basal transcriptional activity are often called the core 
promoter activity. A core promoter includes roughly a 100-200 bp upstream region from 
the start site that enables general transcription factors to help the RNA polymerase II to 
locate the start site and initiates transcription (Lodish et al., 2000). Some of the general 
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transcription factors that are involved are the TATA binding protein (TBP) that binds 
TATA elements, TFIIB, a complex of Pol II and TFIIF, TFIIE and TFIIH (Ranish et al., 
1999; Lodish et al., 2000). A multiprotein complex (enhanchesome), bind, resulting in a 
complex of ~ 65 polypeptides nearly as large as an eukaryotic ribosome (Lodish et al., 
2000).  
 
Elements present on the core promoter can have an upregulation effect above that of 
basal level induction and possibly mediate a control site/mechanism to add value to an 
activation system. Interestingly, a global repressor of core promoter activity, Sud1p, was 
identified in S. cerevisiae (Yamashita et al., 1993). The mutation, sud1, increased 
expression from various core promoters suggesting that the SUD1 gene product is a 
global transcriptional regulator that plays a negative role at or near the TATA element 
and should be avoided in recombinant promoters. For this reason, the promoter fusion 
used in this study did not contain a TATA-box element. 
 
Upregulation above basal transcription levels mediated by core promoter involves the 
recruitment of pre-initiation complex (PIC) components for transcription by gene-
specific activators. This is considered a primary mechanism of transcriptional 
enhancement by increasing the effective concentration of the correctly oriented PIC 
component (Kays and Schepartz, 2002). 
 
 
 
5.2 Signal-specific upstream activation elements 
 
5.2.1 Elements: orientation and localization 
 
The numbers of elements – more are better! 
Synthetic operator sequences introduced into a promoter can be effective as single 
inserts but were found more effective when inserted in multi copies. This co-operation 
was enhanced when DNA binding domains were added in multi copies (Tang et al., 
2002; Minetoki et al., 1998).  
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 Direction of element or strand location and sequence context 
Some elements may induce transcription in either orientation. This may be due to the 
palindrome nature of their sequences. It appears that clamping of the DNA with 
sequences present on both strands is important in induction. The bi-directional 
‘GAL1/10’ promoter fragment with four binding sites for the Gal4p was chosen to fuse 
to the xyn2 core promoter (see Chapter II for detail). Flanking regions may determine the 
effectiveness of binding of an element by a protein. Generally, a 20-bp region flanking a 
core element is considered important when studying a specific element but other up-
stream or down-stream sequences may also be important (Vasconcelles et al., 2001). 
Flanking sequences of elements 
Synthetic promoters may have a different effect even if it contains all the relevant 
elements. Flanking sequences added in a specific context may contribute to activation 
or be essential to mediate activation. 
 
5.2.2 Sequence similarities 
Can an activator prevent (optimal) binding of a repressor if it competes for the same or 
similar sequences? This is pure speculation, based on the similarities between the 
sequences of the Rox1p repressor consensus sequences 5’- YYYATTGTTCTC –3’ (Y= 
pyrimidine) (complementary strand, 3’ –TAACAAGTG –5’) (Lowry et al., 1990) and 
the hypoxia / low oxygen response element ACTCAACAA (Vasconcelles et al., 2001, 
Jiang et al., 2001). The inner core sequences of these response promoter elements are 
similar, and it could be speculated that if the Mga2p-mediated complex binds at this 
sequence, it would prevent binding of the Rox1p/Tup1/Snn6 complex. This could also 
explain the ‘widely varying stringency’ by which Rox1p effects gene expression (Kwast 
et al., 1998; Zitomer et al., 1997). The Rox1-mediated complex can possibly be out-
competed by the Mga2p complex. Some of the flanking regions may be advantageous to 
the Mga2p-mediated low oxygen response (LOR) complex binding.  
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6. Further downstream control: post transcription and translational 
control  
 
Under this heading, the possible modifications that will be encountered by hypoxia 
transactivators will be discussed. Both mammalian and yeast transcription activators will 
be used as examples. The aim of this overview is to indicate the regulation of a gene via 
the regulation of its transcription activators, which are regulated by their processing and 
the domains/motifs of the yeast transactivator protein, Mga2p, included or excluded 
when building a chimeric transactivator.  
 
Why are the post-transcriptional pathways so important in this study? Mga2p and 
Spt23p, partially redundant membrane-bound yeast transcription factors, undergo a 
unique form of proteolytic activation (Hoppe et al., 2000). As indicated in previous 
sections, Mga2p and Spt23p are required for transcription of the tightly regulated  9 
fatty acid desaturase gene under hypoxia and in the presence of unsaturated fatty acids 
or other signals. This section will focus on the proteolytic processing that generates 
active, soluble transcription factors. Stabilizing of proteins in yeast have been 
indicated before; an oxysterol-derived signal acted by modulating the stability of a 
reductase and not endoplasmic reticulum-associated degradation (Gardner et al., 2001). 
It still needs to be determined whether Mga2p activation is mediated by ER processing 
(not degraded) and if this can be considered as stabilization. 
  
How does the proteasome process these ER-membrane-bound factors to their active 
state, rather than targeting the proteins for complete degradation? This suggests a new 
function for the proteasome and ER-associated degradation pathway (ERAD). 
 
6.1 Introduction: destruction for the sake of construction 
 
The mechanisms underlying the delivery of poly-ubiquitylated substrates to the 
proteasome to be degraded into small peptides, and the monoubiquitination processes 
that lead to the protection and/or activation of proteins, are still poorly understood. An 
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extensive overview by Glickman and Ciechanover (2002) shed more light on the 
possible pathways involved. They call it the destruction for the sake of construction 
by the proteolytic ubiquitin-proteosome proteolytic pathway. In Fig. 4, a summary of 
pathways discussed by Glickman and Ciechanover (2002) is indicated. As indicated in 
Fig.4, ubiquitination is reversible by the activation of de-ubiquitinating enzymes 
(DUBs). Whether the enzymes function in the cytoplasm (indicated by 3; black) or 
proteasomal (indicated by 3; orange) they can remove ubiquitin from the substrate. The 
function of mono-ubiquitination is possibly to protect substrates and provide a linkage 
site for an adaptor with a chaperone function. This will lead to an active form of the 
protein and in the case of transactivators, efficient translocation to the nucleus. Addition 
of poly-ubiquitin chains leads to degradation of the protein but processing in the 
proteasome is not always to completion, since it can process a ubiquitinated substrate 
into a truncated form that may be the active form (Glickman and Ciechanover, 2002). 
 
Proteins are marked for degradation through covalent attachment of the small, highly 
conserved ubiquitin protein. Ubiquitination occurs through a well characterized, 
enzymatic cascade involving classes of enzymes known as E1s (ubiquitin-activating 
enzymes), E2s (ubiquitin-conjugating enzymes) and E3s (ubiquitin protein ligases). Once 
a multi-ubiquitin chain is assembled, target proteins are quickly recognized and degraded 
by the 26S proteasome (Glickman and Ciechanover, 2002). The proteasome consists of a 
20S, structural barrel shape particle, and a 19S regulatory particle that forms a lid and a 
base that fit onto the 20S part indicated in blue in Fig.4. 
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Figure 4 Functions of the proteasome (taken from Glickman and Ciechanover, 2002). The proteasome can 
carry out a broad range of tasks, both in substrate selection (green arrows) as well as in product generation 
(orange arrows). 1: Proteins (red) are covalently conjugated to a multi-ubiquitin chain (ubiquitin; blue) by 
the ubiquitin-pathway enzymes. 2: Ubiquitin-protein conjugates are specifically targeted to the 
proteasome. 3: Ubiquitination is reversible; deubiquitinating enzymes (DUBs), whether in the cytoplasm 
(3; black) or proteasomal (3; orange), can remove ubiquitin from the substrate. Some DUBs probably 
release single ubiquitin moieties, whereas others release ubiquitin chains. 4: Deubiquitinated substrates are 
recovered (black) or released (orange) from the proteasome. 5: In some instances, substrates can be 
targeted to the proteasome in an ubiquitin-independent manner. ODC is targeted by antizyme, while for 
p21Cip1, no ancillary protein has been reported. 6: Unfolded proteins might be recognized directly by the 
RP, or after association with molecular chaperones. 7: Proteolysis of proteins to short peptides of varying 
lengths. 8: Further degradation of peptides to amino acids. 9: Binding of peptides to the ER Tap 
transporter for presentation on MHC class I molecules. Peptides may be trimmed to obtain optimal 
binding to the MHC complex by cytosolic and/or ER protease(s). 10: Limited processing of substrates 
(p105 precursor of NF- B). 11: Refolding of denatured proteins and their rescue from proteolysis. 12: 
DUB-mediated processing of polyubiquitin chains, including head-to-tail biosynthetic ubiquitin 
precursors. 
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6.2 Mga2p processing by ubiquitination 
 
A ligase, Rsp5, was discovered that adds ubiquitin molecules to a region at the C-
terminal of proteins and mediates the splicing of the full length 120 kDa Mga2 protein 
(call Mga2p120) (Shcherbik et al., 2003). This process will deliver three forms. The 
active form, a 90kDA protein (call Mga2p90) will be released as a monomer, a slightly 
larger ~ 100kDA Mga2p monomer with a polyubiquitin tail, and the C-terminal, ER 
fused domain of the Mga2p120p used to tether the full-length protein to the ER. The 
large subunit of RNA polymerase, Rpb7, is also a substrate of Rsp5, which effects its 
degradation (Huibregste et al., 1997). 
 
An illustration by Shcherbik et al. (2003) of the Rsp5p mediated process for the full-
length Mga2p, was modified to indicate the (putative) fates of the Mga2p N-terminal 
monomers (Figures 5a, 5b and 5c). It may be speculated that the polyubiquitinated 
protein released from the full-length ER tethered form (p120) would be targeted and 
delivered to the 26S proteasome to be degraded. The Rsp5p may be a component of the 
regulatory particle (lid) of the 19S proteasome (Shcherbik et al., 2003). Whether 
releasing the monomer from the full-length protein by ubiquitination takes place, or if 
the splicing of a dimer (by leaving the C-terminal of the one monomer behind), is 
unknown. The exact role of the chaperone Cdc48Nlp4Udf1 complex in delivery of an 
active monomer or dimer is also unclear. (This complex will be discussed in detail later 
in this section.) 
 
In Fig. 5c, possible mechanisms are illustrated and criticized based on the lost of one 
monomer of Mga2p for each monomer released for activation. This (putative) 
mechanism may illustrate the basal level of induction mediated by the Mga2p when one 
monomer is released. If both monomers could be processed, an upregulated effect could 
be established and the hypoxia induced (or possibly low temperature) induction levels 
could be explained. Shcherbik et al. (2003) did not speculate or proposed the formation 
of “new” docking sites by recycling and or the function of the slightly larger 
Mga2p’100’ monomer (Fig.5c) as proposed in this study. 
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Figures 5 Rsp5 is required for ER bound Mga2p (full-length form) and p120 poly-ubiquitination. The 
processed transactivator Mga2p90 form is tethered to this p120, ER-bound form, and with the 
ubiquitinated release of the 120p, p90 is released as well. The p90 forms translocate to the nucleus and 
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mediate transcription of OLE1 and ATF1 (Shcherbik et al., 2003). The active p90 form is the N-terminal 
part and includes the UBL like domain. Ubiquitination mediated by Rsp5p does operate in the C-terminal 
part close to the transmembrane domain. Other proteins involve in the degradation of the poly-
ubiquitinated monomer that originated from p120, are the complex Cdc48pUfd1pNlp4p. (a) and (b) 
illustrate the putative mechanisms whereby the Mga2p90 is ‘stored’ at the ER, protect and /or activate as 
well as translocate to effect transactivation after the Rsp5p mediated release. The short black lines indicate 
ubiquitin molecules. 
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Figure 5c The current model is that the Mga2p120 form is ubiquitinated by means of Rsp5. This lead to 
splicing of the N-terminal, release of the p90 active form as well as degradation of the N-terminal 
originated from the p120 form via the complex Cdc48pUfd1pNlp4p. It is proposed in this overview that a 
‘p100’ form may also be produced that could be reattached to the ER (indicated by a broken line) or be 
degraded if multi-ubiquitinated. 
 
 
Two scenarios are possible for the two N-terminal forms of Mga2p generated in this 
process. A 100 kDa Mga2p protein that originates from the inactive ER tethered form, 
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p120, could be a poly-ubiquitinated protein that is released from the ER. Due to the long 
tail of ubiquitin molecules added, this protein will be delivered to the 26 proteasome to 
be degraded. The Cdc48pUfd1pNlp4p complex facilitates degradation (Glickman and 
Ciechanover (2002); Shcherbik et al. (2003) and see section 6.7.1 ‘Proteasome 
regulation of Mga2p needs adaptors’) and Braun et al. (2002) suggested that the 
Cdc48pUfd1pNlp4p complex functions as a segregase that liberates ubiquitylated 
proteins from non-modified partners. 
 
The 90kDa or Mga2p90 is the active form of Mga2p. It is important to note the 
differences between Spt23p and Mga2p processing found by Shcherbik and co-workers 
(2003). Rsp5p provides the signal for partial degradation and subsequent activation of 
Spt23p. Rsp5p activates Mga2p’s OLE1 transactivation function by a mechanism that is 
independent of promoting proteasome-dependent processing. Rsp5p is dispensable for 
Mga2p90 generation but not for the release of the processed p90 polypeptide from the 
ER membrane. However, proteasome-dependent processing to activate the p90 
monomer is not excluded. This could be mediate by the UB-like region found at the N-
terminal of Mga2p. A mechanism for this has not been identified yet, but a possible 
scenario will be discussed in the following sections.  
 
 
 
 
6.3 Mga2p processing at the C-terminal domain  
 
The Rsp5p binding site on Mga2p is located within a region in between or around amino 
acids 910-1029, which are located in the membrane bound inactive p120 peptide C-
terminal. It could be speculated that a potentially deleterious modification of the 
membrane bound form 120p by Rsp5p-dependent poly-ubiquitination could take place at 
the C-terminal at a (Leu(L)967 ProLysTyr(PKY)971), LPKY motif (Shcherbik et al., 
2003). As this domain contains the ubiquitination site, it was not included in the 
chimeric Mga2p based activator constructed in this work. 
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Jiang et al. (2002) found that two plasmid-based, truncated forms of the Mga2p did not 
perform as well as the naturally processed Mga2p. Induction levels mediated on a 
chimeric double, repeat LOR element-CYC1 promoter-lacZ (reporter gene) fusion were 
about one third of the induction by the naturally processed Mga2p. The truncated forms 
were generated by inserting stop codons at amino acids 941 and 869, respectively, and 
were expressed in a Δmga2 strain. The L967 PKY971 Rsp5 ubiquitination motif was not 
included in the truncated forms. Jiang and coworkers (2001) speculated that the 
truncated forms created were still larger than the native processed p90 form. This could 
either mean that the ‘surplus C-terminal tail’ of the truncated proteins affected its 
reduced hypoxia induction. Interestingly, the truncated protein with a 244 amino acid 
deletion at the C-terminal showed slightly higher expression levels than the one with 
only a 172 amino acid deletion. My observation was based on Northern blots analysis, 
presented by Jiang et al. (2001). The research group did not comment in the publication 
on the difference and it may be not that significant. However, it could lead to speculation 
that deletion of this region did benefit the activation processing of the protein by 
reducing UFA repression mediated at this region. Furthermore, as both the truncated 
forms were considered to be larger than the native processed Mga2p form by Jiang et al. 
(2001), it was decided to make a construct with a shortened C-terminal protein. The 
general conclusion that could be made was that the truncated proteins used by Jiang et 
al. (2002) need domain function mapping to determine the essential motifs or domains.  
 
Jiang et al. (2002) established with Western blots that equimolar of the membrane-
bound and processed forms were produced under aerobic conditions and this production 
was unaffected by unsaturated fatty acids. UFAs counteracted an approximately five-
fold increase in the soluble active form, under hypoxia. (Data in this paper indicated an 
impressive 29- fold induction under hypoxia compared to normoxic conditions for the 
reporter gene activities. However, these activities were not expressed per cell count).  
 
Although the truncated forms did not perform as well as the naturally processed (native) 
forms, UFAs less affected them under hypoxia conditions. Part of the initial objective 
was to identify this motifs or domains responsible for UFAs repression and hypoxia 
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induction. The main aim was, however, to construct a controllable transactivator that 
will be able to effect gene expression under hypoxia if produced at high levels. The 
findings of Jiang et al. (2002) that a multicopy plasmid expression increased the 
expression of Mga2p90, counteracts the negative effect of UFAs previously observed for 
a CEN-based plasmid production of Mga2p. This changed my whole strategy since it 
was not necessary to determine the domain responsive to hypoxia or UFAs. However, 
finding the domain responsible for Mga2p general transcription activation under both 
normoxic and hypoxic conditions was essential. Adding any domain that would 
upregulate the constitutive response mediated by the activator would be a bonus; 
especially if the regulator responds to externally applied signals (nutrients, carbon, 
hypoxia, low temperatures, etc). The essence was to ensure an ‘overproduction’ of the 
regulator to ensure a ‘high’ constitutive rate of the activator, but at the same time 
different levels of expression (control) should be possible. This high constitutive 
expression could be obtained by multicopy plasmid expression and using a glucose 
inducible promoter to promote transcription of the activator. The activator should be 
able to efficiently bind at the DNA-binding site of the reporter gene and should be able 
to enhance transcription activation. A true chimeric plasmid consisting of the best of the 
best! At such a high production rate, repression of the regulator by UFAs would be out-
diluted when using Mga2p, as indicated by Jiang et al. (2002). It was realized that 
although the fact that Mga2p is upregulated under hypoxia condition, this regulator is 
present in the cell in its soluble active form even under aerobic conditions. 
Understanding the Mga2p up-regulation is clearly more complex than what was 
originally thought.  
 
An interesting link between Rsp5 and thiols is worth mentioning. RSP5, an essential 
gene of S. cerevisiae, encodes an E3 ubiquitin-protein ligase, and Rsp5 is localization at 
multiple sites within the endocytic pathway (Wang et al., 2001). This enzyme recognizes 
protein substrates and promotes the transfer of ubiquitin from a thiol ester intermediate 
to a lysine residue on the target protein or growing poly-ubiquitin chain. Formations of 
disulfide (-S-S-) bonds help stabilize the tertiary and quaternary structure of many 
proteins. Covalent bonds are formed by oxidative linkage of sulphydryl groups (-SH) or 
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thiol groups. In eukaryotic cells, these reactions can only take place in the lumen of the 
rough ER. A hypothesis concerning the role of the acetyl transferase induced under 
hypoxia by Mga2p90 was proposed (Section 3.4.3). The ATF1 gene product effects the 
formation of volatile isoamyl acetate from iso-amyl alcohol and acetyl coenzyme A. The 
by-product of this reaction is SH-CoA. This reaction provides the cell with thiols  
(-groups), by removing the acetate group that can be bind to form thiol ester 
intermediates if necessary or the isoamyl acetate could be the thiol ester intermediate for 
transfer of ubiquitin. Such a role for isoamyl acetate or it CoA group has yet not been 
indicated and there is no experimental data to proof this hypothesis.  
 
 
6.4 Mga2p processing by putative N-terminal ubiquitination 
 
Kim et al. (2004) proposed that the ubiquitin-like element (UB-like) motif, a protein-
protein interaction module, might be used to facilitate coupling between substrate 
ubiquitylation and delivery. This will ensure the orderly handover of the substrate from 
the ubiquitylation machinery to the proteasome. Rad23 (a reversibly-bound proteasome 
cofactor) serves as a putative adaptor molecule that may interacts with ubiquitin chains 
through its ubiquitin-associated motifs (UBA) and with the proteasome through a 
ubiquitin-like element (UBL) (Kim et al., 2004). Rad23p plays a role in scaffolding, 
linking ubiquitin molecules to other molecules and to the proteasome. The N-terminal 
UBL domain present in Rad23p enables the protein to bind tightly to the proteasome 
(Schauber et al., 1998) and with its ubiquitin associated domain in the C-terminal, can 
interact with ubiquitin.  
 
Mga2p only possess a putative UBL-Rad23p-like domain at the N-terminal (based only 
on sequence homology to Rad23p), and is tethered with its C-terminal via a 
transmembrane region. This could indicate an adaptor role for the Mga2p90 N-tail, 
but it is more likely for the Mga2p90 to be modified through this region, rather 
than modifying other proteins. Mga2p90 could interact via its N-terminal RAD23-like 
ubiquitin-like (UB-like) region to the proteasome. The UBL site could provide the site 
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of mono-ubiquitination and protect the active Mga2p90 from degradation and mediate 
activation by the proteosome (Fig.5b).  
 
Important to note is that the UB-like domain at the N-terminal of Mga2p (Fig. 6) has not 
been identified as an UB-like domain. Only in this study, by in silico alignments in 
search for low homology stretches to other proteins, this putative domain was 
“identified” to be a UB-like domain.  
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Figure 6 Putative functions of regions/motifs of Mga2p, identified by homology to other proteins and 
layout of divisions of Mga2p in domains, a to g. (For specification of domains a,b and f, included in the 
chimeric transcription regulator, see Chapter II). 
 
Little is know about the activation domains and the activation complex that Mga2p 
facilitates at promoters to effect hypoxia induction. However, it is known that this 
protein’s activation processing is effected by ubiquitin in part (at least its ‘splicing’ from 
an ER membrane tethered form) and is effected by UFAs.  
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The other possibility mentioned before is the uncharacterized mono-ubiquitination 
pathway that also results in the proteolytic activation of regulatory proteins. It is 
important to note that posttranslational modification of proteins by other proteins is not 
unique to ubiquitination but these proteins are often called UB-like proteins (Glickman 
and Ciechanover, 2002). Small molecules (at least 11 have been described to date) can 
be covalently conjugated to amino residues of other proteins. These proteins are often 
called ubiquitin-like proteins although some show little resemblance to ubiquitin, only 
the conjugation and sites of attachment to the substrate resemble modification by 
ubiquitin. Additional UBL domain-containing proteins are also linked to the ubiquitin 
system. Glickman and Hanover (2002) stated that binding of specific UB-like domain-
containing proteins seems to link the proteasome with potential substrates. These 
proteins may be binding misfolded proteins, or protein involved at sites of DNA damage 
and repair (via Rad23), or with ubiquitin ligases, or polyubiquitinated substrates. The 
term ubiquitin ligase refers to ligation by covalent linking of ubiquitin moieties (or other 
proteins) to a protein. 
 
If Spt23p and Mga2p homologue proteins are ligases, they may function in linking their 
target proteins to the proteasome by means of their UB-like domains at their N-
terminals. These ligase-like regions could be the sites where these activators are 
themselves to form a dimer or to link to other proteins, mediating stable complex 
formation (Fig. 6). The N-terminal region of Mga2p, containing a Rad23-like 
ubiquitin ligase region, was included in the chimeric AR transactivator build due to 
this putative function. 
 
 
 
6.5 Specific lysine groups could determine the active Mga2p form  
 
Protection mechanisms for the active truncated Mga2p90 form, before it is tethered and 
after release from the Mga2p120, is not known. It was speculated that the ubiquitin-like 
domain in the N-terminal of the protein is involved. It is known that if a substrate is 
polyubiquitinated with the first ubiquitin being added through the amino acid Lys 48 of 
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Rad23p, it will be degraded. However, the addition of ubiquitin moieties at lysine 63 
induces processes as diverse as DNA repair and endocytosis (uptake of molecules). It 
does not target the modified protein to the proteasome-mediated degradation. Hitchcock 
et al. (2001) indicated that Nlp4p target the proteasome to ubiquitinated ER-membrane 
bound Mga2p and Spt23 proteins. This mechanism is located at the C-terminal but as the 
truncated versions of (Jiang et al., 2002) does not effect induction as well as wild type 
Mga2p form, this ubiquitination could be responsible for an unknown modification. The 
ubiquitination could also take place at lysine groups at the N-terminal side to effect 
degradation or activation of Mga2p. If activation domains of Mga2p are situated in the 
N-terminal region and overlaps with this possible Rad23 UB-like domain, short 
sequences deletion, or specific lysine modifications, may implicate the function of 
mono-ubiquitination of Mga2p to protect the protein against degradation, in future 
studies. 
 
6.6 An ubiquitin independent form of regulation could determine the active Mga2p 
form  
 
Brown et al. (2000) reviewed an ubiquitin independent form of regulated membrane–
associated proteolysis. This type of processing results in the activation of membrane 
precursors. An example of this activation mechanism is the sterol regulatory  
element–binding proteins (SCREBP proteins). Regulatory proteins in human cells that 
undergo this type of activation are the Alzheimer’s disease-linked ameloid precursor 
protein, cell signaling protein Notch, and the unfolded protein response-signaling kinase, 
Ire1. The structure of SCHREB proteins differs from yeast Mga2p and Spt23 (with only 
the C-terminal tethered to the ER), in that SCHREB proteins contain two membrane-
spanning regions. Both the N- and C- termini are nested in the ER. Up to date, such an 
ubiquitin-independent mechanism has not been found for Mga2p or Spt23 but can not be 
excluded. Misfolding of these proteins caused the formation of prions that is the 
causative agent of Alzheimer disease. Interestingly, Mga2p was isolated in a protein-
protein complex (Cellzome) with a protein encoded by NEW1 Prion Q/N-rich N-
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terminal domain that acts as a prion, termed [NU]+. This association could 
implicate Mga2p in a chaperone role similar to SCREB proteins.  
 
6.7 Further downstream regulation: Proteasome-dependent processing of Spt23p 
and Mga2p 
 
In Fig. 5c, the role in the putative processing of Mga2p of the Cdc48pUfd1pNlp4p 
complex is indicated. Bays et al. (2001) found that NPL4 corresponds to the ERAD gene 
HRD4.  Npl4p’s role in a complex of processing genes in the cytosol is delivery of the 
proteasome to ubiquitinated ER-associated target proteins. They found Hrd4p/Npl4p 
functions at a post-ubiquitination, but pre-proteasomal step in ERAD. Their analysis also 
shows that the primary defect in hrd4/npl4 cells is a lack of proteosomal processing of 
ubiquitinated proteins, not a defect in nuclear transport or fatty acid biosynthesis, and 
Npl4p has been implicated in nuclear transport (Bossie and Silver, 1992; DeHoratius and 
Silver, 1996).  
 
Unsaturated fatty acids and increased OLE1 expression (Hitchcock et al., 2001) was 
found to suppress some of the nuclear defects in npl4 mutants. Fatty acid (FA)-mediated 
regulation of Mga2p activity was found to be independent of its proteolytic processing 
into a soluble transcription activator. However, Mga2p target genes are effected by 
FA/UFA ratios in the cells. Overlapping of Mga2p’s functions to control membrane 
fluidity in response to FA/UFA ratios and to mediate the appropriate response to other 
signals, may be mediated at processing level of Mga2p, but are still to be determined. 
The multiple sites of control mediated by or signal response mediated via this 
transactivator, is summarized in Fig. 7. 
 
6.7.1 Proteasome regulation of Mga2p needs adaptors 
A model in which a protein is directed to different cellular pathways through alternative 
adapters is proposed. This overview is based on research done in mammalian cells by 
Meyer et al. (2000) and in yeast by Hitchcock et al. (2001). It is not an attempt to 
rewrite research done by Hitchcock and co-workers (this would need more elaboration, 
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to fully explain this elegant control system), but rather to summarize information to 
indicate another target for regulation, namely adaptors. Yeast Npl4p associates with 
Cdc48p via Ufd1p to form a Cdc48pUfd1pNpl4p complex. Cdc48Ufd1Npl4 is involved 
in ER-Associated Degradation (ERAD). The complex extracts ubiquitinated proteins 
from membranes and presents the proteins to the proteasome.  
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Figure 7 Yeast transactivator Mga2p response to different signals (see text for references). The repression 
effect of unsaturated fatty acids on the processing of the full-length Mga2p into the truncated active 
Mga2p form is illustrated this figure. This explains the effect of fatty acids (FA), UFA, FA/UFA ratios 
and hypoxia induction on several genes via the Mga2p transcription regulator. (The processing of Mga2p 
is oversimplified in this presentation). 
 
Ufd1p serves as an adaptor required for ubiquitin-dependent protein degradation, 
whereas the yeast translocator Npl4p has been implicated in nuclear transport (See 
section 6.7.2). Cdc48p is an AAA ATPase required for a variety of cellular processes 
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including cell division, protein degradation, and ER membrane fusion (Moir et al., 1982; 
Latterich et al., 1995; Ghislain et al., 1996). The Cdc48 has a chaperone function in the 
cell and assembles cyclin complexes and Moir et al., (1982) identified cdc48 as a 
recessive cold-sensitive cell-division-cycle (cdc) mutation. Cdc48p associates with two 
other Ufd proteins, Ufd2p and Ufd3p/Doa1p, as well as several other proteins with no 
known function in protein degradation (Ghislain et al., 1996; Koegl et al., 1999). It 
could be speculated that it could be involved in the ability of Mga2p to respond to low 
temperatures and upregulate gene transcription. A similar system, mediated by complex 
Ufd1 Npl4p97, has been identified in mammalian cells, and it has been implicated in 
many different pathways, ranging from nuclear transport pathways to membrane fusion 
and ubiquitin-dependent protein degradation.  
 
The involvement indicated in post-mitotic fusion of Golgi membranes for the 
mammalian system may provide grounds for the speculation of a putative involvement 
of Mga2p with the cytoskeleton / tubilin structures of the yeast cell. This was based 
on the putative domain function analysis of Mga2p, its protein associates in the 
Cellzome complex and the presence of ankyrin domains in Mga2p. Michaely et al. 
(2002) stated that ankyrins are multifunctional adaptors that link specific proteins to the 
membrane-associated, spectrin-actin cytoskeleton in human cells. The Ufd1/Npl4 binary 
complex competes with p47 for binding to p97 (in mammalian cells) and so inhibits 
Golgi membrane fusion. Ufd1/Npl4 represents an alternative adapter to p47 that directs 
p97 to another cellular pathway (possibly the ubiquitin-dependent events during mitosis) 
in the same way that p47 directs it to act in Golgi membrane fusion. 
 
Conclusions: Do MGA2 and SPT23 function as adaptors in multi-pathway regulation 
and/or do adaptors affect them? Most of the signals that affect these two transcriptor 
activators indicate a signal pathway under their control, controlling genes involved in 
membrane fluidity. [MGA2 and SPT23 are also modifiers of transcriptional silencing in 
yeast. They are regulators of Ty-induced mutations and Ty1 transcription in S. 
cerevisiae (Dula and Holmes, 2000; Zhang et al., 1997).] In the above description of the 
Cdc48pUfd1pNpl4p complex, it is clear that Cdc48p (p97 in mammalian cells) is the 
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adaptor in the system involved in several systems. Does Mga2p play a similar role? As 
Mga2p does not directly bind promoter elements, but facilitates binding of a complex at 
the promoters, it may be classified as an essential adaptor. It may also be involved with 
mRNA stability, possibly through yet another complex, as indicated by protein-protein 
complex studies (See section 6.8 and chapter IV).  
 
6.7.2 Nucleo-cytoplasmic transport: Is mRNA transportation a site for post-
transcriptional control?  
Mga2p was found with a RAN-binding protein in a protein-protein complex (Cellzome). 
Ran protein is a small GTPase that facilitates nuclear export of cargo proteins with 
leucine-rich nuclear export signal (NES) and may also be involved in the export of fully 
processed mRNA from the nucleus (Lodish et al., 2000). Binding of the mammalian 
homologue of yeast Smt3p, SUMO-1, to the Ran GTP-activation protein (RanGAP) 
directs the latter to the nuclear pore complex (Mahajan et al., 1997; Matunis et al., 
1998). Ufd1p may be involved with ubiquitin-like proteins, Smt3p / SUMO-1 to 
regulation of nucleo-cytoplasmic transport. The interaction of Ufd1 and Npl4 might 
help to explain the role of Npl4 in nuclear transport processes (Meyer et al., 2000).  
 
In S. cerevisiae, Ufd1p is also involved in RNA processing. Uba2 (homologue of 
ubiquitin-activating (E1) enzymes) and Ufd1 interact with Pap1p, a S. cerevisiae 
poly(A) polymerase, and with each other. Del Olmo et al. (1997) found that via 
regulation of Uba2p and Ufd1p, polyadenylation could be regulated. Depletion of Uba2p 
from cells produces extracts which polyadenylate precursor RNA with increased 
efficiency compared to extracts from nondepleted cells, while depletion of Ufd1p yields 
extracts which are defective in processing. These two proteins were indicated as 
components of polyadenylation factors, but instead may have a role in regulating 
poly(A) polymerase activity (del Olmo et al., 1997). 
 
It is possible that the Ufd1 protein function is not only linked to the ubiquitin-mediated 
protein degradation pathway, but also functions in the mRNA processing. This may be 
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mediated by assisting the Mga2p in increasing the stability of OLE1 mRNA transcripts 
(Gonzalez and Martin, 1996; Martin et al., 2001; Kandasamy et al., 2004) by assisting to 
chaperone mRNA molecules. Two-hybrid protein-protein interaction studies should 
indicate such a co-functionality of Mga2p and Ufd1. Induction under low temperatures 
could also be mediated by an increase in the stability of OLE1 mRNA transcripts. It may 
be speculated that this would implicate Ufd1p as a putative co-factor in cold-shock or 
low temperature regulation (for more detail, see discussion in section 6.8). Cdc48p may 
also be involved in the Mga2p’s ability to respond to low temperatures and upregulate 
gene transcription. Madeo et al. (1998) found that S. cerevisiae Cdc48p and its 
mammalian homologue, valosin, are ATPases that have essential functions in cell 
division and fusion of endoplasmic reticulum vesicles. Two hybrid studies indicated that 
the phosphorylation results in a conformational change of the Cdc48p, exposing the 
nuclear import signal sequence previously masked by a stretch of acidic residues. Yeast 
nuclear import of Cdc48p is dependent on its phosphorylation and exposure of its nuclear 
localization signal (Madeo et al., 1998). Npl4 may be part of this mechanism. It is 
possible that Npl4 is involved in the import of Ufd1 into the nucleus. Ufd1p facilitates 
the binding of the activation protein Uba2p (del Olmo et al., 1997). The ubiquitin-like 
protein Smt3p is activated by Uba2p (Johnson et al., 1997). The role of Smt3p, directing 
proteins to the nuclear pore, has been established in mammalian cells and speculation is 
that Ufd1 is involved. Ufd1 not only functions in ubiquitin-dependent degradation, but 
also in other pathways involving ubiquitin-like proteins, including the regulation of 
nucleo-cytoplasmic transport. 
 
 
6.8 Further downstream control: post transcription and translational control of 
mammalian hypoxia –inducible transactivator proteins 
 
Many references to post-transcriptional and translation control mechanisms in 
mammalian cells have been made in this overview. Similar to processing of Mga2p, 
processing in the proteasome of mammalian cells is not always to completion to deliver 
the active form of transactivators (Fig.4, reaction 10). Protein stability and ER-
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associated degradation (to activate or degrade) are two of the major mechanisms in use 
to control mammalian hypoxia transactivators. As mentioned earlier, the mammalian 
hypoxia-induced HIF-1-α is rapidly degraded under normal oxygen concentrations, but 
it is stabilized under hypoxia (Min et al., 2002). The product of the von Hippel-Lindau 
(VHL) tumor suppressor gene pVHL regulates the stability HIF-1-α proteins (Min et al., 
2002). pVHL is a member of an E3-ubiquitin ligase complex that conjugates ubiquitin 
proteins to HIF-1 and targets it for proteosomal degradation. This is an important 
regulation site in protein processing.  
 
The yeast Hrd1/Der3, a membrane protein, is an ubiquitin-protein ligase (E3) involved 
in ER-associated degradation. Gardner et al. (2001) originally identified it as an E3 of 
the yeast cholesterol biosynthetic enzyme HMG-CoA reductase (HMGR). They found 
that the HRD complex discerns between a degradation-competent ‘misfolded’ state and 
a ‘stable, tightly folded’ state. They speculate that the physiologically regulated HRD-
dependent degradation of HMGR is effected by a programmed structural transition from 
a stable protein to a quality control substrate. This processing describes a system for 
yeast of non-degrading and degrading processing in the ER depending on the folded 
state of the protein, but this is not the only processing as ER-independent lysomal 
processing also effects protein modifications. Mga2p does have a region that shows 
homology similar to an ubiquitin ligase, ‘identified’ by in silico alignments made in 
this study (data not shown). It may be speculated that Mga2p facilitates conjugation of 
proteins to facilitate binding to DNA (or possibly mRNA) as it plays a role in OLE1 
stability. Alternatively, it could target reductases (like Hrd1p) and function in ER 
degradation. No experimental proof exists for this hypothesis, however the domain 
function mapping system build in this work (Chapter II) is the ideal ‘tool’ to determine 
this in further work. NPL4 is involved in the complex that targets ubiquitinated Mga2p 
to the proteasome (Hitchcock et al., 2001). The region similar to ubiquitin ligase in 
Mga2p may be the site where the Npl4 protein adds ubiquitin molecules to the ER-
tethered full-length protein.  
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7. Summary of regulation/control mechanisms 
 
This summary is not a complete list of regulatory systems, but does give an indication of 
the multitude of possible sites and systems available for manipulation (or factors that 
need to be taken into account) when building a recombinant transactivator.  
i) Control by dimerization; homo- or hetero- 
Some regulatory proteins contain a certain domain of a protein that is responsible for the 
formation of a homo-dimer, and which can be essential for activation complex 
formation. Regulation can take place by affecting dimerization. An example where 
homo-dimerization affects the regulations of two pathways is in the glycolytic pathway 
and ribosomal protein transcription. Efficient transcription activation of most glycolytic 
genes requires the Rap1p/Gcr1p glycolytic activator complex. This complex is also 
required for ribosomal protein transcription. Gcr2p is necessary only for the activation of 
glycolytic genes with the Rap1p/Gcr1p complex, thus a third factor of the complex for 
glycolytic activation. Gcr1p and Gcr2p homo-dimerizes, and Rap1p’s distinct 
requirement for homodimeric subunits gives the cell the ability to switch between co-
ordinate and uncoupled ribosomal protein and glycolytic gene regulation (Deminoff and 
Santangelo, 2001).  
ii) Regulation of protein-protein complexes 
In the search for new drug discoveries, protein-protein interaction studies are important, 
but more complex to target and regulate. The complexity of protein-protein complexes is 
highlighted by the comment: ‘Although enzymes are easy to inhibit, protein-protein 
interactions are not’, made by Proffesor Nicola Pavletich, (Dana Farber Cancer Institute) 
that captured the crystal structure of HIF-1-alpha protein bound to pVHP (Maher, 2002).  
iii) Two forms of one protein in different cell types 
Oxysterol binding protein is expressed in two different forms. A 950-amino acid protein 
(not the full-length protein) is formed that include ankyrin repeats and a plextrin 
homology domain which is abundant in brain and lung, localized to late endosomes 
(Johansson et al., 2003). In addition, the shorter 437 amino acid protein that has only the 
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C-terminal ligand-binding domain is found largely in the cytosol of skeletal muscle and 
heart. The larger protein is involved in lipid metabolism and able to enhance 
transactivation if overexpressed. The corresponding mRNAs of these proteins are found 
in the different cell types. It could be concluded that this type of control actually lies at 
transcription level and this is not a post-transcriptional modification of a full-length 
protein.  
iv) Dual localization  
It could be hypothesized that if storage substrates are provided with the essential 
enzymes to enable the cell to synthesis essential products, transactivators operating in 
these pathways may also be ‘provided’ in such a way as to enhance the metabolic flow 
in production. Squalene epoxidase is not a transcriptor activator protein, but its storage 
in lipid particles and the ER is an interesting system for yeast cells to survive when 
certain pathways are inactive due to low oxygen levels/hypoxia (Landl et al., 1996). 
ERG1 encodes a protein squalene epoxidase, important in sterol (ergosterol) 
biosynthesis. If ERG1 is deleted, it is lethal to the yeast cell unless ergosterol is supplied 
to the cell. A dual localization of this protein was found in both the ER/microsomal 
fraction and in lipid particles of this protein. Steriod esters stored in lipid particles serve 
as stores if endogenous synthesis is stopped under anaerobic conditions (Leber et al., 
1994; Leber et al., 1998). 
v) Regulation via processing                                     
As detailed discussion in previous sections indicated, ubiquitin (involved in cell cycle 
regulation as well as protein degradation) may be one of the important factors in 
regulation and more specific hypoxia induction. Ubiquitin-mediated control includes 
activation, recycling and degradation. Many oncoproteins, transcription factors, cell 
growth modulators, and signal transducers undergo regulated degradation in response to 
internal and external cues. This processing plays a role in temporally regulated ubiquitin-
mediated degradation of cyclins, cyclin-dependent kinase inhibitors, and other cell cycle 
regulators (Tyers and Jorgensen, 2000). 
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“Activation” and/or “Degradation” processing 
 
The ubiquitin molecule can play a role in degradation as well as nuclear pore targeting, 
co-interacting with, and facilitating increased protease synthesis. Ubiquilin contains 
multiple ubiquitin-related domains typically thought to be involved in targeting proteins 
for degradation. Ubiquitin-mediated regulation plays a role in degradation of prions and 
aberrantly folded proteins. Anti-ubiquilin antibodies stained neurofibrillary tangles and 
Parkinson's disease affected brains. Mah et al. (2000) indicated that ubiquilin may be an 
important modulator of presenilin protein accumulation and that ubiquilin protein is 
associated with neuropathological neurofibrillary tangles (Parkinson's disease), Lewy 
body inclusions in diseased brain, as well as Alzheimer’s disease.  
 
It was shown that ubiquilin facilitates increased presenilin synthesis. Presenilin genes 
encode proteases, presenilin-1 and presenilin-2 (PS1 and PS2), that are linked to early-
onset of Alzheimer's disease. Ubiquilin interacts with both PS1 and PS2 (Mah et al., 
2000). Presenilin-1 is a membrane protein that is postulated to be an aspartyl protease 
(involve in early onset of Alzheimer disease, if mutated). This family of proteins 
includes a membrane-related estrogen receptor, which shares some structural 
homologies with estrogen receptor alpha and may participate in estrogen-mediated 
neuroprotection against amyloid-beta toxicity (Marin et al., 2003). Alzheimer’s disease 
is marked by the formation of plaques and tangles formed in the brain derived from 
amyloid-precursor proteins and others. Degeneration of the brain may be caused by 
prions, an infectious protein agent derived from by proteolysis and refolding of a normal 
brain protein.  
 
As was previously stated, Mga2p was identified in a protein-protein complex with a 
prion, NEW1, termed [NU]+ (Cellzome). It could be speculate that Mga2p operates in 
concert with other proteins, within a complex, to facilitate the degradation of such 
prions.  
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 “Recycling” 
 
Ubiquitin-mediated proteolysis is involved in the regulated turnover of proteins required 
for controlling cell cycle progression. The overexpression of an enzyme,  
disulfide isomerase, in neuronal cells protects against apoptotic cell death induced by 
hypoxia/brain ischemia. Ubiquilin that interacts with protein-disulfide isomerase (PDI) 
were identified using the yeast two-hybrid system (Ko et al., 2002). Data indicate that 
ubiquilin is an endoplasmic reticulum-associated protein in these cells. Overexpression 
of this gene in neuronal cells resulted in significant inhibition of the DNA fragmentation 
triggered by hypoxia. Ubiquilin together with protein-disulfide isomerase have critical 
functions as regulatory proteins.  
 
vi) Regulation through localization 
Exposure of a nuclear localization signal is needed for cytoplasmic to nucleus transport. 
An example of a repressor keeping an activator in the cytosol is the repressor I kappaB 
alpha, a kinase, that binds NF-kappaB activator describe earlier in this overview.  
I kappaB alpha prevents NF-kappaB to localize to the nucleus by folding the protein in 
such a way that the nuclear localization signal can not be accessed (Lodish et al., 2000).  
 
vii) Ubiquitin-independent regulation of cytoplasmic-nucleo transport 
This process is described as an ubiquitin-independent form of regulated membrane-
associated proteolysis (termed regulated intramembrane proteolysis (Rip)), that results in 
the proteolytic activation of membrane-bound precursors of regulatory proteins. An 
example is the Rip mediated activation of the sterol regulatory element-binding proteins 
(SREBPs) (Brown and Goldstein, 1997). SREBP-2 is an example of a transcription 
factor, the activity and nuclear import of which, are regulated by proteolysis. When 
cholesterol levels (in mammalian cells) are depleted, a cleavage-activating protein 
escorts SREBPs to the Golgi apparatus where an active N-terminal fragment is cleaved 
off. This active protein enters the nucleus and activates genes involved in the synthesis 
and uptake of cholesterol and unsaturated fatty acids (Lee et al., 2003). It can be 
speculated that Mga2p may be regulated in a similar way as Mga2p was found in the 
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same protein complex as Sec27p (Cellzome). SEC27 encodes a coatomer that is required 
for the retrieval of proteins from an early Golgi compartment back to the endoplasmic 
reticulum, thus involved in recycling yeast proteins.  
 
Sterol regulatory element-binding protein, SREBP-1, plays an important role in de novo 
synthesis of long-chain saturated and monosaturated fatty acids in conjunction with fatty 
acid synthesis and stearoyl-CoA desaturase (the mammalian homologue of the yeast 
gene OLE1) (Heinemann and Ozols, 2003). Mga2p is implicated in many indirect ways 
to play a role in sterol metabolism or to be controlled by sterol. Mga2p also control 
genes, which affect zinc homeostasis either directly or indirectly by altering sterol 
metabolism (Lyons et al., 2004). A more indirect link may be the putative regulation of 
ATF2 transcription by Mga2p. The human steroid hormone pregnolone is metabolized to 
17α-hydroxyprogesterone if expressed in yeast (Degryse et al., 1999). This reaction is 
catalyzed by ATF2 (Cauet et al., 1999). Atf2p transfers an acetyl-group to human delta5- 
or delta4-, 3-β-hydroxy steroids in a recombinant S. cerevisiae strain. Degryse et al. 
(1999) speculated that Atf2p’s function is to get rid of plant steroids. The yeast cells 
may take up plant steroids when expose to grape or other plants. ATF2 has not been 
identified as a Mga2p target. However, it does contain LOR element sites in its promoter 
(ATF2’s homologue, ATF1, is upregulate by Mga2p that mediating complex formation 
at the promoter LOR element. It may well be that ATF2 is controlled similarly. ATF2 is 
expressed at very low levels seemingly at both hypoxia and aerobic conditions (See 
chapter III for detailed discussion). ATF2 expression levels in the presence of this 
putative signal, plant steroids, need to be evaluated. Mga2p may also be involved in the 
uptake of sterols by mediating up-regulation of SUT1, a possible LOR element-induced 
hypoxia transactivator gene (Vasconcelles et al., 2001).  
 
viii) Self/auto inhibition of DNA binding 
A C-terminal in vitro interaction that was found for the transcription activator Swi4p 
with its own N-terminal (containing the DNA binding domain) suggests an auto-
inhibitory system. This prevents the cell cycle transcription factor from binding DNA. 
(Baetz and Andrew, 1999). 
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8 Low temperature signal sensors or transducers 
 
8.1 Members of the cold shock domain protein family bind both RNA and DNA 
and sense environmental changes 
The Y-box-binding protein is a member of the cold shock domain (CSD) protein family, 
binding both RNA and DNA. It is involved in transcriptional regulation, translational 
regulation, DNA repair, and drug resistance and stress responses to extracellular signals. 
These CSD proteins or Y-box proteins have several family members. Kohno et al. 
(2003) stated that YB-1 represents the most evolutionary conserved nucleic-acid-binding 
protein currently known. A conserved 70 amino acid region or CSD defines them. The 
central domain is responsible for sequence specific RNA binding. A C-terminal domain 
has a more non-specific role in stabilizing binding. The YB-1 functions in regulating 
DNA/RNA transactions: the cold shock domain of the protein is necessary, but not 
sufficient for double-stranded DNA binding while the C-tail domain interacts with both 
single-stranded DNA and RNA independently of the cold shock domain (Lodish et al., 
2000). CSD proteins protect the secondary DNA/RNA structure by their ability to effect 
complex formation. It is involve in initiation of translation, unwinding or masking RNA 
molecules. E. coli CspA functions as an RNA chaperone to prevent the formation of 
secondary structures in RNA molecules at low temperature (Lee et al., 1994).  
 
Cold-shock proteins in prokaryotes and higher eukaryotes also bind the promoter 
element, Y-box motif. The promoter consensus sequence for Bacillus subtilus is either  
‘CTGATTGGC/TC/TAA’ or B. subtilis CspB binds with high affinity to sequences in 
single stranded oligonucleotides that contain both 'ATTGG'- and 'CCAAT' elements 
(Willimsky et al., 1992). The Xenopus Y box factors bind to a similar DNA sequence, 
the Y box, containing a reverse ‘CCAAT’ element to effect DNA binding, 
multimerization and transcription. A Xenopus domain of the Y box factors homologous 
to an E. coli cold shock protein is required for DNA binding. The hydrophilic C-terminal 
tail of the proteins contributes to the assembly of nucleoprotein complexes (Tafuri and 
Wolffe, 1992).  
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8.2 Cold-shock response may be induced by the state of the ribosome affecting the 
translational machinery 
The cold-shock response can also be induced in bacteria by the addition of certain 
inhibitors of translation. Therefore, it has been proposed that the state of the ribosome is 
the physiological sensor for cold induction; the “transfer” of this signal (signal 
transduction) to transcriptional control is unknown. In higher eukaryotes, cold-shock 
domain (CSD)-containing proteins (Y-box proteins) are part of the RNA binding group 
of proteins. These proteins play an important role involved in transcriptional and 
translational regulation of a wide range of genes by controlling the recruitment of 
mRNA to the translation machinery (Raimondi et al., 2003). 
 
8.3 Different responses to cold shock is found for isoforms in E. coli 
Different responses for cold-shock protein isoforms were found in E. coli. The major 
cold-shock protein of E. coli, CspA, has a high sequence similarity with three other  
E. coli proteins CspB, CspC, and CspD. The CspB protein was found to be cold-shock 
inducible at the level of transcription similar to induction of CspA, while CspC and 
CspD were not. Csp proteins share sequence similarity with other prokaryotic proteins 
and with the 'cold-shock domain' of eukaryotic Y-box proteins (Lee et al., 1994). 
Different hypoxia and aerobic isoforms of several genes exist in S. cerevisiae (Kwast et 
al., 1998). 
 
8.4 What types of proteins need to be up-regulated to survive low temperatures? 
Low-temperature induction of genes encoding fatty acid desaturases has been widely 
reported in cyanobacteria, plants, protozoan, dimorphic fungus (Mucor rouxii), and fish 
(reviewed by Nakagawa et al., 2002). However, a low-temperature signal transduction 
pathway has not been identified in yeast. The yeast Mga2p transcription regulator was 
identified to be responsive to cold shock and mediate up-regulation of OLE1 gene 
encoding Δ9 fatty acid desaturase (Nakagawa et al., 2002). They suggested that the same 
low oxygen response element binding complex induced by hypoxia (Jiang et al., 2001), 
is also induced by the low temperature signal. This indicates an overlap of the low-
temperature and hypoxia signal transduction pathways. However, UFAs repressed 
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hypoxia induction, but not the low temperature induction of OLE1. Nagawaka et al. 
(2002) suggested that UFAs did not suppress the low temperature signal because this 
signal inhibits the UFA signal transduction pathway that prevents proteolytic release of 
the active form (processing) of Mga2p. 
 
8.5 Cold-sensing transactivators with RNA binding proteins – link with cold 
induction mechanisms in fungi 
The colds shock domain / Y-box proteins system for low temperature induction is not 
found in fungi. It could be speculated that an increase in mRNA transcript stability under 
low temperatures might be sufficient to effect the necessary upregulation under low 
temperatures.  
 
 
 
 
 
 
 
 
 
 
 
Mga2p complex 
with single strand 
RNA/DNA binding 
proteins at 30ºC 
(Cellzome) 
(S. cerevisiae) 
 
Cold shock domain  and /or polypyrimidine tract binding sites 
revealed a potential site in VEGF mRNA stability, in both non-
induced and induced conditions. Coles et al. (2004) determined that 
the single strand DNA-specific cold shock domain (CSD or Y-box) 
protein represses the hypoxia-responsive region (binding site of the 
Hypoxia Inducible Factor (HIF-1)) at the VEGF promoter via a 
binding site downstream of the HIF-1 site, see text for references. 
(Mammalian cells) 
 
Moderate hypothermia 
and hypoxia  
(hypoxia induction  
HIF -1independent) 
upregulate mammalian 
nuclear RNA-binding 
motif protein 3 (RBM3) 
and cold-inducible RNA-
binding protein (CIRP) 
(Wellmann et al., 2003).  
(Mammalian cells) 
 Mga2p promotes OLE1 
mRNA transcripts 
stability at 30˚C.  
(Kandasamy et al. 2004) 
Does Mga2p belong to a class of 
DNA/RNA-binding proteins 
that mediate cold shock 
regulation? 
Mga2p (hypoxia transactivator) 
responsible for cold shock 
induction and induction at low 
temperature growth of OLE1 
transcription (Nagawaka et al., 
2002) 
 
Figure 8 An illustration to indicate possible overlapping control systems of cold-inducible DNA/RNA 
binding proteins, cold shock (growth at low temperatures) and hypoxia present in mammalian cells 
indicating a putative control system in yeast mediate by the Mga2p. 
A link between cold-inducible DNA/RNA binding proteins and hypoxia has recently 
been established for mammalian hypoxia inducible transcription factors. Significant 
hypoxia upregulation of two related mammalian nuclear ribonucleoproteins, RNA-
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binding motif protein 3 (RBM3) and cold-inducible RNA-binding protein (CIRP), which 
are highly conserved cold stress proteins with RNA-binding properties, were found 
(Wellmann et al., 2004). Interestingly, Mga2p (a transactivator also involved in both 
hypoxia and cold mediated induction) was found to complex with a single stranded RNA 
/ DNA-binding protein, however this study was done at 30˚C (Cellzome).  
 
Hypoxia is considered a reduction in the normal level of tissue oxygen tension in 
mammalian cells (Wellman et al., 2004) and under hypoxia conditions, transcription of a 
variety of genes increases. One of the factors, the vascular endothelial growth factor 
(VEGF), is a key regulator of angiogenesis (growth of vessels) and post-transcriptional 
regulation plays a major role in VEGF expression. Both the 5'- and 3'-untranslated 
regions (UTR) are required for VEGF post-transcriptional regulation, but factors binding 
to functional sequences within the 5'-UTR have not been fully characterized. Coles et al. 
(2004) reported the identification of complexes which bind to the VEGFmRNA 5'- and 
3'-UTR, that contain cold shock domain (CSD) and polypyrimidine tract binding (PTB) 
RNA binding proteins. Analysis of the CSD/PTB binding sites revealed a potential role 
in VEGF mRNA stability, in both non-induced and induced conditions, demonstrating a 
general stabilizing function. Coles et al. (2004) determined that the single strand DNA-
specific cold shock domain (CSD or Y-box) protein represses the hypoxia-responsive 
region (binding site of the Hypoxia Inducible Factor (HIF-1)) via a binding site 
downstream of the HIF-1 site. The repressor site is functional in unstimulated, normoxic 
fibroblasts and represents a novel means to prevent expression of VEGF in the absence 
of appropriate stimuli (Coles et al., 2002, 2004).   
 
The post-transcriptional fate of eukaryotic mRNAs depends on association with different 
classes of RNA-binding proteins (RBPs). Mga2p may be implicated as a RBPs subclass, 
cold-shock domain (CSD)/Y box protein-containing or -like protein. This speculation is 
based purely on shared functionality with Y-box proteins, as no domain similar to these 
proteins are found in Mga2p or has been found in other fungi. The shared functions 
involve DNA-RNA and protein-protein interactions. Similar to Y-box proteins, Mga2p 
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also responds to environmental signals and like the cold shock domain of YB-1 is 
responsible for the mRNA stabilizing activity within a protein complex (Fig. 8). 
 
Kandasamy et al. (2004) showed that the Mga2p does promote OLE1 mRNA stability in 
fatty acid free medium under its native promoter, but also promote this when the OLE1 
was placed under control of a GAL1/10 promoter. This mRNA stability of OLE1 was 
divided in basal stability (not effected by UFAs) and regulatory stability (affected by 
UFAs). If the Kandasamy et al. (2004) study is done at low temperatures, it should 
indicate if Mga2p also promote mRNA stability at low temperatures and if the stability 
(compared to higher temperatures) increases at low temperatures. Both Mga2p and its 
homologue Spt23p are transcription factors responsible for effecting cell membrane 
fluidity in response to hypoxia and /or altering saturated/unsaturated fatty acid ratios by 
mediated regulation of the transcription of OLE1 (Zhang et al., 1999). Gonzalez and 
Martin (1996) indicated that the 5'-untranslated region of the OLE1 mRNA contains 
sequence elements required for fatty acid-triggered destabilization. This group found 
that the disruption of the XRN1 gene, which encodes a 5' --> 3'-exoribonuclease, results 
in an approximate 4-fold increase in OLE1 mRNA half-life in the absence of fatty acids. 
OLE1 mRNA half-life is reduced when those cells are exposed to unsaturated fatty 
acids, indicating that the 5'-exoribonuclease encoded by the XRN1 gene is required for 
the rapid degradation of the OLE1 transcript, but is not required for fatty acid-induced 
destabilization. Spt23p does not play a role in cold shock response (Nakagawa et al., 
2002). Torija et al. (2003) confirmed the findings of Nagawaka et al. (2002) that optimal 
membrane fluidity at low temperatures was modulated by changes in the un-saturation 
degree of fatty acids in S. cerevisiae strains. The differences between Spt23p and Mga2 
have been exploited in the design of a chimeric transactivator (for more detail see 
Chapter II). 
A second protein, the yeast Hsp60 chaperone, is also induced by low temperatures, but is 
not known as a transcription regulator. Hsp60 does not seem to overlap functionally with 
the Mga2p. Cold signals induce Hsp60 to enable cells to recover from a low temperature 
shock; this protein has not been implicated in playing a role in low temperature growth. 
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Oxidative damage increases Hsp60 levels in the cell to protect the cells by preventing 
the release of iron-molecules from several Fe/S proteins. Protection of Fe/S-containing 
enzymes from oxidative inactivation was found to be dose-dependent with respect to 
Hsp60 (Cabiscol et al., 2002). Hsp60 or chaperone CCT (CCT = chaperone containing 
T-complex) consists of subunits, CCTalpha and CCTbeta, in S. cerevisiae. Cold shock 
induces an increase in the CCTalpha protein, which is expressed at 10˚C, but not at 4˚C. 
Transfer of 4˚C cold-shocked cells to 10˚C induced a 5-fold increase in the CCTalpha 
protein level (Somer et al., 2002). The discovery that mutations in individual CCT 
subunits affect assembly of tubulin and actin may indicate similar mechanisms of up-
regulation mediate by Hsp60 and Mga2p. Mga2p has putative links with actin that may 
be similar in function to the CCT subunits of Hsp60. Firstly Mga2p contains ankyrin 
regions, which are multifunctional adaptors that link specific proteins to the membrane-
associated, spectrin-actin cytoskeleton. Secondly, Mga2p was also found in a protein-
protein complex with Tef4p (Cellzome).  
 
8.6 Compartmentalization of mRNA mediates stability and/or protection 
Proteins involve in mRNA stabilizing may assist in both processing and transport of 
mRNAs. One of the most intriguing facts of mRNA processing is that most transcription 
and RNA processing occurs in certain domains in the nuclei. A nuclear matrix or 
skeleton formed by fibrous protein network creates domains. This is composed of actin 
and many other proteins. Tef4p is known to interact with cell membrane tubilin. In 
higher eukaryotes cells the cytoskeletal actin microfilaments participate in mRNA 
localization (Lodish et al., 2000). Both Hsp60 and Mga2p may protect mRNA 
transcripts by effective localization of mRNA and facilitate transport through the nuclear 
pore. [The mangrove plant, Bruguiera sexangula, CCTalpha facilitates the folding of 
proteins without ATP and may play an important role in salt induced osmostress 
tolerance (Yamada et al., 2002).] Mga2p and p50 (a NF-kappaB subunit) may share a 
putative link in downstream mechanisms involving an interaction with actin. p50 is the 
mammalian cold shock domain or Y-box transactivator protein that mediates hypoxia 
induction. Huang et al. (2003) indicated that two RNA molecules bind independent of 
each other to the p50 N-terminal immunoglobulin (Ig) -like domains (Huang et al., 
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2003). Ruzanov et al. (1999) found an interaction of p50 with actin that may provide a 
possible link between mRNA and microfilaments similar as that have been suggested to 
be the case for the yeast Hsp60 (and possibly Mga2p). The actin connection may suggest 
a similar pathway of mRNA regulation for these proteins.  
 
NF-kappaB is a heterodimer consisting of p50 and p65. If the major mRNA-associated 
protein YB-1/p50, a cap-dependent mRNA stabilizer, is overexpressed, an increase in 
mRNA stability is found. Evdokimova et al. (2001) found that the cold shock domain of 
YB-1 is responsible for the mRNA stabilizing activity and a blocked mRNA 5' end is 
required for YB-1-mediated stabilization. It was found that exogenously added YB-1 
destabilizes the interaction of the cap binding protein, eIF4E, (IF = initiation [of 
translation] factors) with the mRNA cap structure. They purposed that either the down-
regulation of eIF4E activity or increasing the YB-1 mRNA binding activity or 
concentration in cells activates a general default pathway for mRNA stabilization 
(Skabkin et al., 2001).  
 
Mga2p as the cold shock or low temperature inducible protein in yeast, that also form 
multi-protein complexes, does show functional similarities to those of p50 Y-box-like 
protein but an interaction with a cap binding protein has not been found. Unless the 
interacting in the same protein-protein complex with the TEF2 and TEF4 (Cellzome) 
would indicated such an interaction. Interesting is the elegant control mechanism 
whereby p50 mediates its regulation of gene expression when present at different 
concentrations in the cell. Skabkin et al. (2001) found p50 catalyzes strand exchange 
between double-stranded and single-stranded RNAs, yielding a product bearing a more 
stable extended double-stranded structure. The Mga2p may mediate a similar 
mechanism. Strikingly, p50 displays both RNA-melting and -annealing activities in a 
dose-dependent manner; a relatively low amount of p50 promotes formation of RNA 
duplexes, whereas an excess of p50 causes unwinding of double-stranded forms 
(Skabkin et al., 2001). The alteration of nucleic acid conformation could be a basic 
mechanism of the p50-dependent regulation of gene expression. Alterations of nucleic 
acid conformation (that p50 mediates) are regulations of gene expression at transcription 
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level and by affecting the packaging of the RNA, the translation process. Post-
transcriptional fate of eukaryotic mRNAs depends on association with different classes 
of RNA-binding proteins (RBPs).  
 
The protein motifs responsive to low temperatures, as well as the transduction 
mechanism of the Mga2p transactivator, need to be identified to be able to manipulate 
recombinant yeast strains under low temperatures. Additionally, the low temperature 
growth responsive promoter elements targeted by Mga2p needed to be identified. This 
relies on the hypothesis that low temperature promoter DNA binding elements do exists 
in yeast. The fact that Y-box –like elements or transactivators binding promoter DNA 
under low temperature have not been identified for fungi, does indicate a different 
mechanism such as mRNA stabilization could be the only (or preferred) mechanism 
under low temperatures in yeast (and other fungi).   
 
  
8.7 Why are fungi (yeast) so different from prokaryotes and eukaryotes when 
looking at low temperature induction? 
Some cold shock proteins have different binding domains for binding double stranded 
DNA (the Y-box-element) and binding single stranded RNA (or DNA). This may not be 
true for all proteins as in silico sequence analysis by Landsman (1992) showed the 
RNA-binding motif is found conserved in the DNA-binding cold shock domain of some 
proteins. If Y-box proteins bind DNA and RNA with different domains, it may be that 
these domains (in other species) are located on separated proteins or it could be that 
fungi evolved in a different direction. They may have retained only the proteins that 
have RNA binding function. In general the optimal growth temperature for fungi grow 
are lower than prokaryotes such as E. coli or higher eukaryotes (warm blooded 
organisms) and fungi could have “lost’ or never inherent the Y-box proteins DNA 
binding domain. Low temperature induction will therefore be effected on a post-
transcriptional level ‘utilizing’ the RNA binding mechanisms. These post-transcriptional 
mechanisms occur at many sites, e.g. mRNA stabilizing during transcription, transport 
of mRNA from the nucleus and even initiation of translation. All these mechanisms 
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could induce a low temperature response (rather than a single event on transcriptional 
level) in yeast (fungi). It may be speculated that Mga2p play a central role in the cold-
sensing and complex formation under low temperatures.  
 
However, it may also be that a promoter DNA-binding function also plays a part in the 
low temperature induction mediated by a yet unidentified protein. This would place 
Mga2p as the linker protein in a low temperature complex that co-ordinate the promoter 
DNA binding proteins and mRNA binding proteins. Furthermore, some factors are 
common to both transcriptional initiation and termination by RNA polymerase II 
processes. DNA exists in a looped conformation, bringing together promoter and 
terminator regions of genes (O'Sullivan et al., 2004). It may be speculated that this form 
of gene regulation, in which both ends of the transcription unit are defined before and 
during the transcription cycle, is the mechanism whereby Mga2p mediated induction. 
The AR regulator constructed in this study (See Chapter II) will be the ideal protein to 
use in protein-protein pull down studies to identify the proteins involved in these 
(putative) low temperature complexes.  
 
 
9. Conclusion  
 
To conclude this section, an elaboration on the initial definition of transcriptional 
control will be presented. To the definition: ‘Differential transcription of different genes 
determines actions and properties of cells. Transactivators mediate actions to effect 
metabolic control of gene expression, and by responding to changes in the environment, 
effects differential transcription and metabolic control’, one should add that 
transactivators can be controlled at both transcriptional and post-transcriptional levels to 
enable the cell to respond to changes in the environment to effect differential metabolic 
control. Interaction with other proteins determines the localization of a transactivator 
and the processing to be converted into its active form by means of folding, splicing, 
dimerization, etc. Therefore, the domain architecture and functions of domains of 
transactivators are very important. Important downstream regulation methods control 
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and facilitate the storage of proteins as well as regulate mRNA stability. These 
mechanisms determine the cells’ ability to survive stress conditions and can effect an 
immediate response to changes in the environment.  
 
To shed further light on the signal sensing and transducer abilities of transactivators and 
the mechanisms controlling transactivator domain functions, a synthetic transcriptor 
activator based on the yeast hypoxia-induced transactivator, Mga2p, was constructed. A 
regulation system with both workhorse and prospector capabilities was build. This 
study’s specific aim was two-fold: firstly to show that the concept of a plasmid-based 
chimeric transcriptor transform to yeast cells will effect signal-specific transcriptional 
responses and secondly, to determine the functions of the yeast activator Mga2p 
domains. 
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Chapter II 
 
 
 
An introduction to the design of pAR regulatory system 
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Object ive: Construction of a chimeric transactivation regulatory system.
Transcription of a reporter gene mediated by the AR or RR chimeric
transcriptors (encoded from the same plasmid) mediated
through a fusion target promoter.
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1. Transcriptional regulatory networks  
 
Transcriptional regulatory networks are networks of regulator-gene interactions or 
multi-protein enhancesomes, controlling the cell regulatory circuitries. Segal et al. 
(2003) stated that much of a cell's activity is organized as a network of interacting 
modules, sets of genes coregulated to respond to different conditions. Interacting 
modules should include the different functional domains of a transactivator. The 
modular nature of many proteins (consisting of subdomains) (Gerstein et al., 1994) can 
be exploited and integrated to form new multifunctional transactivators. Transcription 
activators consist of functionally different domains (regions). The main functions of 
the transactivator proteins are listed in Table 2.1. In this work, a chimeric 
transactivator was built and incorporated in a mini-regulatory circuit. The aim of the 
modular design of this plasmid-based system was to allow functional mapping of the 
different domains included in the chimeric transactivator and to confer additional 
chemical and kinetic complexity to the Mga2p based chimeric protein.  
 
Table 2.1 Domains of transcription activators and (some putative) functions 
Transactivator protein Function 
Activation site (transactivator may 
contain several but may need only one) 
Assembly of the basal transcription machinery  
DNA binding facility To bind general or specific elements at promoters or 
mediate complex formation at these elements 
Region with a signal sensing ability  Respond to specific signals  
Flexible linker Function unclear, possibly responsible for signal sensing, 
binding co-factors, lending steric flexibility to the protein 
 
 
Before discussing the design and components of the regulatory system that was 
constructed, the in silico methods used to determine which domains to incorporate, 
will be highlighted.  
 
 
110
2. In silico mining and mapping 
 
In silico♣ methods to determine the probability of a specific domain to be functional 
under specific conditions (or to confer a specific function), are crucial to minimize the 
risk when constructing chimeric transactivators. Computational data analysis is an 
invaluable tool in “identifying” or predicting putative targets for regulation from gene 
expression data. Segal et al. (2003) designed a “probabilistic method for identifying 
regulatory modules from gene expression data”. Their procedure identifies modules of 
coregulated genes, their regulators and the conditions under which regulation occurs, 
generating testable hypotheses. They presented microarray experiments supporting 
three novel predictions, suggesting regulatory roles for previously uncharacterized 
proteins. In this study data available in the public domain was search and comparisons 
were made to determine possible activation mechanisms mediated by Mga2p or 
modifications that may effect Mga2p processing. Recently, Bussereau et al. (2004) 
carried out a similar search by using data sets of  S. cerevisiae to mine data sets of 
other yeasts by low homology searches using general search engines and re-analysis of 
“old” data sets with new tools or tricks∝. Dahl et al. (2002) used a two-way approach, 
similar to this study, combining bioinformatics and experimental techniques. However, 
they took their research a step further, using protein models to plan experimental site-
directed mutagenesis experiments. They also used protein models to examine ligand-
protein interactions and signalling/transport mechanisms. Protein-based screening 
tools using antibody molecules, antibody fragments, antibody mimics or libraries of 
aptamers (which are single-stranded oligonucleotides that express high affinity for 
protein molecules (Lopez and Pluskal, 2003)) can be applied to verify computational 
predictions. In order to put the contribution of computational data analysis in 
perspective, Table 2.2 presents a summary of some of the in silico bioinformatics tools  
                                                 
♣ In silico search can be defined as electronic search without (or prior to) experimental validation, using previously 
characterized promoter elements or protein motifs/domains as paper homologues. 
∝ Bussereau et al. (2004) re-analyzed the “Genolevures” data (FEBS Lett. 487 (2000), at http://cbi.labri.u-
bordeaux.fr/Genolevures/, for the presence of zinc finger proteins (transcriptional transactivators). They used 
random sequence tags (paper homologues) to search databases and to ‘fetch’ the corresponding gene of 13 different 
hemi-ascomyceteous yeasts. After analysis of 239 (“random sequence tag”) sequences they described 161 
homologues of the S. cerevisiae zinc finger proteins present in one or several of 13 different hemi-ascomyceteous 
yeasts.  
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Table 2.2 Computational and experimental tools available for mining databases to 
provide information to create components of a new regulatory circuit or to find novel 
elements or motifs/domains. 
Computational tools Drawback Experimental tools This study 
Mine the sequenced  
S. cerevisiae for activating 
sequences sensitive to specific 
signals 
Could identify 
derepression rather than 
activation 
 
Bi-directional 
cloning vector 
 
DNA arrays 
Yes 
 
     
      No 
Search for known promoter 
(elements) to incorporate in a 
synthetic promoter  
 
Search for protein motifs and 
functional domains in 
transactivators  
Overlapping of multi-
signals could mask 
positive results or give 
false positive results 
Many motifs or domains 
unidentified or not fully 
characterized 
Computational 
analysis  
 
 
Mine published 
data element 
information. 
Yes 
 
 
 
Yes 
Protein models to plan 
experimental site-directed 
mutagenesis, in silico selection of 
putative promoter for in vitro 
shuffling experiments  
Site-directed mutagenesis and or in vitro shuffling 
of  promoter elements and cloning to add to core 
promoters (use PCR, and basic cloning 
techniques) 
       No 
Predict metabolic networks based 
on specific environmental and 
regulatory constraints. In silico 
imaging of metabolic networks 
and computation of their 
integrated functions is an 
important method to predict flux 
through integrated metabolic 
pathways. •
Need access to biochemical 
enzyme interaction data 
determined under specific 
conditions 
Need in vivo information on 
ratio of gene products 
Need to incorporate 
transcriptional control data 
Computer 
programming 
 
Mine published 
data 
 
DNA array 
studies to confirm 
predictions 
       No 
 
 
Yes 
       
 
      No 
Metabolic flow patterns may 
facilitate in identifying signal 
sensitive transactivator(s) if target 
genes are known 
Need to characterised target 
promoter sequences  
Protein-DNA 
interaction studies 
Mine published 
data 
          No 
 
Yes 
                                                 
• Famili et al. (2003) predicted of metabolic flow patterns in S. cerevisiae using in silico analysis of 
genome-scale metabolic networks. The authors calculated that the in silico results were consistent with 
observed phenotypic functions for approximately 70-80% of the conditions considered. 
 
112
available, the drawbacks linked to specific methods and experimental tools used (or 
available) to confirm predictions. In this study, in silico searches were used to find 
promoters containing characterized hypoxia (and other signal sensitive) promoter 
elements, to find homologue regions in protein motifs and domains present in Mga2p, 
and to find regions of homology between Mga2p and other proteins to be able to 
predict domain function.  
 
 
2.1 In silico search for promoter elements 
 
Identification of elements in promoters in a straightforward blast for sequence 
homology to known elements is limited, as among other factors, flanking regions also 
needs to be compared. Element searches have to be repeated for the minus strand if the 
element is not direction sensitive. The presence of palindromes on the same or 
opposite strands needs to be checked. This procedure does not take into account 
degenerative elements (mismatches). The alternative is to analyze a promoter region 
with the tools available at S. cerevisiae Promoter Database (SCPD). At this site a list 
of identified regulator-binding sites are also provided  (http://cgsigma.cshl.org/jian/, 
©1998 Cold Spring Harbor Laboratory). The ideal tool with which to search for new 
or putative elements up to 20 bp long is “Search putative regulatory elements - using 
self-defined consensus”. It is possible to insert any sequence and element as well as set 
the parameters to search for degenerative sequences, as the design of the search 
program allows for mismatches.  
 
This tool was used extensively to search for promoters containing hypoxia elements.  
It was used to identify putative glucose repression sites at the GAL1/10 promoter to 
exclude when constructing a target fusion promoter for the pAR regulatory system. 
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2.2. In silico search for protein motifs or domains 
 
Motifs are specific conserved amino acid sequences essential to confer a specific 
function of a protein. Motifs are located within domains (regions with a specific 
activity). To identify a putative signal sensing motif (or motifs with other functions) in 
the Mga2p, an in silico search was initiated with an across-species sequence 
alignment. Blast searches at http://www.ncbi.nlm.nih.gov/BLAST/ included regions of 
proteins with low homology and alignment of short sequences, to compile a profile of 
the protein. Proteins were analyzed with NCBI’s CDART: Conserved Domain 
Architecture Analysis Program (a list of some of the motifs identified is provided in 
the APPENDIX). All relevant publications and databases had to be screen for any 
indication of putative co-factors, proteins that may complex with Mga2p or any 
peculiar processing that may indicate the function of the transactivator’s 
domains/motifs. The location site in the yeast cell as well as the control mechanisms of 
the proteins associated with Mga2p was looked at as an indication of function.  
 
 
2.3 In silico search for homology to other sequenced proteins and comparison 
with protein-protein interaction studies 
 
Facilities to study protein-protein interaction are not available in our research group. In 
silico homology data sets of Mga2p were compared in this study to the Mga2p-protein 
interaction studies of Cellzome (Detail provided in Chapter I, IV and APPENDIX, 
supplement B). An in silico analysis to determine the putative functions of Mga2p 
based on the function of proteins it associates with, was attempted. Complexes of the 
proteins identified with regions of homology to domains of Mga2p included in the AR 
regulator were analyzed to determine “protein domain function by association”. 
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The following process was repeated for all regions found with homology to Mga2p: 
Example: Step 1: Alignment with NCBI BLAST programs identified region/domain of Mga2p similar 
to Protein kinase C conserved region 1.  Step 2: Profiling  protein kinase C: Some protein kinase C’s 
indicated to bind some phorbol esters and diacylglycerol, others binding RasGTP zinc-binding 
domains.  Step 3: Profiling putative co-factor proteins: RasGTP is an intracellular switch protein 
that transduces signals (Lodish et al., 2000). Step 4: Link to Cellzome protein interaction study: 
Mga2p complex with Efb1p∝. Step 5 Profile Efb1p: EFB1 encodes the translation elongation factor 
EF-1beta, GDP/GTP exchange factor for Tef1p/Tef2p ∂. Ribosome Product: Translation elongation 
factor EF-1beta, GDP/GTP exchange factor for Tef1p/Tef2p: Phenotype: Null mutant is inviableϖ. 
Results: Linkage of data sets indicated the region under study could be involved in 
transducing signals via co-factors and should therefore considered essential for 
Mga2p’s sensing or transducing of signals. The putative UBL-like sequence (putative 
target site for poly-ubiquitination) and the Rad23p-like region (located in the N-
terminal region of Mga2p) were also identified and characterized in a similar way 
(Chapter I). 
 
In future, computational searches will be increasingly applied to mine the immense 
volume of data generated by high-throughput technologies. Databases are frequently 
updated and provided with new analytic tools: Protein-DNA interactions and 
transcription regulation studies are supported by the “Stanford Protein-DNA 
Interactions – Motif Bioprospector” search program that can be used to ‘mine’ proteins 
for known motifs (http://BioProspector.stanford.edu/Mdscan). Mdscan searches data 
(obtained with a method based on chromatin immunoprecipitation followed by cDNA 
microarray hybridization (ChIP array)) for DNA sequence motifs representing the 
protein-DNA interaction sites. This is a powerful tool to use in transcription studies 
although it cannot yet pinpoint interaction sites down to the base-pair level. In 
determining regulatory circuits, another helpful addition to the Stanford database∂ is 
                                                 
∝ http://yeast.cellzome.com  It is important is to note that the ‘bait’ proteins used in protein-protein pull-
down experiments as well as the experimental conditions will determine the complexes found. Certain 
interactions may only be found under specific conditions. 
∂  http://genome-www4.stanford.edu/cgi- bin/SGD/search /quickSearch
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the visualization of metabolic pathways, providing a unified source of information 
explaining the biochemical pathways in yeast. 
 
3. Construction of the chimeric AR regulator 
In the following sections the rational behind the design, inclusion or exclusion of 
specific promoter elements and the reasons for selecting certain protein 
domains/regions to construct the plasmid-based regulatory circuit, will be presentedω.  
 
 
3.1. Providing a target promoter to the reporter gene for binding of 
the chimeric transactivator 
 
Fusion of ‘GAL1/10’ –xyn2 core promoter 
The T. reesei xyn2 reporter gene used in this study was cloned with a core promoter 
region of the native xyn2 TATA-less core promoter. A truncated ‘Gal1/10’ promoter 
was inserted upstream from the core promoter fragment. The Gal4p DNA binding 
domains (DBD) present in ‘Gal1/10’ promoter facilitate binding of the chimeric 
transactivator to mediate transcription of the reporter gene. Four Gal4pDBD are 
present at the GAL1/10 promoter. The GAL1/10 promoter is a bi-directional promoter 
and the four Gal4p binding domains present on both strands are not direction sensitive. 
In the absence of glucose, the transcriptional activator Gal4p binds constitutively to the 
17 bp recognition sequence upstream of the GAL genes (Giniger et al., 1985). The 
presence of putative repression binding sites of the glucose induced repressor proteins, 
Mig1 and Mig2, flanking the Gal4p binding sites at the GAL1/10 bi-directional 
promoter, was found with an in silico promoter sequence analysis (this study). These 
regions were excluded when constructing the truncated ‘Gal1/10’ promoter. In silico 
                                                 
ω The cartoon presented on front-page of this chapter illustrates the layout of the regulatory circuit. 
Details of plasmid construction are provided in article presented in the second part of this chapter. 
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analysis of the promoter fragment incorporated in the regulatory cassette did not show 
known binding sequences (of high homology) of other known repressor proteins. 
 
The fusion target promoter construct does not contain a TATA box. At the time of 
construction of the regulatory circuit, work done in our laboratory (personal 
communication, Ancha Zietsman) showed that transcription was initiated when the 
same core promoter of the T. reesei xyn2 was fused to either the ADH2 or ENO1 
promoters (both TATA-box promoters) or to the PGK1 promoter (not a TATA–box 
promoter). Zhang et al. (1997) also reported the functionality of a Mga2p - Gal4DBD 
fusion protein and did not report any detrimental effects mediated by a truncated 
Mga2p fused to the GAL4DBD in the recombinant yeast cells. Therefore, both systems 
were considered appropriate for incorporation in the chimeric regulation system. 
 
 
 
3.2 Providing the AR regulator with a promoter to drive the chimeric 
transcriptor 
 
The glycolitic ENO1 promoter was inserted to drive transcription of the chimeric AR 
transactivator. DNA array studies done by ter Linde et al. (1999) indicated high 
expression levels mediated by the ENO1 promoter under both aerobic and hypoxia 
conditions in yeast. 
 
 
 
3.3 Building the AR regulator 
 
3.3.1 Providing a DNA binding domain to the regulator 
GAL4 DNA binding domain  
Gal4p is a positive regulator for the gene expression of the galactose-induced genes of  
S. cerevisiae and is present only in fungi (Giniger et al. 1985). In this study, the Gal4p 
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DNA binding domain (Johnston and Dover, 1988) was incorporated in the AR 
regulator. The most important function of this domain is to directly favor the 
recruitment of transcription initiation complex, which in turn modifies the nucleosome 
structure (Axelrod et al., 1993). This provides the first step in which transcription 
independent binding of the activator(s) to a target promoter establish the architecture 
that favors contact between transcription activation domain and then the transcription 
initiation complex (Di Mauro et al., 2000). Glucose repressing of the processing of the 
Gal4p transactivator itself has not been reported, however, other repressors effecting 
Gal4p had to be taken in consideration. Normally the native Gal4p forms a tight poised 
complex with the repressor Gal80p. The Gal80 repressor protein binds to a 28 amino 
acid region at the very C-terminus of Gal4p, which coincides with Gal4p’s core 
activation domain and thereby physically blocks interactions of the activation domain 
with the transcriptional machinery (Wu et al., 1996; Koh et al., 1998). This domain 
was not included in the AR construct and therefore the AR regulator will not be 
subjected to Gal80p repression. Melcher and Xu (2001) found that, while binding of 
Gal4p to DNA is necessary for transcriptional activation, it is not sufficient and the 
chimeric transactivator had to be provided with a transactivation domain. 
 
 
3.3.2 Providing a transactivation domain to the AR regulator  
ADR1 transcription activation domain (TAD) III  
The transactivation domains (TADs) enable sequence-specific DNA binding proteins 
to stimulate transcription by recruiting the basal transcription proteins. It is unknown if 
the Mga2 protein has a domain directly responsible for the assembly of the pre-
initiation complex of transcription. It is more likely (my opinion) that the Mga2p 
facilitates a co-factor in the activation protein – DNA binding complex (enhancesome) 
at promoters to recruit the basal transcription machinery. As good constitutive 
expression was the main aim when building this transactivation system, it was thought 
to be wise to supply the regulator with this basic requirement for transcription. Even if 
the Mga2p domains inserted into the AR regulator contain transactivation domains, the 
region responsible for activation complex structure could be disturb in such a way that 
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the requirements for assembly of the pre-initiation complex would not be met. The 
ADR1TADIII was incorporated in the chimeric AR regulator to effect transcription 
from the fusion ‘GAL10/1’ (TATA-less) xyn2 core promoter. TADIII of Adr1p can 
recruit TBP and other components in the absence of a high affinity TATA binding site 
due to other protein-protein and/or protein-DNA interactions.  This ability however, 
depends on some additional function to form an active pre-initiation complex present 
in the ADR1 DNA binding domain (Ranish et al., 1999). The function (effected by a 
region within the ADR1DBD not included in the ARp construct) had to be provided by 
the DBD of Gal4p or MGA2 domains, ab or f, with a similar function. 
 
Adr1p has four transcription activation domains and a DNA binding domain. Only 
TADIII (amino acids 420-462) is active when fused to the Gal4 DNA binding domain 
(Young et al., 1998). The mode of function, recruiting of the pre-initiation complex 
proteins and /or chromatin remodeling can be summarized as follow. Adr1pTADs 
interacts with TFIIB, TFIID, Ada2 and Gcn5, thus recruiting active polymerase II 
complex to the promoter where it is involved in transcription of the target gene. TAD 
III of Adr1p is sufficient for remodeling the chromatin at the ADH2 promoter (Di 
Mauro et al., 2002).  
 
Adr1p is a well-characterized transactivator that functions as a metabolic switch 
protein acting in more than one pathway. The regulator is involved in ethanol 
metabolism, β-oxidation of fatty acids and peroxisome biogenesis (Gurvitz et al., 
2001; Schuller, 2003) and therefore plays an important role in non-fermentative 
metabolism of ethanol, glycerol, lactate, acetate and oleate. Adr1p activates alcohol 
dehydrogenase (ADH2) and acetyl-CoA synthetase (ACS1) in combination with a 
second transcription factor, Cat8p, required for two-carbon metabolism (Walther and 
Schuller, 2001). Adr1p and Ino2/Ino4p were implicated in derepression of the GUT1 
gene encoding glycerol kinase (Grauslund et al., 1999). Gurvitz et al. (2001) found 
that Adr1p is essential for fatty acid degradation and peroxisome proliferation as the 
oleic acid-inducible yeast gene SPS19 encoding the peroxisomal beta-oxidation 
auxiliary enzyme 2,4-dienoyl-CoA reductase is Adr1p-dependent. An interesting link 
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relevant to this study is that oleic acid is the substrate of OLE1 gene product and the 
Mga2p transcription activator regulates OLE1 transcription. Oleic acid induces OLE1 
transcription through fatty acid activation sequences (FAA) elements (Gurvitz et al., 
2001). 
 
 
3.3.3. Providing the AR regulator with signal sensing abilities  
Domains responsive to signals of Mga2p  
The aim of this study was two-fold: firstly to create a regulatory system ‘responsive’ to 
fermentation conditions and secondly, the experimental determination of domain 
functionality of specific regions of Mga2p. In silico predictions made in this study of 
functionality and hypotheses concerning the role of certain Mga2p domains/motifs 
(Chapter I and IV) needed to be confirmed by experimental data. The AR regulatory 
system can be described as an experimental tool to map domain function.  
 
Important regions of interest identified in in silico searches are: 
A putative ubiquitin-like region located in the N-terminal considered as a possible 
mono-ubiquitin site that may lead to activation processing of Mga2p. The N-
terminal region also included a putative nuclear localization site (NLS) and this 
domain was included in the AR regulator. 
♦ 
♦ 
♦ 
A motif located at the C-terminal, putative poly-ubiquitination site essential for 
degradation (and/or processing) of the Mga2p effected by UFA (and /or possibly 
hypoxia). This region was not inserted in the AR transactivator. 
A region containing ankyrin regions (similar to the NF-kappaB mammalian 
hypoxia transactivator) that facilitates DNA binding, dimerization (homo- or 
hetero-) and could be critical to the efficient sensing, signal transduction and/or 
formation of the activation complex at target promoters. Furthermore, ankyrin 
protein domains are described as multifunctional adaptors that link specific 
proteins to the membrane-associated, spectrin- actin cytoskeleton (Lodish et al., 
2001). 
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Similarities and differences between Mga2p and its homologue Spt23p were also used 
to determine which domains to incorporate in the AR regulator. 
 
Control of the Mga2p activator, and its homologue, is effected on protein level. By 
looking at the functions that Mga2p and Spt23p share, as well as differences in their 
activation patterns (described in Chapter I), it was possible to determine putative 
functions for certain Mga2p domains. The 50 amino acid N-terminal of Spt23p is 
necessary for transactivation as well as sufficient to function as a dosage dependent 
suppressor of Ty-induced promoter mutations and the essential functions of Spt23 
(Zhang et al., 1997). Based on studies that indicated that multicopy expression of a C-
terminal truncated form of Mga2p, unlike Spt23p, suppresses a narrow subset of Ty-
induced mutations, Zhang et al. (1997) stated that the Spt23 and Mga2 proteins are 
functionally and genetically related, but their functions do not completely overlap. The 
sequences of N-terminal regions of Mga2p and Spt23 were aligned and are presented 
in Fig. 2.1. Nakagawa et al. (2002) shown that Mga2p, but not Spt23p, plays a role as 
a transducer of low temperature signal.  
 
 Two of the important regions identified that influence the design of the AR regulator 
are the N-terminal and C-terminal regions of the two transactivators: 
The N-terminal of Spt23p shows only a 52% homology to the ab region of Mga2p 
(Fig. 2.1) with no homologies found from amino acids 1 to 26. These regions could 
be essential to confer abilities unique to Mga2p, such as low temperature sensing, 
and were included in the AR regulator. 
♦ 
♦ Spt23p and Mga2p differentially activate and regulate OLE1 transcription, 
especially in the presence of UFAs. Unsaturated fatty acids (UFAs) regulate both 
the release of the Spt23p from the ER and its processing but only Mga2p’s release 
and not its processing. In general, the repression effect mediated by UFA is more 
severe (‘effective’) for Spt23p than Mga2p. UFAs with more than one double bond 
almost completely block the processing of the precursor Spt23p (Hoppe et al., 
2000). UFAs repress the C-terminal truncated form of Mga2p but only at high 
UFA concentrations (Chellappa et al., 2001). The C-terminal domain of Mga2p 
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was not included in the AR regulator. In further studies the differences in the C-
terminal regions of theses two proteins can be exploited to find putative UFA 
controlled motifs and to determine the ‘graded’ mechanism of UFA control of 
these two transactivators.  
 
Alignment of Spt23p and a,b domains of Mga2p   
 
Translated ORF YIR033W align to translated ORF YKL020c [S. cerevisiae] 
Length = 1082 Score =  145 bits (367), Expect = 9e-36 
Identities = 90/268 (33%), Positives = 141/268 (52%), Gaps = 55/268 (20%) 
 
No homologies found from amino acids 1 to 26 
MGA2 : 26  VMESQLLDDFLLNGSPMYQDDSMAHINIDE--GANFQNFIKTDEGDSPNLLSFEGIGNNT 83 
           ++ES+LLD  LLN     QD  +  +N ++   A      K DEG+               
SPT23: 30  LLESELLDIALLNSGSSLQDPGLLSLNQEKMITAGTTTPGKEDEGE-------------- 75 
 
     : 84  HVNQNVSTPLEEEMESNRALKEEEEDEHENKVFNEKNIGNPAHDEIVFGRKETIQSVYIN 143 
                    L +++ S + L     D H                 + FGRK  +++ Y N 
Sbjct: 76  ---------LRDDIASLQGLL----DRH-----------------VQFGRKLPLRTPYAN 105 
 
Query: 144 PLDYLKVNAAQLPLDVEVSGLPQVSRVENQLKLKVKITSETPLNQSMLYLPSDSISREKF 203 
           PLD++ +N   LPL +E+ GLP+VSRVE Q+KL  +I +        ++LPSD I+++KF 
Sbjct: 106 PLDFININPQSLPLSLEIIGLPKVSRVETQMKLSFRIRNAHARKNFFIHLPSDCIAKDKF 165 
 
Query: 204 YLKK----NIEDFSEDFKKNLLYINAFVLCAVSNRTTN-----VCTKCVKREQRRAARRK 254 
           +       N+   + D  +  L+++AF+LCA +N + N     VC +C+ RE+RRA+RRK 
Sbjct: 166 FTSSDDPTNLTIPNRDINERTLFLDAFLLCASNNNSNNFKQTYVCNRCINREKRRASRRK 225 
 
Query: 255 SGIADNLLWCNNINRRLVVFNNKQVFPI 282 
           SG+ DN +W NN N+R ++FN+KQ+F I 
Sbjct: 226 SGLNDNSIWQNNENKRAIIFNSKQLFII 253 
 
Figure 2.1 Alignment of Spt23 protein and the a,b region of Mga2 protein. Unique Mga2p domains 
are blocked. 
 
 
In the next section of this chapter the evaluation of chimeric transcriptor- reporter gene 
construct transformed in yeast host cells will be presented in an article format. The 
sequence of pAR will be provided in the APPENDIX. 
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Engineering of a chimeric transcription regulator - reporter 
gene construct for gene expressing in Saccharomyces cerevisiae 
using Mga2p domains 
 
E.C. Van Schoor-Conradie and W.H. Van Zyl 
 
Abstract  A chimeric transcription activator regulatory system for Saccharomyces 
cerevisiae was constructed that induced gene transcription under all oxygen conditions 
(aerobic and hypoxia) with a further upregulation at low temperatures. The chimeric 
transcription activator (called AR transactivator) consisted of two domains of the yeast 
transcription regulator, Mga2p, the GAL4 DNA binding domain and the ADR1 TAD III 
transactivation domain. A fusion promoter consisting of a fragment of the GAL1/10 
promoter (providing GAL4 DNA binding elements) and a Trichoderma reesei core xyn2 
promoter was constructed as target for the AR transactivator and fused to a reporter 
gene. Both chimeric transactivator and reporter gene were expressed from the same 
episomal plasmid. At 30ºC, a 2 to 3-fold induction under aerobic conditions and an 
overall 3- to 4-fold induction under hypoxia conditions were found. The chimeric 
transactivator mediated a 7-fold induction of the reporter gene at 23ºC under aerobic 
conditions and a 2 to 3-fold (after 24 h and 48 h, respectively) at 23ºC under hypoxia 
conditions, when compared to a reference strain expressing a transcription activator 
without the Mga2p domains. This chimeric transactivator system allowed functional 
domain mapping of Mga2p and has a wider application to identify signal-sensing 
domains/motifs of other transcription factors. (200 words) 
Keywords: Mga2p, transcription regulator, low growth temperatures, Gal4pDBD, Adr1p 
TADIII 
 
Article will be presented in the format as requted by the Journal Applied Microbiology and 
Biotechnology. Patentrights have been applied for A CHIMERIC TRANSCRIPTION REGULATOR 
-REPORTER GENE CONSTRUCT, created in this work. Provisional patent number: PA38871-2 
 
______________________________________________________________________ 
Introduction 
 
The yeast Mga2p transcription regulator responds to cold shock and mediates 
upregulation of the OLE1 gene encoding a Δ9 fatty acid desaturase (Nakagawa et al., 
2002). The optimal membrane fluidity at low temperatures in Saccharomyces cerevisiae 
is modulated by changes in the degree of unsaturation of fatty acids (Nakagawa et al., 
2002; Torija et al., 2003). The transcription factor Mga2p and its homologue Spt23p, are 
responsible for changing cell membrane fluidity in response to hypoxia and /or altering 
saturated/unsaturated fatty acid ratios by mediating regulation of the transcription of 
OLE1 (Zhang et al., 1999). The upregulation of the OLE1 gene, mediate by Mga2p, is 
not uncommon as low-temperature induction of genes encoding fatty acid desaturases 
have been widely reported in cyanobacteria, plants, protozoan, the dimorphic fungus 
(Mucor rouxii), and fish (reviewed in Nakagawa et al., 2002). However, a low-
temperature signal transduction pathway has not been identified in yeast. 
 
In higher eukaryotes, cold-shock domain (CSD)-containing proteins, also called Y-box 
proteins, is part of the RNA binding group of proteins. These proteins play an important 
role in transcriptional and translational regulation of a wide range of genes by 
controlling the recruitment of mRNA to the translational machinery (Raimondi et al., 
2003). Low temperature signal sensors or transducers (also described as cold response 
proteins) that mediate upregulation of gene expression in response to a cold shock, has 
been identified and their respective promoter binding regions identified as the Y-box 
elements (Kohno et al., 2003). Protein motifs responsive to low temperatures, as well as 
the transduction mechanism of the Mga2p transactivator or the low temperature growth 
responsive promoter elements (if present in yeast) targeted by Mga2p, need to be 
identified before it will be possible to manipulate recombinant yeast strains under low 
temperatures. The yeast Hsp60 chaperone, is also induced by low temperatures, but is 
not known as a transcription regulator and seems not to overlap functionally with the 
Mga2p, except to sense and respond to similar signals. Cold and oxidative damage 
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signals induce Hsp60 to enable cells to recover from a low temperature shock and to 
protect the cells by preventing the release of iron-molecules from enzymes induced by 
this shock. Protection of Fe/S-containing enzymes from oxidative inactivation was found 
to be dose-dependent with respect to Hsp60 (Cabiscol et al. 2002). 
 
The production of single-chain antibodies in Pichia pastoris under low temperatures 
ensured reduced protease levels, allowing recovering of recombinant protein for up to  
96 h after induction at 15°C compared to 24-48 h at 30°C (Shi et al., 2003). 
Furthermore, the yeast cell numbers continued to increase at approximately the same 
rate when incubated at 30°C or 15°C, this suggested biomass accumulation at 30°C 
followed by a shift to lower temperature for extended recombinant protein production. 
Beer and wine production processes also could benefit from upregulation at low 
temperatures and hypoxia, but its application would depend on the acceptability of the 
use of genetic modified organisms in food and beverage production. This means that two 
conditions/signals are critical in the design of a global transcription activation system in 
yeast, namely hypoxia (low oxygen) and low temperatures (cold). The transcription 
activator Mga2p mediates both cold/low temperature upregulation as well as hypoxia 
induction of the OLE1 gene transcription (Nakagawa et al., 2002).  
 
To evaluate the signal response of Mga2p domains to cold/low temperature upregulation 
and hypoxia induction, the chimeric transcription regulator, AR, was constructed. This 
chimeric transcription regulator provided the two essential functions of a transactivator, 
namely to facilitate DNA binding and to provide the regulator with a domain able to 
facilitate assembling of the basal transcription machinery.  DNA binding was facilitated 
by inserting the well-characterized Gal4p DNA binding domain often used in yeast two-
hybrid studies (a system to study protein-protein interaction developed by Fields and 
Song, 1989) and shown to be functional when fused to Mga2p (Zhang et al., 1997). The 
transactivation domain TADIII of Adr1p confers the transactivation function of the 
Adr1p, a yeast transcriptional activator that controls glycerol metabolism, expression of 
the glucose-repressible alcohol dehydrogenase (ADH2) and genes involved in 
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peroxisome biogenesis and function (Young et al., 1998). The third characteristic of the 
transcription regulator is its responsiveness to cold and hypoxia signals. Mga2p mediates 
complex formation under hypoxia at the OLE1 low oxygen response element 
(Vasconcelles et al., 2001, Jiang et al., 2001). Through in silico searches for homologies 
to other proteins, or differences to Spt23, two domains of the Mga2p were identified as 
putative sensing domains and incorporation into the chimeric transactivator.  
 
Transcription activation by the chimeric AR transcription regulator under different 
conditions was evaluated by introducing a receptor promoter containing a truncated 
‘GAL10/1’ fragment (target of the GAL4 DNA binding domain) linked to the 
Trichoderma reesei core xyn2 promoter. Transcription levels were monitored by using 
the T. reesei xylanase II (xyn2) reporter gene. This synthetic promoter-reporter gene 
construct was incorporated onto the same episomal plasmid as the chimeric AR 
regulator expression cassette. The multicopy episomal plasmid with the AR regulatory 
system was transformed to S. cerevisiae Y294 strain and the levels of signal induction of 
the system was compared to a reference strain containing a control plasmid similar to 
pAR in all respects, except that it did not contain any Mga2 protein domains. This paper 
describes the construction and evaluation of the AR transcription regulatory system in 
recombinant yeast strains. 
 
___________________________________________________________________ 
Materials and methods 
Strains, media and culture conditions  
The genotypes and sources of the yeast and bacterial strains used in this study are 
summarized in Table 1. Yeast strains were grown in YPD medium (2% peptone, 1% 
yeast extract, and 2% glucose) or selective double strength synthetic (SC-URA) dropout 
medium. LB broth (Luria Bertani) was used for growth of E. coli strains at 37°C and 
supplemented with ampicillin at a concentration of 100 µg/ml (Sambrook et al., 1989). 
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5-Bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal) was added to a final 
concentration of 20 mg/ml when required.  
Table 1. Plasmids and strains: genotypes and sources 
 Genotype Source/references 
Strains   
E. coli   
XL1-Blue endA1 supE44 thi-1 recA1 gyrA96 relA1 lac[F' proAB lacIqZΔM15 
Tn10 (tet)] 
Stratagene 
S. cerevisiae   
Y294 α leu2-3,112 ura3-52 his3 trp-289 This laboratory 
Y294[pAR] α leu2-3,112 ura3-52 his3 trp-289 This work 
Y294[pRR] α leu2-3,112 ura3-52 his3 trp-289 This work 
Y294[p∆AR] α leu2-3,112 ura3-52 his3 trp-289 This work 
Y294[pARreverse 
ENO1p] 
α leu2-3,112 ura3-52 his3 trp-289 This work 
CBS 8066 wild type NRRL Y132  / ATTC 
4126  
Plasmids   
pDLG5 
 
pGEM-T-Easy 
pGEM-T 
bla URA3 ADH2P-xyn2-ADH2T 
 
bla 
bla 
YEP356 bla URA3 lacZ-1
La Grange et al. (1996) 
Promega 
Promega 
Myers et al. (1986) 
pEEC bla URA3 - RCO linker -ADH2t -LacZ This work 
pECX bla URA3 - RCO linker - ADH2t , core xyn2p xyn2 PGK1T This work 
pAR rev ENO1p bla URA3 ADH2t- AR-cassette1 ENO1p (rev) core xyn2p xyn2 PGK1t 
(ENO1p  (rev) insert  orientated in reverse of xyn2) 
This work  
p∆AR bla URA3 bla URA3 ENO1p ADH2t – ‘GAL10/1’ p core xyn2promoterp 
xyn2- PGK1t
This work  
pAR 
 
bla URA3 ENO1p AR-cassette1 ADH2t ‘’GAL10/1’p core xyn2 
promoter-xyn2-PGK1t 
This work  
pRR bla URA3 ENO1p RR–cassette2 ADH2t ‘’GAL10/1’p core xyn2 
promoter-  xyn2-PGK1 t 
 
This work  
 
1 AR-cassette = GAL4DBD - MGA2a,b,f  - ADR1TADIII 
2 RR-cassette = GAL4DBD - ADR1TADIII 
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Recombinant and reference yeast strains were cultivated and induced for reporter protein 
synthesis as follow: A single colony of a strain expressing the recombinant AR 
regulator-induced xyn2 reporter gene (or the reference regulator pRR), was used to 
inoculate 10 ml YPD medium and incubated overnight at 30 °C with shaking at 110 rpm 
and used to inoculate 90 ml YPD medium (final volume of 100 ml) and incubated 
overnight at 30 °C to late-log phase (A600 at 1.5-1.7). Between 5-10 ml cell suspensions 
were used to inoculate an 80-ml sealed serum flask containing 50 ml  
SC–URA medium, (hypoxia) or 500-mL Erlenmeyer flask containing 50 ml SC–URA 
medium, (aerobic) to an A600 of 0.4 to 0.5. Experiments were done in duplicate or 
triplicate for each condition at each temperature and incubated at 30°C, 23°C or 17°C 
with shaking at 80 rpm (New Brunswick Scientific Gyratory water bath shaker Model 
G76D). Regular sampling (2-ml aliquots) of the culture was done to determine cell 
density (at A600) converted to cell yields; cell yields (yeast cells were counted with 
haemocytometer) and to measure xylanase activities. For oxygen limited (hypoxia) 
cultivation, cells were grown in 80 ml serum flasks containing 50 ml growth medium 
and stirred at 110 rpm. Serum flasks were capped and treated after inoculation and 
sampling with N2 flushing to remove atmospheric oxygen. The serum flasks were sealed 
with a rubber stopper equipped with a syringe needle to release pressure, except in 
experiments reporting pressure. Sampling was done though the stopper with a sterile 
needle. In experiments under pressure, pressure was release when taking samples by 
inserting a syringe needle. Hypoxia conditions were effected by headspace exclusion 
during fermentation (Passoth et al., 2003). In experiments studying the effect of UFAs, a 
sterile mixture of ergosterol (1mg/l) /Tween80 (1.5% v/v) was added directly to the 
growth medium at time of inoculation. 
 
 
PCR reactions 
The polymerase chain reaction was carried out using the primers described in Table 2. 
The reaction was performed in a PCR Sprint Temperature Cycling System (Perkin-
Elmer GeneAmp® PCR System 24000). DNA was amplified in 50-µl reaction mixtures 
using the Expand High Fidelity PCR System (Roche Molecular Biochemicals) according  
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 to the manufacturer’s instructions.  After initial denaturation at 94°C for 120 s, 
amplification was done with 25 cycles of 15 s at 94°C, 45 s at the annealing 
temperatures listed in Table 2 for each primer set, and 45 s at 68°C. A final extension 
step of 7 min at 72°C before cooling to 4oC completed the reaction. Genomic DNA 
(gDNA) from S. cerevisiae strain CBS 8066 (for Mga2p domain fragments) was used as 
template. All primers included specific restriction sites to enable in-frame fusion of the 
fragments, easy excision of the fragments, as well as the insertion of other elements in 
future. 
 
Table 2. Primer sequences and annealing temperatures for genes fragments & linker 
 
Gene/cassette fragment  
Primer sequences 
Annealing 
temperatures  
RCO-linker 
5’- gca agc tta gct gtc atg ccc ggg cgg atc cgc ccg ggc atg aca gct aag ctt gc-3’ 
 
core xyn2 promoter-L 
5’-cgc gga tcc gcc cgg gca tgc aag ctt aaa tag aat tcg cca aac ctg aac aac c-3’ 
62°C 
xyn2- PGK1t -R 
5’-gcg acg tac gat atc ccc gaa cat aga aat atc gaa t-3’ 
62°C 
GAL4DBD-L 
5’-cgaagcttggatccgaattcatgaagctactgtcttctatcg-3’ 
62°C  
GAL4DBD-R 
5’-cgcgatatcagatcttggccacgatacagtcaactgtctttg-3’ 
62°C  
ADR1TADIII-L 
5’-gaagatcttacgtaatgcctgatttcgtcgattt-3’ 
61°C  
ADR1TADIII-R 
5’-gcggatatcgtcgacttagtcaatctcatttgacgtg-3’ 
61°C 
MGA2ab-L 
5’-gtgtggccaatgcagcagaacagtga-3’ 
60°C 
MGA2ab-R 
5’-ggaagatctcgtacgtcgcttaacacttggt-3’ 
60°C 
MGA2f-L 
5’-ttgcgtacgatgaatccagctttacattca-3’ 
59°C 
MGA2f-R 
5’-ggaagatctaggcctcatcttaataattttagggtcac-3’ 
59°C 
ELEG-L ‘GAL10/1’promoter fragment) 
5’-cgcggatcctggaactttcagtaatacgct-3’ 
60°C 
ELEG-R  
‘GAL10/1’ promoter fragment 
5’-gaagatctgaattcattgttcggagcagtgc-3’ 
60°C 
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 Plasmid constructs 
The yeast episomal plasmid, YEp365, was modified by making a XbaI-EcoRI deletion, 
follow by Klenow treatment to produced blunt ends and insertion of a multiple 
restriction site linker (RCO-linker, see Table 2). The S. cerevisiae ADH2 terminator, 
obtained with PCR from S. cerevisiae strain Y294 gDNA, was inserted as an EcoRI-SalI 
fragment into the linker to yield pEEC.  
 
A BamHI–BsiWI deletion was made in pEEC and a cassette containing the xylanase II 
(xyn2) gene of T. reesei was inserted. This cassette consists of a 118 bp native core 
promoter of xyn2, the xyn2 gene and the PGK1 terminator (Fig. 1) was obtained from 
plasmid pDLG5 amplified by PCR (Primers, Table 2). This vector was renamed, pECX 
(Fig. 1A). 
 
Fig. 1 Schematic representations of, (A) RR regulatory, and (B) AR regulatory cassettes
and (C) construction of plasmid pAR and pRR by inserting these cassettes into plasmid
pECX. See materials and methods for detailed description of construction.
p-xyn2
URA3
2µ
bla
pECX
A
PGKtADH2t
RCO
ENO1p GAL1/10P
BamHI BamHI/BglII
NotI MGA2
BsiWI Bal IBglIINot I BamHI
abf
ADR1
TADIII
GAL4
DBD
BalIBglIINot I BamHI
ADR1
TADIII
GAL4
DBD
B
C
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 The low temperature inducible expression vector pAR was created by inserting a 
chimeric transcription regulatory protein sequence, the AR regulator under control of the 
ENO1 promoter, in pECX. The S. cerevisiae ‘GAL1/10’ promoter sequence and the 
different fragments fused to form the AR regulator (GAL4 DNA binding domain, 
MGA2a,b and f, and the transcription activator ADR1 transactivation domain III), were 
created by first cloning all the relevant DNA sequences in pGEMtEasy or pGEMt 
(Promega). The criteria, for selecting specific domains of Mga2p to confer signal 
sensing, were based on their putative functions determined by in silico alignment to 
other known proteins and protein motif searches. Details of the transcription regulator 
and the reference regulator (RR) cassettes are illustrated in Fig. 1B and C, respectively. 
Primers used for all PCR amplifications are listed in Table 2.  
 
The enolase (ENO1) promoter used was a –512 to –1 bp upstream promoter region of 
the ENO1 gene. This promoter insertion was cloned upstream from the AR or RR 
regulator in pAR and pRR, respectively, to promote the transcription of the transcription 
regulator proteins. Plasmid pECX was restricted with BamHI and ligated to a BamHI–
BglII digested ENO1 promoter sequence to promote the transactivators. 
 
The target ‘GAL1/10’ promoter fragment was amplified by PCR using primers ELEG –L 
and R listed in Table 2 (which provided BamHI and BglII sites flanking the promoter for 
future cloning) and cloned in pGEMtEasy. This bi-directional 174-bp (-340 to –166, 
upstream of GAL10) promoter sequence contained multiple binding sites for the Gal4p 
protein, but excluded the putative glucose repression sites of the GAL/10 promoter. 
Plasmid pECX was restricted with BamHI, treated with CIP and the ‘GAL1/10’ 
promoter sequence was inserted upstream of the xyn2 reporter gene, containing a 118-bp 
core xyn2 promoter fragment, in pECX (Fig. 1A).  
 
Construction of reference plasmids 
 
Assembly of the reference regulator (RR) domains was done in pGEMtEasy as follow: 
A 168 bp ADR1TADIII fragment was amplified by PCR, using primers ADR1TADIII-L 
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and -R listed in Table 2, and cloned in pGEMtEasy. (ADR1TADIII-L provided a BglII 
site and ADR1TADIII -R provided an EcoRV site and an in-frame stop codon) This 
fragment was obtained as a BglII-EcoRV fragment and fused to GAL4DBD cloned in 
pGemtEASY, pre-digested with BglII and EcoRV. (The 441 bp GAL4DBD fragment 
was amplified by PCR using primers GAL4DBD-L and –R, listed in Table 2. The 
GAL4DBD fragment includes the native GAL4 start codon and the primers provided 
several restiction sites for further cloning). The resultant plasmid was sequenced to 
confirm the in-frame fusion of DNA sequences encoding GAL4DBD and ADR1TADIII 
to form the reference regulator (RR) cassette (Fig. 1C). The RR cassette was inserted as 
a BamHI and NotI fragment into plasmid pECX (Fig. 1A).  
 
A further two reference plasmids included plasmid pARrevENO1p containing a 
construct with the ENO1 promoter sequence directed towards the reporter gene and 
plasmid p∆AR, which lacks the AR or RR regulator gene (Table 1). 
 
 
AR regulatory cassette construction 
 
The AR regulator cassette (regulator with Mga2 domains a, b, and f) was constructed as 
follow: All domains of the AR transcription regulator protein were amplified by PCR 
(Table 2) and first cloned in pGEMtEasy. The pGEMtEasy vector containing the 
GAL4DBD was digested with BalI and BglII, treated with CIP and the MGA2 domain 
a,b was inserted as a 735 bp BalI-BglII fragment. After confirmation of the in-frame 
fusion of GAL4DBD and MGA2ab, the plasmid was digested with BsiWI and BglII and 
the 960 bp MGA2 domain f fragment inserted. This resulted in a plasmid containing a 
cassette consisting of GAL4DBD, MGA2a,b and MGA2f, which was digested with BglII 
and NotI, to enable insertion of the BglII – NotI ADR1TADIII fragment. The DNA 
sequence of the chimeric gene encoding this fusion protein was confirmed and the fusion 
activator protein was named the AR regulator (Fig. 1B). The AR cassette was inserted as 
a BamHI - NotI fragment into plasmid pECX (Fig. 1A).  
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Yeast transformations  
 
DNA transformation of E. coli was carried out by standard techniques described by 
Sambrook et al. (1989). Transformation of S. cerevisiae was done by the lithium acetate 
dimethylsulfoxide method described by Hill et al. (1991) or by electrophoration method 
(Sambrook et al., 1989). The yeast strain Y294 was transformed with plasmids pAR and 
pRR and the resulting transformants were called strain Y294[pAR] and Y294[pRR], 
respectively. The presence of plasmids in yeast transformants were confirmed with 
colony PCR (Akada et al., 2000), using primers based on the xyn2 gene. 
β-xylanase activity 
 
Recombinant strains were screened for β-xylanase induced activity by the AR regulator 
and compared to reference strains by patching on SC-URA agar medium containing 0.2% 
2-O-methyl-D-xylan-remazol brilliant blue R (RBB)-xylan (Sigma). Liquid xylanase 
assays were performed using the azoxylan (Megazyme, International Ireland Ltd.) 
method as instructed by the manufacturer with all volumes scaled down to one third of 
the prescribed volumes.  
 
 
Layout of both chimeric transactivator and reporter gene on plasmid pAR 
 
 
The strand orientation layout of the AR transactivator and the target fusion promoter-
reporter gene is illustrated in Fig. 2. pECX without a regulatory gene is illustrated in  
Fig. 2A. The AR transactivator gene and the xyn2 reporter gene are transcribed in 
opposite directions to avoid read-though between the two transcriptional units (Fig. 2B).  
A similar construct was made for pRR (Fig. 2C). The layout of the pRR, the reference 
regulator-reporter plasmid, is the same except for the absence of the Mga2 domains.  
The transcription and translation of the regulator proteins and the subsequent binding of 
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the activator at the Gal4p target elements present in the ‘GAL1/10’ promoter fragment to 
mediate transcription of the reporter xyn2 gene are demonstrated in Fig. 2. 
 
 
D
E
B AR transactivator
‘GAL1/10’-xyn2pADH2t ENO1p xyn2 gene
Fusion promoter
C RR transactivator
‘GAL1/10’-xyn2pADH2t ENO1p xyn2 gene
Fusion promoter
F
A
xyn2pADH2t xyn2 gene
 
 
Fig.  2  The strand orientation of reporter gene and chimeric transactivator on plasmids (A) pECX, (B) 
pAR and (C) pRR.  The orientation of the transcription activator (– strand) and the reporter gene construct 
(+ strand) are indicated by arrows. Transcription under control of the ENO1 promoter, and translation is 
illustrated.  Binding of the AR regulatory protein at the Gal4p target sites of the ‘GAL1/10’ promoter 
fragment to reporter gene transcription is indicated to illustrate the functioning of the AR regulator.  
β-xylanase producing recombinant strains transformed with the plasmids in A-C are indicated in D-F, 
respectively. SC-URA medium with 0.2% RBB-xylan was spotted with (D) S. cerevisiae Y294 [pECX], (E) 
S. cerevisiae Y294 [pAR], (F) S. cerevisiae Y294 [pRR], and photographed aerobic incubation at 30°C for 
3 days. 
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Results  
 
 
 
 
Screening for β-xylanase activity 
 
 
The xyn2 gene of T. reesei, encoding the β-xylanase II, was used as reporter gene in this 
study. To evaluate the induction of transcription by the chimeric transactivator-promoter 
construct, the S. cerevisiae Y294 host cells transformed with the respective plasmids 
were checked for activity on RBB-plates to form a clear zone after three days of growth 
at 30 ˚C under aerobic conditions (Fig. 2 D-F). The recombinant Y294[pECX] strain 
showed no clearing zone formation on the RBB-xylan plates (Fig. 2D). This was 
expected as this strain expressed xylanase only under control of the core xyn2 promoter. 
The Y294[pAR] and Y294[pRR] strains showed clearing zone formation on the RBB-
xylan plates indicating that both the RR regulator and AR regulators are functional 
transcription activators able bind at the target ‘GAL10/1’- core xyn2 fusion promoter to 
mediate transcription of the xyn2 gene.  
 
The size of the clearing zone indicated that the level of induction mediated by the AR 
regulator (Fig. 2E) was found to be higher than level of induction mediated by the RR 
regulator (Fig. 2F). The evaluation of transformants of two independent transformations 
of Y294[pAR] and Y294[pRR] yielded comparable results. 
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Evaluation of the AR regulatory system under aerobic and hypoxia conditions at 17˚C, 
23˚C and 30˚C. 
 
The chimeric transactivator strain Y294[pAR] was analyzed for its ability to induce 
reporter gene transcription at different temperatures (17°C, 23°C and 30°C) under 
aerobic and anaerobic conditions by measuring β-xylanase activities. To quantify the 
levels of induction, the recombinant strains were grown in liquid cultures. The 
expression increased significantly at low temperatures under aerobic conditions. Three–
fold higher β-xylanase activity was found at 23°C (at 24 h to 72 h) relative to at 30°C 
(Fig. 3). The chimeric AR regulator system induced 5-fold higher β-xylanase activity at 
26 h and 3-fold at 48 h, compared to induction mediated by the reference RR regulator at 
30°C (Fig. 4). A 10-fold induction levels by the AR system was found under aerobic 
conditions at 23°C (at 26 h, Fig. 4) and at 17°C (at 48 h, Fig. 3A). compared to induction 
mediated by the reference RR regulator at the same temperatures. 
Induction levels by the AR system were found under aerobic conditions at 17°C similar 
to induction levels found at 23°C at 72 h (Fig. 3A) and this induction was sustained until 
178 h (data not shown). Statistical analysis of induction at 23°C compared to induction 
at 30°C under aerobic conditions was made and the difference between the two 
temperatures at different time-points, indicated in Fig. 3B, was significant. A significant 
difference was also found when reporter gene induction levels calculated per 106 cells 
were analyzed at the two temperatures (Analysis presented in APPENDIX, Chapter II). 
At 23°C, the induction levels under hypoxia conditions increased to ~ 3 fold relative to 
the induction found for that of the RR regulator over a period of 78 hrs (Fig. 4).  
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Fig.  3 (A) β-xylanase reporter gene expression mediated by the AR regulator in strain Y294[pAR] under 
aerobic conditions at 17, 23 and 30°C (23 and 30°C, n = 3 to 4 experiments, 17°C, n = 2,  # = not done) 
(B) The gene expression levels at 23 and 30°C (n = 3 to 4 experiments) were compared using Two-way 
Anova statistical test (*p < 0.001). For detail see Appendix to Chapter II♣. 
 
                                                 
♣ Expression levels reported in terms of activity/cell count as well as data including activation levels and 
activity / cell count determined for two transformants are included and discussed in Appendix Chapter II 
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Fig.  4 β-xylanase reporter gene expression directed by the AR regulator in strain Y294[pAR] compared 
to the reference strain Y294 [pRR] at different oxygen levels and temperatures. The black line indicates 
the maximum induction found for the references strains, Y294 [pARrevENO1p] and Y294[p∆AR], which 
lack the AR or RR regulator genes (n = or > 3 experiments).  
 
Under hypoxia conditions at 30°C, the level of reporter gene activity induction by the 
AR system was lower than under aerobic conditions, but was still upregulated relative to 
the reference strain (2-fold at 26 h and 3-fold at 48 h) (Fig. 4). Under hypoxia, at 23°C, 
the level of induction was approximately 2 to 3-fold higher at 26 h compared to 
induction levels at 30°C mediated by the AR regulator, however, similar levels were 
found at 48 h. Upregulation at 23°C under hypoxia compared to the reference strain was 
2-fold and 3-fold at 26 h and 48 h, respectively, compared to levels found at 30°C  
(Fig. 4). 
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Low induction was mediated by the RR regulator at 26h under hypoxia at low 
temperatures and at 30°C. A similar trancient low level induction, only at 48 h, was 
found under aerobic conditions at 30°C mediated by the RR regulator. 
 
The effect of pressure release under hypoxia  
Evaluation of the expression levels under hypoxia showed a marked difference between 
data obtained when pressure was release continuously (method applied describe by 
Passoth et al. (2003)), compared to induction levels found under CO2 pressure, with 
pressure only released during sampling. Under pressure, at 23°C, induction mediated by 
the AR regulator was two to three-fold reduced compared to induction levels if pressure 
was constantly released (Fig. 5). Studies of expression levels under pressure at 30°C 
showed a similar induction effect with the release of pressure on reporter gene induction 
levels (Data not shown).  
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Fig.  5 The effect of pressure on hypoxia induction at 23°C (n = 3 experiments) of the β-xylanase reporter 
gene expression directed by the AR regulator in strain Y294[pAR]. 
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 Evaluation of other reference constructs  
The reference strains Y294[p∆AR] and  Y294[pARrev ENO1p] showed a low basal 
expression level of the reporter gene. This may indicate basal expression mediate by the 
xyn2 core promoter. Baseline expression levels mediated under aerobic and hypoxia 
conditions mediated by the reference strain Y294[pAR (rev ENO1p)], containing a 
construct with the ENO1 promoter sequence directed towards the reporter gene are 
indicated in Fig. 5. 
 
Growth of recombinant strains S. cerevisiae Y294[pAR] and Y294[pRR] 
 
The effect of different growth conditions on cell growth of the recombinant Y294[pAR] 
strain and the reference strain was monitored over a 48 - 78 h period (Fig. 6). Average 
cell yields of the recombinant strain Y294[pAR] at 23 °C was similar to that found at 
higher temperatures under aerobic conditions at 24 h and 48 h, but lower than the 
average cell yields under hypoxia conditions at 30°C. Cell yields studies of 
transformants indicate that expression of the multicopy plasmid based pAR regulator 
does not have a negative effect on cell yields in the host Y294 if compared to the 
reference strain (expressing the RR regulator) (Fig. 6). The hypoxia cell yields of the 
reference strain Y294[pRR] (Fig. 6), was lower than that of Y294[pAR]. Cell yields of 
the other two reference strains Y294[pAR (rev ENO1p)] and Y294[p∆AR] where both 
lower than Y294[pAR] at 30°C under aerobic and hypoxia conditions but cell yields 
were not as severely affected as found under hypoxia for the Y294[pRR] strain (data not 
shown).  
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Fig. 6 Growth yields of recombinant strain Y294[pAR] and reference strain Y294[pRR] at different 
temperatures and oxygen levels (n = 3 or > 3 experiments). 
 
 
_____________________________________________________________________ 
Discussion 
 
The AR chimeric transactivator was engineered, inducing gene expression at low 
temperature, mediated through two Mga2p regions/domains. In silico searches with 
sequence alignments across-species at both the nucleotide and the amino acid levels 
were done to identify putative functional domains of Mga2p for incorporation in the AR 
regulator. These domains included a putative RAD23 ubiquitin-like region1, putative 
                                                 
1 RAD23 encodes a proteasome cofactor and Rad23 is a putative adaptor molecule for the delivery of 
ubiquitylated substrates to the proteasome since it interacts with ubiquitin chains through its ubiquitin-
associated motifs (UBA) and with the proteasome through a ubiquitin-like element (UBL) (Kim et al., 
2004). 
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nuclear localization signal (NLS) motif and an ankyrin region2 (possibly responsible for 
protein- or DNA-dimerization) also found in the NF-kappaB mammalian hypoxia 
transactivator. This cold-induction mediated transcription was over and above the 
expression levels found at aerobic and hypoxia conditions at 30°C. The reference 
regulator (RR) that lacks the Mga2p domains, did not induce gene expression under 
similar conditions and only a low-level transient upregulation was found at low 
temperature at 24 h. 
The AR regulation system directed gene upregulation at both 17°C and 23°C. Difference 
between 17°C or 23°C for the yeast cell could mean cold stress conditions and optimal 
temperature for survival, respectively. In this study, cells were not exposed to a sudden 
cold shock. In general, temperatures below 20°C are considered as stress conditions for 
yeast cells. The upregulation mediated by the AR regulatory system at 17°C indicates a 
putative application for the AR system at even lower temperatures or possibly in yeast 
cells exposed to cold shock conditions.  
 
The AR regulatory system should also be evaluated in large-scale fedbatch or chemostat 
bioreactors in future studies to simulate the conditions the AR regulatory will be 
subjected to when implemented as a tool in e.g. controlled recombinant protein 
production3. Simultaneous and synergistic saccharification and fermentation of 
amorphous cellulose to ethanol with the use of recombinant yeast encoding three types 
of recombinant cellulolytic enzymes was recently attempted by Fujita et al. (2004). If 
this one step conversion could be upregulated at low temperatures, it will translate into 
energy-saving ethanol production. The temperature optima of the different degradation 
enzymes should be compatible to the host organism and optimal induction temperature 
(indicated in this study to be at between 17ºC and 23ºC) of the AR regulatory system. 
Akila and Chandra (2003) recently found a cold-tolerant Clostridium strain PXYL1 that 
                                                 
2 Ankyrin domains are multifunctional adaptors that link specific proteins to the membrane-associated, 
spectrin- actin cytoskeleton (Michaely et al., 2002). 
3 Preliminary studies in a ‘fedbatch’ system (see Appendix, Chapter II) did indicate that the pAR system 
mediate upregulation of the reporter gene for up to ~100 h under aerobic conditions. 
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produces extracellular hydrolytic enzymes (xylanase, endoglucanase, beta-xylosidase, 
beta-glucosidase and filter paper cellulase) all of which had maximal activity at 20ºC. 
The AR regulatory system can, apart from manipulating heterologous protein 
production, also be employed to regulate metabolic control at the transcription level by 
upregulating targeted promoter(s) of essential genes in metabolic processes in 
recombinant yeast under certain fermentation conditions. The incorporation of the 
chimeric AR regulatory system on a wider scale in the yeast cell would allow regulation 
of all the “connected” metabolic processes in response to temperature or could mediated 
a two to four -fold induction above basal levels under aerobic and hypoxia conditions at 
30ºC.  
 
The C-terminal truncated plasmid encoded yeast Mga2p hypoxia transcription regulator 
was identified to be responsive to cold shock and mediated upregulation of OLE1 gene 
encoding Δ9 fatty acid desaturase when yeast cells were shifted from 30˚C to 10˚C 
(Nakagawa et al., 2002). Nakagawa et al. (2002) suggested that low temperatures also 
induce the same low oxygen response (LOR) element-binding complex induced by 
hypoxia (Jiang et al., 2001, Vasconcelles et al., 2001) 4. This implies an overlapping of 
the low-temperature and hypoxia signal transduction pathways. However, unsaturated 
fatty acids affect hypoxia induction, but do not repress the low temperature induction of 
OLE1, indicating the existence of two signal transduction pathways. Nakagawa et al. 
(2002) suggested that UFAs did not suppress the low temperature signal, because this 
signal inhibits the UFA signal transduction pathway that prevents proteolytic release of 
the active form (processing) of Mga2p. UFAs could also suppress the modification of 
the N-terminal active form of the transactivator MGA2p (Chellappa et al., 2001). The C-
terminal region of Mga2p was not included in the AR regulator. Lack of UFA sensitivity 
(data not shown) and an inability to confer hypoxia upregulation above aerobic levels by 
the AR regulator (Fig. 4) could confirm an essential function for the C-terminal domain 
of the Mga2p in sensing hypoxia of UFAs levels. The AR regulator provides the ideal 
                                                 
4 In Chapter IV the possible role of the putative LOR element present at the core xyn2 promoter will be 
discussed, as well as scenarios illustrating the possible activation complexes formed to induce 
transcription mediated by the AR regulator. 
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system to test this hypothesis. By inserting regions of C-terminal domain of Mga2p in 
the AR regulator, motifs responsible for sensing hypoxia and/or UFA levels, could be 
identified.  
 
The RR regulator may well be not a fully functional transcription activator, as it could 
not induce transcription similar to the levels found for the pAR regulator (Fig. 4). The 
RR regulator also may have a deleterious effect on gene expression, effecting cell 
growth (Fig. 6) by interfering with the functioning of native transactivators5. 
 
Speculations that Mga2p could be a RNA-binding, cold-shock domain (CSD)/Y box-
containing or Y box-like protein could be tested if the AR regulator is used as bait 
protein in DNA-RNA and protein-protein interactions studies. No domains similar to Y-
box proteins found in higher eukaryotes and bacteria are present in Mga2p nor has any 
been found in other fungi. Speculations are based on the similarities between the role 
Mga2p plays in the yeast cell and that of Y-box proteins. The shared functions involve 
DNA-RNA and protein-protein interactions. Similar to Y-box proteins, Mga2p also 
responds to environmental signals and like the cold shock domain of YB-1, Mga2p is 
responsible for mRNA stabilizing activity within a protein complex (Kandasamy et al., 
2004). The post-transcriptional fate of eukaryotic mRNAs depends on association with 
different classes of RNA-binding proteins. A recent study showed significant hypoxia 
upregulation of two related mammalian nuclear ribonucleoproteins, the RNA-binding 
motif protein 3 (RBM3) and cold-inducible RNA-binding protein (CIRP), which are 
highly conserved cold stress proteins with RNA-binding properties (Wellmann et al., 
2004). Coles et al. (2002) report the identification of complexes, binding to the 
VEGFmRNA 5'- and 3'-untranslated region (UTR), that contain cold shock domain 
(CSD) and polypyrimidine tract binding (PTB) RNA binding proteins. CSD/PTB 
binding sites revealed a potential role in VEGF mRNA stability, in both non-induced 
and induced conditions, demonstrating a general stabilizing function as was indicated for 
Mga2p (Kandasamy et al., 2004). Overlapping of signal responses complicates the study 
of regulatory mechanisms but does indicate putative control mechanisms of 
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transactivators. Another example is the single strand DNA-specific cold shock domain 
(CSD or Y-box) protein found to repress the hypoxia-responsive region (binding site of 
the Hypoxia Inducible Factor (HIF)) via a binding site downstream of the HIF-1 site 
(Coles et al., 2002) in mammalian cells. The repressor site is functional in unstimulated, 
normoxic fibroblasts and represents a novel means to prevent expression of vascular 
endothelium growth factor (VEGF) in the absence of appropriate stimuli. 
 
The effect of CO2 pressure under hypoxia should be considered when applying the AR 
regulatory system to host cells for recombinant gene production as the AR regulator did 
not mediate induction under hypoxia under pressure at 30˚C similar to aerobic levels 
(Fig. 5). It will be interesting to study the effect of both pressure and low temperatures 
on the AR regulatory system as Palhano et al. (2004) found that the cell stress response 
to high hydrostatic pressure (220 MPa) shares common features with hydrogen peroxide 
and ethanol stresses in yeast, but differs in some way to cold-shock. Interestingly, one of 
the enzymes involved in Mga2p proteolytic activation processing, the ubiquitination 
enzyme Rsp5 (Shcherbik et al., 2003) is implicated in playing a major role in a response 
to reduced uptake of tryptophan (leading to cell cycle arrest) in cells subjected to high 
hydrostatic pressure at low temperatures (Nagayama et al., 2004)5. The AR regulatory 
system could provide new insights in the induction pattern induced by these signals 
commonly found in large-scale beer production. 
 
 
The mechanism by which the AR regulator mediates expression levels of the reporter 
gene is unknown. Kandasamy et al. (2004) showed that the Mga2p does promote OLE1 
mRNA stability in fatty acid free medium under its native promoter, but also promote 
this when the OLE1 was placed under control of a GAL1/10 promoter. This mRNA 
stability of OLE1 was divided in basal stability (not effected by unsaturated fatty acids) 
and regulatory stability (affected by unsaturated fatty acids). Preliminary studies showed 
that induction mediated by the AR regulator was not affected by unsaturated fatty acids 
(UFAs) under aerobic or anaerobic conditions (data not shown). It can be speculated 
                                                 
5 See chapter IV for more detail 
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when comparisons are made to the work done by Kandasamy et al. (2004), that the two 
Mga2p domains, annotated ‘’ab’’ and ‘’f’’ may enable the AR regulator to mediate basal 
mRNA stabilizing ability (not affected by UFAs) under aerobic and hypoxia conditions 
at 30°C.   
 
The study by Kandasamy et al. (2004) did not include low temperature growth 
conditions. In this study, the xyn2 reporter gene was cloned under control of a synthetic 
promoter that consists of a partial GAL1/10 promoter fragment - core T. reesei xyn2 
promoter. Again, RNA stability is implicated as the method of upregulation mediated by 
Mga2p rather than gene transcription, unless the GAL1/10 promoter (or the partial 
fragment used in this study) is a target of the Mga2 transactivator. It should be noted that 
in this study, both the native Mga2p and the chimeric AR regulator are present in the 
cells (the plasmid encoded AR regulatory system was not tested in a mga2 spt23 strain). 
No adverse affect on cell growth of recombinant strains expressing the AR regulator was 
found.  
 
The question remains how does the Mga2 protein or AR regulators recognize the OLE1 
transcripts or xyn2 reporter gene transcripts? The Mga2p might, under certain 
conditions, indiscriminately enhance stabilization and/or enhance export of all mRNA 
transcripts once transcription is underway. This mechanism could explain the 
unregulated basal stability mediated by Mga2p irrespective of the promoter that drives 
transcription (Kandasamy et al., 2004) and the aerobic and anaerobic unregulated 
induction of the reporter gene mediated by the AR regulator in this study. Mechanisms 
whereby further upregulation above ‘unregulated levels’ are mediated by transcription 
activators under low temperatures, could be determined if the proteins are identified that 
interact with the AR regulator under these conditions. 
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Appendix Chapter II 
 
The t-test evaluates differences in means between two independent samples and the two-
way ANOVA (ANalysis Of VAriance) evaluates the means across different levels of 
factor 1 (temperature) averaging across levels of factor 2 (time). Temperature proves to 
be significant, the means differed statistically significant with p < 0.001 (Note: Different 
transformants indicated as AR-1 and AR-2). 
 
TWO-WAY ANOVA for Y294[AR-1] only (mUnits without cell counts) 
 
Between-Subjects Factors 
 Value Label N
temperature 1.00 30 degrees 15
2.00 23 degrees 12
time 1.00 24h 10
2.00 48h 10
3.00 72h 7
 
Tests of Between-Subjects Effects 
Dependent Variable: growth  
Source Type III Sum of 
Squares 
df Mean Square F Sig.
Corrected Model 910.418 5 182.084 25.894 .000
Intercept 5480.847 1 5480.847 779.420 .000
TEMP 888.546 1 888.546 126.358 .000
TIME .156 2 7.809E-02 .011 .989
TEMP * TIME 17.247 2 8.623 1.226 .314
Error 147.671 21 7.032
Total 6478.732 27
Corrected Total 1058.089 26
a  R Squared = .860 (Adjusted R Squared = .827) 
 
TWO-WAY ANOVA for Y294[AR-1] (-1 indicate transformant)  only (mUnits with cell counts) 
 
Between-Subjects Factors 
 Value Label N
temperature 1.00 30 degrees 15
2.00 23 degrees 12
time 1.00 24h 10
2.00 48h 10
3.00 72h 7
 
Tests of Between-Subjects Effects 
Dependent Variable: growth with cell growth  
Source Type III Sum of 
Squares 
df Mean Square F Sig.
Corrected Model 2.594E-02 5 5.187E-03 19.631 .000
Intercept .247 1 .247 933.619 .000
TEMP 2.528E-02 1 2.528E-02 95.685 .000
TIME 3.429E-05 2 1.715E-05 .065 .937
TEMP * TIME 3.335E-04 2 1.667E-04 .631 .542
Error 5.549E-03 21 2.642E-04
Total .279 27
Corrected Total 3.149E-02 26
a  R Squared = .824 (Adjusted R Squared = .782) 
 
Descriptives (means and standard deviations) 
 
Descriptive for Y294[AR-1] at 24H 
 
Descriptive Statistics 
Mean Std. Deviation
Activity 13.7050904 6.1081467
Activity/ cell 
growth
9.396112E-02 3.493564E-02
Descriptive for Y294[AR-1] at 48H 
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Descriptive Statistics 
Mean Std. Deviation
Activity 13.5857763 5.7959786
Activity/ cell 
growth
9.219335E-02 3.129333E-02
Descriptive for Y294[AR-1] at 72H 
Descriptive Statistics 
Mean Std. Deviation
Activity 15.6654495 8.1520417
Activity/ cell 
growth
.1030291 4.312658E-02
 
Comparison of two transformants
 
TWO-WAY ANOVA for Y294[AR-1] and Y294[AR-2] 
In the following two tables it was determine that P < 0.001, indicating that the nil-hypothesis is true in the case of activity and 
activity/cell count. 
However, the R-squared value indicates that when both transformants are compared in terms of activity/ cell growth, only 53% of 
variance in activity/ cell growth could be explain by temperature and time.  
(It may be speculate that differences in viability and vitality of the pre-inoculum could have been the reason for this.) 
 
General Linear Model = TWO-WAY ANOVA for AR-1 and AR-2 
 
Post hoc tests are not performed for temperature when looking at two transformants because there 
are fewer than three groups when the two transformants are compared. 
 
Between-Subjects Factors 
 Value Label N
temperature 1.00 30 degrees 17
2.00 23 degrees 15
time 1.00 24h 12
2.00 48h 12
3.00 72h 8
Multivariate Tests 
Effect  Value F Hypothesis df Error df Sig.
Intercept Pillai's Trace .971 445.017 2.000 27.000 .000
Wilks' Lambda .029 445.017 2.000 27.000 .000
Hotelling's Trace 32.964 445.017 2.000 27.000 .000
Roy's Largest 
Root 
32.964 445.017 2.000 27.000 .000
TEMP Pillai's Trace .646 24.631 2.000 27.000 .000
Wilks' Lambda .354 24.631 2.000 27.000 .000
Hotelling's Trace 1.825 24.631 2.000 27.000 .000
Roy's Largest 
Root 
1.825 24.631 2.000 27.000 .000
TIME Pillai's Trace .043 .306 4.000 56.000 .873
Wilks' Lambda .957 .297 4.000 54.000 .878
Hotelling's Trace .044 .289 4.000 52.000 .884
Roy's Largest 
Root 
.040 .564 2.000 28.000 .575
a  Exact statistic 
b  The statistic is an upper bound on F that yields a lower bound on the significance level. 
c  Design: Intercept+TEMP+TIME 
 
Tests of Between-Subjects Effects 
Source Dependent 
Variable 
Type III Sum of
Squares
df Mean Square F Sig.
Corrected Model growth 1201.816 3 400.605 4.699 .009
growth with cell 
growth 
2.867E-02 3 9.557E-03 10.481 .000
Intercept growth 10241.610 1 10241.610 120.125 .000
growth with cell 
growth 
.361 1 .361 395.815 .000
TEMP growth 1195.356 1 1195.356 14.020 .001
growth with 
cell growth 
2.841E-02 1 2.841E-02 31.163 .000
TIME growth 14.082 2 7.041 .083 .921
growth with cell 
growth 
3.736E-04 2 1.868E-04 .205 .816
Error growth 2387.222 28 85.258
growth with cell 
growth 
2.553E-02 28 9.118E-04
Total growth 13917.778 32
growth with cell 
growth 
.420 32
Corrected Total growth 3589.037 31
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growth with cell 
growth 
5.420E-02 31
a  R Squared = .335 (Adjusted R Squared = .264) 
b  R Squared = .529 (Adjusted R Squared = .478) 
 
Descriptives for both Y294[AR-1] and Y294[AR-2] at 24H 
Descriptive Statistics 
Mean Std. Deviation
Activity 17.6904371 10.9650276
Activity/ cell 
growth
.1072920 4.509558E-02
Descriptives for both Y294[AR-1] and Y294[AR-2] at 48H 
Descriptive Statistics 
Mean Std. Deviation
Activity 17.7228091 10.9986094
Activity/ cell 
growth
.1037501 3.914807E-02
Descriptives for both Y294[AR-1] and Y294[AR-2] at 72H 
Descriptive Statistics 
Mean Std. Deviation
Activity 18.7436850 11.5224290
Activity/ cell 
growth
.1110003 4.585336E-02
 
ANOVA 
Two-way ANOVA (Analysis of variance) is conducted to test whether the population means on the dependent variable (GROWTH) 
differs across levels (23 °C and 30°C) of the first factor (TEMPERATURE) averaging across levels (24, 48 and 72h) of the second 
factor (TIME). As TEMPERATURE prove to be significant, the means differed statistically significant with p < 0.001, follow-up 
tests were done to establish the difference between the two temperatures without the effect of the factor TIME.  
 
Acknowledgements:  We are grateful to Marina Muller for her statistical analysis of 
data. 
 
 
‘Fedbatch’ evaluation of the AR regulatory system 
 
A preliminary study indicated that in a ‘fedbatch’ system the AR regulatory system could mediate YFG 
(xyn2 reporter gene in this system) induction up to 6-fold for an period of up to 155 h under aerobic 
conditions at 30 °C (Fig. 7). A ~5-fold induction level mediated by the AR regulator in the pre-culture of 
the recombinant strain Y294[pAR] (above that found for the reference strain, Y294[pRR]) was sustained 
under aerobic conditions at 30 °C until the culture was divided (Fig.7). A supplement of 200ml, 2% 
glucose double strength SC-URA3 minimal medium was made to the fermentation at 24 h, 48 h and 78 h. A 
sustained production of xylanase were found under these conditions. Interestingly, a high level of xylanase 
production was found in the pre-culture after 24 h (0 h in Fig. 7). The pre-culture was prepared under non-
selection conditions (500ml YPD medium) under aerobic conditions at 30 °C. 
 
The culture was divided at 155 h. A 250ml Erlenmeyer flask was filled with 200ml to induce ‘semi-
anaerobic’ (hypoxia) conditions and another 1 liter flask was filled with 200ml of the 155 h old culture 
(aerobic conditions). A supplement of 2% glucose was made at 192 h, 216 h and 240 h to both cultures, 
but no additional nutrients were added. Induction levels under both anaerobic and aerobic conditions (~3-
fold higher compared to the reference strain) were found when only 2% v/v carbon source was added, 
however reporter gene levels steadily decrease within 24H. The age of culture, nutrient depletion as well 
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as pH could play a role in the reduction of xylanase production, however further studies are needed in a 
controllable system on an industrial scale of the pAR regulatory system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  7 “Fedbatch” study in Erlenmeyer shakeflasks of the recombinant strain Y294[pAR] compared to the 
reference strain Y294[pRR]. Reporter gene induction under aerobic conditions were determine in 
duplicate at 24 h -155 h at 30°C. The culture was divided at 155 h (see text for detail) and evaluated under 
aerobic and hypoxia (headspace exclusion in shake flasks). (These bar graphs each represent only one 
experiment). 200ml, 2% glucose v/v double strength SC-URA3 minimal medium was added at time points  
24 h, 48 h and 78 h. Induction mediated by the AR regulator in the overnight grown pre-culture (500ml, 
YPD medium at 30°C) is indicated at time point, 0 h.  
 
(This preliminary study was not done in triplicate nor induction determined for reference strain at all time 
points and should be repeated). 
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 Chapter III 
 
 
 
Design of a bi-directional reporter gene vector and screening for hypoxia 
inducible promoters  
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1. Introduction 
 
The versatile yeast, Saccharomyces cerevisiae, is used by man as a bread raiser, an 
alcohol producer, as well as the production of yeast and non-yeast recombinant proteins. 
The applications of this already versatile yeast could be further enhanced for industrial 
processes by using hypoxia signals to upregulate gene transcription. Upregulation of 
both enzyme production and fermentation under hypoxia (or anaerobic conditions) could 
increase ethanol production. The objective of this study was to search for promoter 
elements, sensitive/responsive to hypoxia, to simulate conditions that the recombinant 
yeast will be exposed to in a one-step conversion of complex lignocellulolytic substrates 
to ethanol in an industrial process. Recently the simultaneous degradation of a complex 
substrate (amorphous cellulose) and ethanol production in genetically modified yeast did 
become a reality (Fujita et al., 2004). Initial promoter screening in this study was done 
under anaerobic conditions in minimal media, containing raffinose and low glucose, to 
find promoters that could be modified and applied in recombinant yeast expressing 
hydrolytic enzymes∝.  
 
A classical genomic library screening technique was used, using a designer bi-
directional reporter gene promoter-screening vector. The plasmid vector was build, 
using YEp356 as basis and the following components were added: 
1. Multiple cloning sites to insert promoters sequences; 
2. The Trichoderma reesei xylanase II (xyn2); and 
3. The Streptomyces hydroliticus resistance hygromycin marker (hph-1) inserted in the 
opposite direction as a second reporter gene, flanking the multiple cloning linker.  
 
Screening promoter libraries with the bi-directional reporter gene vector increased the 
probability to ‘find’ promoter fragments mediating upregulation by 50%, as uni-
directional promoter elements were checked simultaneously in both directions. Low 
basal levels were found with the core xyn2 promoter. Due to this ability to facilitate 
                                                 
∝ The production of xylulose (to be included in growth medium as possible induction “signal”) was not 
cost-effective. 
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basal induction, the core promoter was used to build the fusion target promoter 
described in Chapter II. However, this low activity mediated by the core xyn2 promoter, 
precludes the use of the reporter gene vector in the search for weak promoters in future 
studies. Putative sequences serving as hypoxia promoters (identified with the bi-
directional reporter vector) and the comparative studies of one of the promoters, ATF2a, 
to the ADH2 promoter (evaluated under hypoxia, anaerobic, aerobic, low temperatures 
and cold shock conditions) will be presented.  
 
 
2. Materials and methods 
 
Strains, media and culture conditions 
 
The genotypes and sources of  yeast and bacterial strains used in this study are 
summarized in Table 1. Escherichia coli was cultivated on Luria-Bertani medium, 
supplemented with ampicillin (100 µg/ml) for plasmid selection. S. cerevisiae strain 
Y294 and CEN PK K42 were cultivated on either YPD medium (1% yeast extract, 2% 
peptone, 2% glucose) or selective synthetic complete (SC) medium (containing 0.2% 
glucose and 2% raffinose, yeast nitrogen base without amino acids [Difco], 20 mM 
succinate [pH 6], and all the required growth factors except uracil [SC-URA]. Solid media 
contained 2% agar. Bacteria were routinely cultured at 37°C. Yeast was cultured at 30°C 
either in 300-ml Erlenmeyer flasks containing 50 ml of medium on a rotary shaker at 
100 rpm for aerobic cultivation or in 100 ml Shott bottles containing 50 ml of medium 
for anaerobic cultivation with magnetic stirrers. Small-scale preliminary anaerobic 
cultivation was done in McCartney bottles or test tubes, containing 10-15 ml SC-URA 
media in an anaerobic FORMA cabinet (80 % N2 / 10% H2 / 10% CO2) with the 
appropriate catalysts. Subsequent larger scale (50 ml) anaerobic cultivation was done in 
blue-top screw bottles either incubated in anaerobic flasks (anaerobic conditions induce 
by an Oxiod gas pack) or in the anaerobic FORMA cabinet.  
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Table 1. Genotypes and sources of microbial of yeast strains and plasmids  
Strains  Genotype Source/references 
E. coli   
DH5 α supE44ΔlacU169(∅80lacZΔM15)hsdR17 recA1 
endA1 gyrA96 thi-1 relA1 
Sambrook et al., 1989 
 
XL1-Blue endA1 supE44 thi-1 recA1 gyrA96 relA1 lac[F' proAB 
lacIqZΔM15 Tn10 (tet)] 
Stratagene 
S. cerevisiae   
Y294 α leu2-3,112 ura3-52 his3 trp-289 ATCC 201160  
This laboratory 
CEN PK K42 MATa/α; leu2-3,112 ura3-52 his3 trp-289;MAL2-8c; SUC2 Eliasson et al. (2000) 
CBS 8066 wild type ATTC 4126  
Plasmids Genotype Source/references 
pGEM-T-easy bla Promega 
pGEM-T bla Promega 
pDLG5 bla URA3 ADH2P-xyn2-ADH2T la Grange et al. (1996) 
YEp356 bla URA3 lacZ-1 Myers et al. (1986) 
pEEC bla URA3-RCO linker-ADH2T -LacZ This work 
pECC hph-1 bla URA3 hph-1-ADH2T -LacZ This work 
pECX hph-1 bla URA3 hph-1 -ADH2T , xyn2-PGK1T This work 
pBluescript SK+ II bla Stratagene 
pDLG1  bla URA3 ADH2P-ADH2T la Grange et al., (1996) 
Recombinant yeast strains with promoter inserts
Reference strain 
CC33
CEN PK K42 [[xyn2 core promoter]- pECX hph-1] This work 
FF66 CEN PK K42 [[Alcohol acetyltransferase ATF2 promoter and 
partial ORF of ATF2, named ATF2a] promoter – pECX hph-1] 
This work 
HH88 CEN PK K42 [pDLG5] la Grange et al. (1996)  
LL12 CEN PK K42[ [Protein YD9346.12c of unknown function ] 
promoter – pECX hph-1] 
This work 
ZZ26 CEN PK K42[ [Ribosomal 37S rRNA operon transcription 
initiation region]  (containing a putative site LOR element)] 
promoter – pECX hph-1] 
This work 
 
 
 
160
Plasmid construction  
 
Promoter screening vector  
The vector pECX was based on the YEp356 episomal plasmid with the URA3 yeast 
marker. Plasmid YEp356 was digested with XbaI and EcoRI, treated with Klenow to 
produce blunt ends and ligated to yield plasmid YEp356ΔEcoRI-XbaI. A 56-bp linker 
(RCO-linker) was designed to consist of a BamHI site (for promoter fragments 
insertion) flanked by SfiI, SmaI and HindIII sites on both sides of the BamHI site (For 
linker sequence, see Table 2). The synthetic bi-directional promoter cloning oligo-linker 
(Integrated DNA Technologies) was first cloned into pBS SKII+ and its sequence 
confirmed. The resulting plasmid was amplified in the dam- E. coli strain DH5α, cut 
with Hind III to obtain the linker. The linker was isolated using a YM-100 micron 
column. This linker fragment was cloned into the Hind III restricted, CIP treated 
YEp356ΔEcoRI-XbaI and the plasmid was renamed Yep356 linker. Plasmid pEEC was 
constructed by inserting the S. cerevisiae ADH2t as an EcoRI-SalI fragment into 
YEp356 linker. The ADH2 terminator was obtained with PCR from S. cerevisiae strain 
Y294 genomic DNA (for primers sequences, see Table 2). 
 
Reporter genes   
To provide the plasmid vector with two divergent reporter genes flanking the RCO-
linker, the hygromycin resistance hph-1 gene from Streptomyces hydroliticus (modified 
to be functional in yeast) was inserted, oriented in the opposite direction from the lacZ 
gene (without start codon). The lacZ gene was replaced with the T. reesei xylanase II 
(xyn2) encoding gene provided with the PGK1 terminator. 
 
The hygromycin resistance marker  
The S. hydroliticus hygromycin resistance modified gene (hph-1, an allele functional in 
yeast) from plasmid pHgr-1 (kindly provided by Dr. Ricardo Condero Ortero, 
Stellenbosch University) was used as a reporter gene/selectable marker. The hph-1 gene 
was amplified by PCR (for primers see Table 2.) and digested with XbaI and EcoRI 
(partially) to obtain the gene as a XbaI - EcoRI fragment. 
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Table 2. Primers and linker sequences (Tm), templates and PCR products 
PCR 
product 
DNA source Primers/ 
linker 
name 
PRIMER SEQUENCES  (Tm) 
HPHXba 
(168-R) 
5’- CGA GAT CTA GAC TAT TCC TTT GCC CTC -3’ (55°C) hph-1  gene pHgr-1
 
 IC HGH-L 
(143-L) 
5’- AGA ATT CGT CGA CAT GCC TGA ACT CAC CGC G -3’ 
(61°C) 
PGK1pro-
R (151-R) 
5’- GCA AGC TTG GCA TTG TTT TAT ATT TGT TGT AAA 
AAG TAG -3’ (61°C) 
PGK1 
promoter 
S. cerevisiae 
Y294 gDNA 
 
PGK1 pro-
L (151-L) 
5’- CAA GCT TCC TTT ATT TTG GCT TC - 3’ (54°C) 
GAL1-10 
pro – R 
5’- GCAAGCTTGGCATTATAGTTTTTTCTCCTT -3’ 
(55 °C) 
GAL10-1 
promoter 
 
S. cerevisiae 
Y294 gDNA 
GAL1-10 
pro – L 
5’- GCAAGCTTGGCATTTATATTGAATTTTCAA  -3’ 
(55 °C) 
xyn2 – out 
(214) 
 
5’- GGGT GAAGGAGACCATGTT G -3’ (65°C) 
 
Promoter 
sequencing 
primers  
 
pECX with 
putative 
promoter 
inserts HPHSECC 
(189) 
5’- TGT CAA GCA CTT CCG GA -3’ (64°C) 
Hem13-R 
(198) 
5’- GGA TCC GCG TGG GTA CCT CTA TCG TAG ATT 
A  -3’ (59°C) 
ATF2a  
promoter 
and partial 
ORF 
S. cerevisiae 
Y294 gDNA 
Hem13-L 
(198) 
5’- TCG GGA TCC GTG CGG GCA TAG TAG AAA -3’ 
(62°C) 
 
xyn2-linker 
(212) 
 
 
5’- CGC GGA TCC GCC CGG GCA TGC AAG CTT AAA 
TAG AAT TCG CCA AAC CTG AAC AAC C  -3’(62°C) 
core xyn2 
promoter - 
xyn2   -
PGKt 
cassette 
pDLG5 
xyn2-
PGK1t 
(199) 
5’- GCG ACG TAC GAT ATC CCC GAA CAT AGA AAT 
ATC GAA T -3’ (65°C) 
ADH2-L 
 
5’- GCT ATC TAG ACT TTG CCA GAG GTC TAG  -3’ 
(55°C) 
ADH2t  
 
S. cerevisiae 
Y294 gDNA 
 ADH2-R 5’- CTA CGA ATT CTT ATA GGG TGG ACG TC -3’ 
(53°C) 
Linker with BamHI site 
flanked by start codons and  
SfiI, SmaI  and HindIII sites 
RCO-linker 5’- GCA AGC TTA GCT GTC ATG CCC GGG CGG ATC 
CGC CCG GGC ATG ACA GCT AAG CTT GC -3’ 
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Before cloning the hph-1 reporter gene in the bi-directional cloning vector in yeast, the 
gene was first inserted into the ADH2 promoter/terminator cassette in the yeast shuttle-
vector, pDLG1 (la Grange et al., 1996) to confirm its functionality in yeast. This 
constructed plasmid was transformed into S. cerevisiae CEN PK K42 host cells and 
tested on hygromycin plates for activity.  
 
Plasmid pEEC was restricted with SalI, phosphorylated and ligated to the hph-1 gene. 
Restriction analysis and sequencing of the renamed plasmid, pECChph-1, was done to 
confirm the right orientation of hph-1 gene. The promoter regions of PGK1 and GAL1/10 
of S. cerevisiae were obtained with PCR (Table 2), cloned into pGEMt to confirm 
sequence, and inserted into plasmid pECChph-1. These constructs were transformed into 
the yeast host strains S. cerevisiae, Y294 and CEN PK K42, to test for hygromycin 
activity. Yeast colony PCR was performed to confirm the presence of the plasmids. 
Hygromycin resistance was found with both promoters. Transformed yeast cells were 
incubate in YPD for a 2-h growth period, cooled for 1 h, then plated onto selective 
media supplemented with hygromycin. Determining of the optimal hygromycin 
concentration levels, of 350 μg/ml, took several transformations to optimize and for 
plate tests the optimal hygromycin concentration was determine to be 450 μg/ml, since 
adjusting the SC-URA agar plate media to pH 6 with succinate affected the hygromycin 
concentration required. 
 
The xylanase II (xyn2) reporter gene  
The xyn2 core promoter-xyn2-PGKt cassette was obtained by PCR with a left (upstream) 
primer design to replace half the RCO-linker with two restriction sites, BamHI, and 
HindIII. The right (downstream) primer was design to include the PGK1t terminal fused 
to xyn2, with an appropriate BsiWI cloning site. The LacZ gene on YEp356 was 
removed as a BamHI –BsiWI fragment and replaced with the xyn2 core promoter - 
xyn2-PGK1t cassette. This bi-directional cloning vector was renamed, pECX hph-1. The 
primers used are listed in Table 2 and the layout of reporter genes illustrated in Fig. 1. 
The xyn2 reporter gene included a 118 bp native xyn2 core promoter (see Chapter II & 
IV for more detail).  
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Screening of genomic fragments for promoter activity under hypoxia   
Initial screening of genomic fragments for putative promoter sequences activity under 
hypoxia was done using the hph-1 hygromycin resistance marker. Sau3AI restricted 
DNA fragments (600-1500 bp average in length and purification with gel 
electrophoresis) were inserted in plasmid pECC hph-1 (restricted with BamHI and CIP 
treated) and screened for promoter activity. Genomic DNA from strains Y294 and CBS 
8066 (Table 1) isolated with the spheroplast method (Sambrook et al., 1989) were used 
to generate DNA libraries. PCR products obtained with primers (designed with BamHI 
restriction sites for easy cloning) based on the HEM13 hypoxia induced gene, were also 
inserted and screened for inducing reporter gene activity. The ATF2a promoter fragment 
listed in Table 3 (and described in Fig. 1) was obtained with these primers. Plasmid 
vectors containing these S. cerevisiae libraries were transformed to S. cerevisiae CEN 
PK K42 competent cells (Chapter II). 
Figure 1 Cassettes of the bi-directional reporter genes with terminators inserted in the promoter screening 
cloning vector pECX hph-1 with detail of an ATF2a promoter sequence insert. The putative low oxygen 
response (LOR) elements are indicated at the promoter region as well as the putative AR hypoxia response 
element as the Z- element located at the ORF region of ATF2a. The promoter sequence, ATF2a, cloned in 
both directions as indicated by the open arrows. (For more detail on pECX, see also Chapter II, Fig. 1). 
upstream region ATF2a ORF
Z
ATF2a promoter region
LORE LORE
hph -1ADH2 t xyn2 PGK1 t
LORE
xyn2 core promoter
 upstream region
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Xylanase reporter gene assays 
β-xylanase plate-assay: Recombinant strains were screened for β-xylanase activity and 
compared to reference strains by patching on SC-URA agar medium containing 0.2 % 2-
O-methyl-D-xylan-remazol brilliant blue R (RBB)-xylan (Sigma).  
 
β-1,4-xylanase liquid assays: Either, the DNS method was used to quantify β-1,4-
xylanase reporter gene activity as previously described by Bailey et al. (1992), or the 
azoxylan (Megazyme, International Ireland Ltd., Bray Business Park, Bray, Co. 
Wicklow, Ireland) method for determining xylanase activity was used as instructed by 
the manufacturer with all volumes scaled down to one third of the prescribed volumes. 
The experiments were done in triplicate or more (n = 3 or n > 3), unless otherwise 
indicated. 
 
Media and anaerobic culture conditions 
The Oxoid gas generating kit BR38 (hydrogen and carbon dioxide gas generating 
sachets in the presence of an active catalyst) was applied for generating anaerobic 
conditions in anaerobic flasks. Alternatively, anaerobic conditions were induced by 
growing recombinant strains in a anaerobic cabinet (90% N2 / 10% CO2  / H2). 
Recombinant strains were spotted on hygromycin SC-URA plates (or RBB SC-URA –
plates) in duplicate. Plates were incubated aerobically and anaerobically at 25ºC or 30°C 
and check at day three for growth on hygromycin SC-URA plates or for zone formation on 
RBB-plates. To quantify the xylanase activities mediated by promoter inserts, 
recombinant strains were cultured (with stirring) in 10 ml, 50 ml, or 100 ml SC-URA 
minimal media with 2% raffinose and 0.2% glucose as carbon source. Pilot experiments 
to screen transformants were done in 10 - 15 ml SC-URA minimal medium with either 2% 
raffinose or 2% raffinose & 0.2% glucose as carbon source and incubated at 25 - 30ºC in 
anaerobic cabinet without stirring. 
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3. Results and Discussion 
 
Promoters identified screening a genomic S. cerevisiae library 
 
RBB plate test and genomic DNA promoter-library screening  
More than a thousand yeast transformants were screened either on hygromycin plates or 
on RBB-plates for promoter activity under hypoxia conditions. Putative promoter inserts 
mediating reporter gene induction under hypoxia or anaerobic conditions were identified 
by re-isolating plasmid DNA from the recombinant yeast and determining the DNA 
sequence of the inserts using primers listed in Table 2. Four promising promoter 
sequences that mediated reporter gene induction under anaerobic conditions are listed in 
Table 3.  
 
Table 3. Promoter sequences mediating anaerobic reporter gene induction  
1. Alcohol acetyltransferase ATF2 promoter and partial ORF of ATF2, named ATF2a 
2. Promoter sequence of protein YD9346.12c of unknown function 
3. Promoter sequence of the ribosomal 37S rRNA operon transcription initiation 
region containing a putative low oxygen response (LOR) element 
4. Partial promoter sequence of the OXI3 (alias AAPI / COX) gene which contains 
four TATA boxes 
 
The recombinant strain, ZZ26 (Table 1), with the ribosomal 37S rRNA operon 
transcription initiation region (containing a putative LOR element site) promoter insert 
and another transformant with a promoter fragment that consists of part of the OXI3 
gene (which contains four TATA boxes) were not included in further studies, as these 
promoters mediated reporter gene induction at very low induction levels in liquid 
cultures (below that found for the reference strain, CC33, (CEN PK 42 [pECXhph-1]) 
(data not shown). The recombinant CEN PK K42 [LL12] strain did show a late 
fermentation induction of the xylanase reporter gene at 200 h of 27 nkat/ml under 
anaerobic conditions in minimal low glucose medium (data not shown). It contained a 
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sequence identified as a 164 bp ORF region of the YD9346.12c gene with unidentified 
function present on chromosome IV. However, as upregulation mediated by this 
promoter earlier in the fermentation was below induction levels mediated by the ATF2a 
promoter in strain FF66 (Fig. 2), it was not included in further studies. The putative 
fragment that showed to mediate the most promising induction under anaerobic 
conditions, ATF2a was studied in detail under aerobic, anaerobic and hypoxia 
conditions. 
 
ATF2a promoter fragment 
The ATF2 promoter plus a partial 1531 bp fragment of the ORF (called ATF2a) (Fig. 1) 
inserted upstream of the hph-1 gene conferred hygromycin resistance to the host cells 
under anaerobic conditions. ATF2 encodes the minor alcohol acetyl transferase in yeast, 
its homologue, ATF1, is the main contributor to the alcohol acetyl transferase activity 
(~80 %) in the yeast cell (Mason and Dufour, 2000). The ATF2a fragment was cloned in 
both orientations in the pECX hph-1 promoter-cloning vector (Fig. 1). 
 
The ATF2a fragment mediated under anaerobic conditions at 48 h (Fig. 2) an 
approximately 100-fold induction of the xyn2 reporter gene. Transformants were grown 
in 15 ml low glucose/raffinose minimal medium in the anaerobic cabinet. Despite 
numerous attempts, the transient induction mediated by the ATF2a promoter under 
anaerobic conditions was found only once again when the transformant was grown in 50 
ml, 2% glucose minimal medium (Fig. 5A). At 18 h, a ~2-fold induction of the xyn2 
reporter gene activity was mediated by the ATF2a promoter under anaerobic conditions 
compared to the core xyn2 promoter (data not shown). In general, anaerobic or hypoxia 
(at 4h) induction were found to be similar to induction under aerobic conditions (Fig. 3). 
The inconsistent induction found in two experiments (Fig. 2 and 5A) under anaerobic 
conditions, exceeding the aerobic levels mediated by the ATF2a promoter, could not be 
repeated (data not shown), although an extensive evaluation of the ATF2a promoter and 
comparison to the ADH2 promoter under different conditions (2-4% glucose or different 
nutrient content and different methods to induce hypoxia or anaerobic conditions) were 
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attempted in the hope to find the specific conditions that effected ATF2a mediated 
induction.  
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omoter insert pECX hgr -1 ] CEN PK K42   [ core xyn  2 pr
[ATF2a promoter pECX hgr -1 ]
  Strain LL12
Figure 2  Reporter gene induction mediate by the ATF2a promoter compared to the reference strain and 
induction found with strain LL12 containing the construct with a promoter sequence of protein 
YD9346.12c of unknown function. ((n =2) Anaerobic cabinet, 15 ml 0.2 % glucose; 2% raffinose, SC-URA 
minimal meduim, CEN PK K42 host strain, xylanase activities determine with DNS method). 
 
It may be speculated that the batch cultivation conditions led to the depletion of specific 
nutrients that could contribute to the low level of induction found for the ATF2a 
promoter or possibly for the transient high induction level at 48 h and 56h (Fig. 2 and 
5A, respectively). In S. cerevisiae, the fermentable-growth-medium-induced (FGM) 
pathway plays an important role in utilization of fermentable carbon source and all 
growth nutrients. ATF1 and ATF2 transcription increased with increased concentrations 
of nitrogen source induced through Sch9p, a protein kinase in the FGM pathway, under 
anaerobic conditions (Yoshimoto et al., 2002; Crauwels et al., 1997).  
 
 
 
168
The overlapping of signals (e.g. depletion of certain nutrients and hypoxia) may have 
masked and prevented induction of transcription under certain conditions. This led to the 
conclusion that a multitude of signals overlap with hypoxia and that the transient 
induction mediated by this promoter may have been a response to another signal or 
signals and not necessarily hypoxia. 
Figure 3  A comparison of induction mediated of the reporter gene under aerobic conditions by the ADH2, 
core xyn2 and the ATF2a promoter up to 512 h ((n>3) aerobic shake flasks, 100 ml 0.2 % glucose; 2% 
raffinose, SC-URA minimal meduim, CEN PK K42 host strain, xylanase activities determine with DNS 
method). 
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The ADH2 promoter (fused to the same core xyn2 promoter - xyn2 reporter gene used in 
pECXhgr-1) was used as positive control when fluctuating induction levels with the 
ATF2a promoter were found and ATF2a mediated anaerobic induction could not be 
repeated. This promoter was a tried and tested promoter in our laboratory known to drive 
aerobic induction to high levels (personal communications, Dr. D. la Grange) and the 
ideal promoter to serve as an internal control for the xylanase assays. The pDLG5 
plasmid was transformed into the S. cerevisiae K42 CEN PK strain (HH88) and a 
comparison of aerobic ATF2a promoter induction and the ADH2 promoter mediated 
induction was made (Fig. 3). The ADH2 promoter mediated excellent aerobic induction 
of the xyn2 reporter gene. A low level of induction at 42 and 512 h (above induction 
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mediated by the xyn2 core promoter (reference promoter) was found for the ATF2a 
promoter (Fig. 3). Yoshimoto et al. (1999) indicated aerobic repression for up to 30 h 
mediated by the S. pastorianus ATF2 promoter at 20ºC that correlates with this study. 
The S. pastorianus ATF2 gene has a 100% amino acid homology to the S. cerevisiae 
ATF2 gene, 98.9% nucleic acid homology for promoter region and 99.3% for ORF.  
 
Changes made in follow-up experiments and reasons 
Changes were introduced (Table 4) in subsequent experiments to counter the unexpected 
high fluctuations found in standard deviations of xylanase activity values (especially at low 
xylanase concentrations) when using the DNS assay. This would allow us to use the bi-
directional cloning as a promoter-screening vector in further studies, to address the 
problem of depletion of essential nutrients in batch cultures and to optimize the conditions 
for pre-culture preparations.  
 
Table 4. Changes made in follow-up experiments and reasons 
Changes Previous work Follow-up 
experiments 
Reason(s) 
Determination of reporter 
gene activities 
DNS method Megazyme 
azoxylan 
(this study) 
Variability of data obtained with DNS method  
fluctuated with up to 10 –20% Azoxylan method 
found to be more sensitive at low concentrations  
Medium  1 x SC-URA 2 x SC-URA To avoid depletion of essential nutrients 
Use a different  
S. cerevisiae host strain 
CEN PK 42 Y294 Y294 gave good xylanase yields (la Grange et al., 
1996) 
Pre-inoculum preparation  1 x SC-URA Used non-
selective YPD 
medium 
To ensure repeatability by increasing  cell 
viability and vitality of pre-culture 
Higher density inoculum 
(danger of carrying over enzyme 
formed in pre-culture) 
No Used 
 
 
 
Activities early in the fermentation undetectable 
due to low cell count 
Promoterless xyn2 reporter 
construct or removal of 
upstream sequences  
No 
 
No Native T. reesei core xyn2 promoter or upstream 
sequences maybe responsible for background 
activity  
Different method to induce 
hypoxia 
♦ 
♦ 
To simplify sampling 
Full anaerobic conditions 
not essential 
Follow-up experiments 
Use capped serum bottles with rubber stoppers & N2 flushing 
In some experiments headspace exclusion was used (no N2   flushing)  
Anaerobic flasks,  inoculate for each time point and terminated after sampling using  
McCartney bottles or blue-top screw bottles with stirrers or placing samples on shaker. 
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Analysis of in silico putative promoter elements of the ATF2a promoter 
The ATF2a sequence was analyzed with computational in silico methods describe in the 
introduction of Chapter III. The sequence contains promoter elements that may function 
under hypoxia in vivo. In silico searches revealed a putative AR2-element (indicated as 
the Z element in Fig. 1) responsible for hypoxia induction in DAN/TIR anaerobic genes 
(Abramova et al., 2001, Cohen et al., 2001). This promoter also contains putative LOR 
elements that may provide sites for complex formation under hypoxia upregulation of 
the OLE1 genes (Vasconcelles et al., 2001). The AR2 element is present in the ORF 
region of ATF2 gene and LOR elements at the promoter of ATF2 (Fig. 1). The ATF2a 
fragment was cloned in both directions and fused to the xyn2 reporter gene to be able to 
determine the role of these putative hypoxia elements. Hypoxia induction, at 4 h, 
mediated by the ATF2a promoter in the reverse orientation (Fig. 4), was similar to 
induction mediated by the reference promoter (xyn2 core promoter).  
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Figure 4 (A) Comparison of the effect of hypoxia on the promoter induction of the ATF2a promoter 
cloned in both directions compared to the reference xyn2 core promoter. (B) The high level of reporter 
gene induction at 288h obtained with the ADH2 promoter indicating. (Serum bottles, 50 ml 2% glucose, 
double strength SC-URA minimal meduim, Y294 host strain). 
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Lack of induction in the early stages of fermentation, mediated by the ATF2a promoter 
in the forward direction, may indicate that the ATF2a might contain repressor sites that 
are not functional in a reverse orientation. Induction mediated by the core xyn2 promoter 
exceeds the induction mediated by the ATF2a promoter in both forward and reverse 
orientation. A high level of induction was found under late fermentation conditions (288 
h) mediated by the core xyn2 promoter if compared to the ATF2a promoter (Fig. 4A). 
However, the ADH2 promoter mediated a two – three fold induction at 4 and 45 h and a 
5-fold induction at 288 h compared to induction mediated by the core xyn2 promoter 
(Fig. 4B).  
 
The high but inconsistent anaerobic induction found mediated by the ATF2a fragment 
indicate that this sequence may contain elements that mediate induction in response to 
other signals. Szczebara et al. (2003) speculated that the ATF2 gene product function in 
the yeast cell could be responsible for degradation of plant flavanoids (detoxification) as 
they found that Atf2p degraded one of the key enzymes of a 13-enzyme recombinant 
metabolic pathway inserted in yeast to produce hydrocortisone. 
 
Evaluation of ADH2 promoter under different temperature and oxygen conditions 
The effect of low temperatures and cold shock on ATF2a and ADH2 promoters mediated 
induction was also investigated (Fig. 5A). Data described as cold shock was obtained 
when recombinant strains grown anaerobically at 30ºC, and shifted to 17ºC after 24 h. 
The ATF2a promoter induction mediated at 30ºC under anaerobic was included as 
reference point in Fig. 5. Induction for the ADH2 promoter was found at 24 h under cold 
fermentation in aerobic conditions. This was tested in a 0.2% glucose / 2% raffinose 
double strength minimal medium, in a Y294 host strain.  
 
The ADH2 promoter induction at two temperatures (17ºC and 30 ºC) was evaluated 
under both aerobic and anaerobic conditions. Cultivation was done in double strength 
SC-URA minimal medium and the aerobic culture was only incubated at 17ºC. To study 
the effect of cold shock, recombinants were also grown anaerobically at 30ºC and then 
shifted to 17ºC after 24 h (cold shock). When the inoculum size was increased, hypoxia 
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induction was found for the ADH2 promoter at the early stages of fermentation (Fig. 5) 
in contrast to previous data (data not shown). Induction in the pre-culture (carried over) 
may have been responsible for this early induction and need to be investigated further. 
 
The anaerobic induction mediated by the reference promoter at 30ºC (24 h) was not 
found at low temperatures. The highest levels mediated by the ADH2 promoter were 
found at  
120 h under anaerobic conditions at low temperatures. Compare to induction mediated at 
the same time point by the reference promoter, a > 8-fold induction was found. The 
ADH2 promoter also mediated reporter gene induction under low temperature/ aerobic 
conditions above levels found for the reference promoter over a time period 24 h to 120 
h and at 120 h under hypoxia/cold shock conditions. 
 
Low temperatures may contribute to the response (or derepression) mediated at the 
ADH2 promoter. Again, late fermentation induction was found mediated by the ADH2 
promoter under anaerobic conditions at low temperature growth or cold shock similar 
(Fig. 5) to induction found at 30°C (Fig. 4). The high induction levels mediated by the 
ADH2 promoter in the late fermentation might be due ethanol formed. The ADH2 gene 
encodes for alcohol dehydrogenase II that favours the oxidation of ethanol to 
acetaldehyde (James et al., 2003). The ethanol (in g/l) was determined at three time 
points (Fig. 5B) under anaerobic/low temperatures (17ºC) conditions by the recombinant 
strain 88FF (transformed with the ADH2 promoter construct plasmid, pDLG5).  
 
Under aerobic conditions and low temperatures, the ADH2 promoter consistently 
induced good expression levels of the reporter gene. Cold-shock did not have an effect 
on induction on the reference promoter construct. This study included the ATF2a 
promoter (forward and reverse orientations) induction levels under cold shock and low 
temperature growth conditions. Inconsistent induction levels were found for the ATF2a 
in both orientations (data not shown) presumably due to the depletion of specific 
nutrients. The ATF2a promoter induction mediated at 30ºC under hypoxia/anaerobic 
conditions was included as reference point in Fig. 5. 
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Figure 5 (A) Analysis of ADH2 promoter under cold fermentation conditions. Comparison of the 
induction levels found mediated by the ADH2 promoter to the reference promoter at 17ºC and 30ºC under 
anaerobic or aerobic conditions and cold shock conditions. (Experimental data obtained for the ATF2a 
promoter, was taken at 16 h and not at 24 h, and at 56 h not at 48h). (B) Ethanol production at low 
temperatures (17ºC) by a recombinant strain 88HH (transformed with the ADH2 promoter construct 
plasmid, pDLG5). (McCartney bottles incubated in anaerobic flasks with stirring, 50 ml 2% glucose, 
double strength SC-URA minimal meduim, and Y294 host strains). 
 
 
4. Conclusions  
Results that influenced the design a chimeric AR regulation system will be printed in 
bold. The work presented in this chapter was done before the transcription regulatory 
system was build: 
 A very low and inconsistent induction was observed for the ATF2a promoter under hypoxia. 
The ATF2a promoter was not a suitable candidate for further manipulation.  
 Cold-shock did not have an effect on induction on the reference promoter construct or the 
ADH2 promoter, but cold growth conditions did mediate upregulation in the early and late 
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fermentation. Low temperature growth should be applied rather than cold shock 
as signal to control transcription activation. 
 Promoter screening with the bi-directional reporter gene vector can be used to screen 
for strong promoters, mediating high induction levels.  
 Excellent aerobic and late anaerobic induction levels were found mediated by the 
ADH2 promoter, as well as induction under low temperatures at 120 h. The ADH2 
promoter could be described as a ‘late fermentation’ inducible promoter. 
 
In this study, a promoter fragment containing the ATF2 promoter sequence and a partial 
open reading frame (renamed ATF2a) conferring hypoxia induction at low levels was 
identified, using the bi-directional cloning vector. In silico analysis of the fragment 
identified several LOR elements similar to those found at the promoters of the OLE1 and 
ATF1 genes (Vasconcelles et al., 2001), as well as a hypoxia AR element as found in the 
DAN/TIR genes (Abramova et al., 2001; Cohen et al., 2001). Despite the abundance of 
these elements present in the ATF2a promoter, this sequence mediate reporter gene 
induction at low levels, in contrast to induction levels reported for the ATF1 or OLE1 
genes containing only a single LOR element site (discussed in Chapter I and II). This 
confirm that the putative function of an in silico identified motif or element needs to be 
confirmed experimentally. The risk associated with the construction of a transcription 
regulatory circuit (based on the known hypoxia inducible transcription regulator, 
Mga2p) was considered less compared to the probability to find novel hypoxia inducible 
promoters using computational (in silico) searches or to find promoters using the bi-
directional reporter gene cloning vector to screen a promoter libraries. Even if novel 
promoters that are induced under hypoxia have been identified, these promoters have to 
be characterised for induction by other signals. It was also rationalized that it was not so 
much an induced, but rather a system that can be controlled was needed to mediate 
metabolic control of new enzyme pathway synthesis for specific biotechnological 
processes. 
 
Not all data obtained in the study applying to the bi-directional cloning vector used to 
screen under anaerobic conditions were reported here. However, as discussed in 
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previous chapters, if optimal ethanol production and cell viability were both taken into 
consideration, hypoxia rather than anaerobic growth conditions would be preferable. In 
follow-up studies, hypoxia promoter sequences mediating reporter gene upregulating 
were not found when screening a library of DNA fragments of a S. pastorianus strain 
(the bottom-fermenting yeast) with the bi-directional reporter gene screening vector. 
Screening promoter libraries of industrial yeasts may be a viable option in future if other 
techniques (such as DNA array technology) are not available. In my opinion, the key to 
successfully using promoter-screening vectors will be to select the conditions of 
screening to simulate industrial fermentations/degradation/etc. conditions under which 
the promoter will be used. Furthermore, unless chemostat fermentation will be used, a 
range of promoters will be necessary, as the ‘signals’ will constantly change.  
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1. Introduction 
 
What specific mechanisms are involved in the different type of regulations mediated by 
the chimeric activator regulator (ARp) and how they may overlap, is not known. 
Putative mechanisms under discussion in this chapter that may play a role in ARp 
mediated regulation are summarized in Table 1.  
 
Table 1. The putative induction mechanisms of the AR regulator. Arrows indicate the 
possible overlap of regulation mechanisms in response to different signals. 
SITE AND MECHANISM OF REGULATION Regulator ARp mediated:  
 
Transcription enhanced complex formation mediate 
upregulation at the ‘GAL1/10’- xyn2 core fusion 
promoter 
 
 
 Unregulated (‘constitutive’) induction under all oxygen conditions  
         
Post-transcription mechanism e.g. 
mRNA stabilization 
 
 
Upregulation at low temperatures 
under aerobic conditions above 
unregulated (‘constitutive’) induction 
 
 
Before discussing the methods and sites of regulation of induction mediated by the ARp, 
the following question needs to be addressed. Will there be synergy or competition 
between the native regulator and a recombinant regulator in the yeast cell? Recombinant 
versus native context will always be a problem in recombinant technology. If the 
chimeric AR transactivator induces or represses native target genes, it may affect cell 
viability or vitality. The question can be asked if the suppressor function of Mga2p  
of dosage-dependent suppression of a Ty-induced promoter mutation, such as lys2-61, 
(Zhang et al., 1997; Dula and Holmes, 2000) will be affected by the presence of an AR 
fusion protein containing certain domains of Mga2p. Due to its Gal4p DNA binding 
domain region, Arp will be targeted to the native Gal4-p binding sites, however the ARp 
could compete with the native protein Mga2p (or possibly its homologue Spt23) in 
protein-protein complexes. Domain f of Mga2p included in the AR regulator, contains 
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ankyrin regions that are responsible for protein-protein or membrane-protein interactions 
and may enable pAR to mediate the formation of a hypoxia-induced complex at Mga2p 
target promoters. Complexes formed could be similar to that found at the OLE1 or ATF1 
promoters mediated by Mga2p (Vasconcelles et al., 2001; Jiang et al., 2001). If the 
added control system (AR regulatory plasmid based system) influences native genes in 
the yeast cell under control of Mga2p, specific conditions needs to be verified in a Δ 
mga2 or a Δ mga2 Δspt23 background. As the ARp does not contain the C-terminal 
region of Mga2p (or Spt23), the site of proteolytic activation and regulation of these 
proteins (Hoppe et al., 2000), it will be processed differently.  
 
We found in this study that the presence of the AR regulator did not seem to affect yeast 
cell viability or vitality (Chapter II, Fig.6). However, it could be speculated that the AR 
regulator may have acquired other yet unidentified functions of Mga2p, in addition to an 
ability to sense low temperatures (Nakagawa et al., 2002). The transactivator Mga2p has 
not been fully characterized. The AR protein may for example play a role in the 
degradation or processing of proteins. This hypothesis is based on speculations that 
Mga2p operates in concert with other proteins within a complex to facilitate the 
degradation of prions. Mga2p was found in a protein-protein complex with a prion, 
NEW1, termed [NU]+ (Cellzome®) (for details see Chapter I, Section 7 - Regulation via 
processing). This hypothesis depends on whether the specific domains of Mga2p 
involved in this function, were included in pAR. The AR regulatorory system may be 
used to confirm and link functionality to specific domains or motifs in future protein-
protein interaction studies.  
 
 
 
2.  Classification of AR regulator mediated regulation
 
2.1 Unregulated (‘constitutive’) induction mediated by the AR regulator 
In Chapter II we demonstrated that the AR regulator mediated upregulation of the xyn2 
reporter gene under both aerobic and hypoxia conditions. We also showed that the 
reference regulator consisting only of the Gal4 DNA binding and Adr1 transactivation 
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III domains could not mediate the induction found for ARp. This would suggest that 
the Mga2p domains included in the AR regulator are responsible for the induction 
of the reporter gene in the AR regulatory system under both aerobic and hypoxia 
conditions that is above basal induction levels mediated by the core xyn2 promoter.  
 
2.1.1 Lack of hypoxia induction above expression levels under aerobic conditions 
mediated by the AR regulatory system 
The objective to build a controllable regulatory circuit system to mediate (at least) 
constitutive expression levels under all oxygen conditions was reached. However, the 
expected hypoxia upregulation (above aerobic induction levels) was not found. Hypoxia 
induction may be separated in induction similar to aerobic induction and induction over 
and above aerobic induction. This can only be confirmed if a direct comparison of the 
ARp-mediated induction to the native Mga2p-mediated induction levels is made. 
Incorporation of domains Mag2 (a,b and f) does not confer the ability to the ARp 
regulator to mediate induction under hypoxia conditions above induction levels found 
under aerobic conditions.  
2.1.2 The effect of pressure on ARp induction mediated under hypoxia 
A reduction in the AR regulator mediated upregulation under hypoxia was found under 
pressure (pressure levels were not measured) at 30˚C and 23˚C (Chapter II, Fig. 5). This 
effect could be due to a reduced uptake of tryptophan under pressure. One of the 
enzymes involved in Mga2p proteolytic activation processing, the ubiquitination enzyme 
Rsp5 (Shcherbik et al., 2003), is implicated to play a major role in a response to reduce 
uptake of tryptophan by cells under pressure. Nagayama et al. (2004) found that the 
tryptophan uptake was down-regulated in growing cells of S. cerevisiae that are 
subjected to high hydrostatic pressure at low temperatures leading to cell cycle arrest. 
Rsp5p mediates regulation of tryptophan permeases under hydrostatic pressure. The two 
yeast tryptophan permeases, Tat1 and Tat2, are differentially regulated by Rsp5 
ubiquitin ligase in response to high hydrostatic pressure. Tat2 was degraded in a manner 
dependent on ubiquitination by Rsp5p. Ubiquitination was shown as an important 
determinant of the localization and regulation of the tryptophan permeases, TAT1 and 
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TAT2 (Nagayama et al., 2004). If the domains of Mga2p included in the AR regulator 
are involved in the response to pressure, it could shed more light on a putative 
overlapping regulatory role in different signaling pathways for Rsp5p in yeast cells. The 
AR regulator does not have the C-terminal of Mga2p, but it was shown that the regulator 
was effected by pressure (Chapter II, Fig. 5). This could confirm another role for Rsp5 
other than its involvement of the C-terminal proteolitic regulation of Mga2p. This 
hypothesis would need further studies as the effect of pressure on cell growth of the 
specific strain used as host, need to be established.  
 
2.2. Regulated induction mediated by the AR regulator 
 
The presence of the Mga2 a,b, and f domains provide to the AR regulator a 
sensing/signal transduction ability to mediate induction under low temperatures. 
Low temperature induction mediated by the AR regulator was higher than the 
aerobic and hypoxia induction levels found at 30ºC (Chapter II, Fig. 3 and Fig. 4). 
All elements of the AR regulator could contribute to its ability to sense and mediate 
induction under low temperatures. The reference transactivator Adr1pTADIII fused to 
Gal4pDBD did not confer this ability, except for a very slight transient induction at 26 
hours under hypoxia conditions (Chapter II, Fig. 5). Deletion studies of the a,b and f 
domains may indicate specific motifs responsible for low temperature/cold shock signals 
in yeast.  
 
 
3. Putative mechanisms of AR regulator mediated upregulation
 
Mga2p is essential for complex formation at the low oxygen response (LOR) promoter 
element, but does not bind the promoter DNA directly (Vasconcelles et al., 2001; Jiang 
et al., 2001). The unknown co-factor protein in the complex that binds the promoter 
DNA element is indicated as Factor X in the illustration presented in Fig.1A. Hypoxia 
may have a direct or indirect influence on the X factor or other factors involved in 
mediating the activation complex. Recently the aerobic induction mediated by Mga2p 
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was indicated to be due to an increase in the stability of the OLE1 mRNA transcripts 
(Kandasamy et al., 2004).  
 
Schematic representations of the putative AR regulator mediated complex formation are 
presented in Figures 1B and 1D. The design of the AR regulator was such that the X 
factor was replaced by providing the AR regulator with a Gal4pDNA binding domain. If 
the a, b and f Mga2p domains are responsible for the complex formation at the LOR site, 
the AR regulator will be able to mediate complex formation at the putative xyn2 LOR 
site (Fig.1B). The Mga2p N-terminal domains (a and b), as well as a domain f, were 
provided to the AR regulator (Chapter II) (Sequences supplied in APPENDIX: Draft for 
Provisional Patent) to function as a flexible linker, sensing hypoxia (or other signals) 
to facilitate the binding of co-factor proteins (indicated by Y and Z in Fig. 1B). Mga2p a, 
b or f domains may also contain a transcription activation domain (TAD) or domains 
(similar to the ADR1TADIII) that would increase binding and assembly of the basal 
transcription machinery.  
 
Low levels of expression were found under both aerobic and hypoxia conditions for the 
reference strain without Mga2p domains. The lack of upregulation similar to the AR 
regulator indicates that the chimeric reference regulator does not facilitate optimal 
binding of the basal transcription proteins, i.e. it does not ‘sense’ signals. This may be 
due to an inability to bind co-factors (Fig. 1C).  
 
The architecture of the activation complex mediated by AR at the receptor promoter, if 
the LOR element of xyn2 core promoter is non-functional, is presented in Fig.1D. The 
transactivator provided with the Gal4DBD – ‘GAL10-1’ docking system could effect 
complex formation even if the xyn2 LOR element is non- functional.  
 
Photographs of the RBB-plate test results that indicated the xylanase activity induced by 
the RR regulator (Fig.1F) and the AR regulator under aerobic conditions at 30˚C (Fig. 
1E and G) are included in Fig. 1.  
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Figure 1A. The putative Mga2p complex formation at the ATF1 and OLE1 promoters under hypoxia and 
aerobic conditions are indicated. Mga2p does not bind directly to DNA at the LOR element site and an 
unknown factor of the hypoxia complex binding DNA is indicated as factor X (Vasconcelles et al., 2001). 
The ER processed p90 form of Mga2p mediated complex formation. Mga2p was divided in hypothetical 
domains, a-h. Domain h was not included in this illustration, as the C-terminal region is needed to tethered 
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the full-length Mga2p120 to the ER and not part of the processed Mga2p90 form (See chapter I for a 
detailed description of this process). Region ‘g’ is indicated in italics to indicate that it may be part of the 
C-terminal domain. Unidentified co-factors are indicated with the symbols Z, Y and T.  B. An illustration 
of possible complex formation of the AR regulator at the synthetic receptor promoter is presented. 
Domains of the chimeric regulators are indicated, Gal4DBD binding the GAL4 binding sites present at the 
‘GAL1/10’ promoter fragment, the Mga2 a,b and f domains providing a linker region that facilitate 
binding of the putative LOR element present at the core xyn2 promoter, and the Adr1p TAD domain 
facilitates the assembly of the pre-initiation complex indicated by the circle (white) and PolII (green). In 
this presentation, the putative binding of the X element to putative LOR element was indicated in contrast 
to the illustration in Fig.1D that suggests a dysfunctional xyn2 core promoter LOR element.  C. An 
illustration of complex formation mediated by the reference regulator at the synthetic receptor promoter. 
Note the lack of a flexible linker that could provide co-factor bindings sites. D. Another scenario 
indicating a possible complex formation mediated by the AR regulator at the synthetic receptor promoter 
if the AR regulator could not facilitates activation complex formation at the LOR element. This scenario 
may indicate the complex formed to mediate expression under both aerobic and hypoxia conditions and 
the illustration in Fig1. B could indicate the complex formed under elevated low temperature induction. 
Photographs of the RBB-plate test to show results that indicated the xylanase activity induced by the RR 
regulator (Fig.1F) and the AR regulator under aerobic conditions at 30˚C (Fig. 1E and G) are included in 
Fig. 1).  
 
It is also possible that the domains a, b and f of Mga2p (included in the AR regulator) 
were not the hypoxia sensing domains. The AR regulator may still not be able to 
mediate hypoxia upregulation above ‘constitutive’ induction levels even if a functional 
LOR element is provided. In future studies site-directed mutations of the xyn2 LOR site 
may indicate to what extent and if the putative LOR element plays a role. 
 
The mechanism whereby unregulated induction under all oxygen conditions and further 
upregulation at low temperatures was mediated, could overlap. Upregulation could be 
mediated via complex formation at the putative LOR element present at the xyn2 core 
promoter, but could also be mediated by, for example an increase in mRNA stability.  
 
3.1 The putative role of the LOR element in the core xyn2 promoter and the role of 
Rap1p and other factors in unregulated ‘constitutive’ induction
The objective of this study was to build a system where upregulation was constitutive or 
at least controllable. The putative LOR element present at the core xyn2 promoter may 
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not have been sufficient to effect hypoxia complex formation due to its closed proximity 
to the start codon and one mismatch if compared to the OLE1 LOR element. However, 
Vasconcelles et al. (2001) found the nucleotides outside the core element to play an 
important role in DNA binding and DNA sequences alignment revealed a region of high 
homology between the two promoters in the regions flanking the LOR sites (Fig.2A).  
 
A mutated OLE1 LOR element that was similar to the ATF1 LOR element (Fig.2B) 
facilitated the formation of a stable protein complex under both aerobic and hypoxia 
conditions (Vasconcelles et al., 2001), described as a “constitutive complex formation.”  
 
A 
OLE1 promoter fragment with LOR element and flanking regions (underlined) 
 
AGGTTCTCTTCGCATAGTCGGCAGCTTTCTTTCGGACGTTGAACACTCAACAAACCTTATCTAGTGCCCAACC-AG 
                              //  / /    ⏐⏐ ⏐⏐⏐⏐⏐⏐⏐⏐⏐ \\\⏐⏐ ⏐⏐⏐   ⏐⏐ ⏐⏐ ⏐ ⏐⏐              
ACCCCAGCACCTGAACAGTCATACAACCCCTCCAAGCCCAAAAGACACAACAACTCCTA-CTAG--CCGAAGCAAG 
xyn2 core promoter and flanking regions (Italics)  
 
 
B 
ATF1 promoter                                                            
                                                                                                          
.                 LOR (hypoxia)          Azf1p (glucose) 
GGAAGCGTCTTTTTGAAGCCAACCCAACAAAAATTCGAGACAAGAAAATAAAAAACGGCACTTCATCAGTATCACAAATACCATCAAT
TTATCAGCTCTCMET 
 
              gMyb2 binds C(T/A)ACAG (similar to Rap1p-binding region)      LOR(hypoxia) 
AAGCTTAAATAGAATTCGCCAAACCTGAACAACCCCAGCACCTGAACAGTCATACAACCCCTCCAAGCCCAAAAGACACAACAACTCCT
ACTAGCCGAAGCAAGAAGACATCAACATMET                
          Azf1p (Glucose) 
xyn2 core promoter and flanking regions (italics) 
 
Figure 2A Alignment of the region of OLE1 promoter flanking the LOR element sequence with the xyn2 
core promoter with putative LOR element sequence. B.  An alignment of ATF1 and xyn2-core promoters 
to show LOR element upstream locations and mismatches to the LOR consensus sequences. Putative 
Myb2p and putative Azf1p binding sites are indicated (see text for more detail). 
 
An 18-bp element (that includes a LOR element) is essential for transcriptional 
activation of ATF1 (Fujiwara et al., 1999). Vasconcelles et al., (2001) indicated that the 
complex formed at the ATF1 promoter LOR element was mediated by the transactivator 
Rap1p protein, however this complex did not bind the LOR site during hypoxia 
induction. This data indicated that a complex, other than the Mga2p mediated complex, 
plays a role in the ‘constitutive’ (similar hypoxia and aerobic) induction of OLE1 and 
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ATF1 transcription, but the Mga2p mediated complex facilitate hypoxia induction over 
and above this ‘constitutive’ induction. Rap1p DNA binding domain consists of Myb–
like domains. These domains will not be discussed here in detail but it is interesting that 
the consensus sequence (C(T/A)ACAG) of the Giardia lamblia Myb2 is partially 
present (Fig. 2B) on both the xyn2 and the OLE1 promoters (Sun et al., 2002). (Giardia 
lamblia is an important human intestinal parasite).  
 
Other signals, such as glucose, may also play a role. Transcription of the CLN3, G(1) 
cyclin in S. cerevisiae is positively regulated by glucose in a process that involves a set 
of DNA elements with the consensus sequence AAGAAAAA (A(2)GA(5)) (Newcomb 
et al., 2002). Downstream from both the ATF1 and xyn2 LOR elements, motifs similar 
to the glucose induced CLN3 motifs are present. These sequences are, respectively, 
AAGAAAATA and AAGAAGACA (Fig.2B).  
 
 
3.2 Post-transcription mechanisms: RNA stability as induction mechanism
 
The post-transcription mRNA stability mediated by Mga2p was recently indicated in 
yeast cells grown in fatty free medium at 30ºC. Mga2p mediated upregulation by 
increasing the stability of the OLE1mRNA transcripts (Kandasamy et al., 2004). They 
showed that the Mga2p mediates OLE1 mRNA stability in fatty acid free medium under 
control of its native promoter, but also when the OLE1 was placed under control of the 
GAL1/10 promoter. This indicates a mechanism of upregulation independent of 
promoter mediated induction. Expression of soluble forms of Mga2p (C-terminal 
truncated) stabilized OLE1 mRNA transcripts, but did not confer UFA mediated 
instability (Kandasamy et al., 2004). OLE1 mRNA has normally a half-life of ~10 
minutes (described as basal stability) that becomes highly unstable when cells are 
exposed to unsaturated fatty acids (described as regulated stability). 
  
The fate of mRNA can be determined by termination of transcription. In most 
mammalian protein encoding genes, polymerase II (Pol II) terminate at multiple sites 
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located over a distance of 0.5-2kb beyond a poly (A) site. Termination is coupled to a 
process that cleaves and polyadenylates the 3’ end of the transcripts. Termination earlier 
in the transcription process may occur or transcription may be paused depending on a 
specific protein or external signals. Regulation takes place at both capping of the 5’- and 
the 3’- cleavage/polyadenylation un-translated region of mRNA transcripts. mRNA 
processing in the nucleus includes 5’ capping, 3’ cleavage/polyadenylation (termination) 
and RNA splicing (of introns) before transport takes place. The transport of the 
functional mRNA into the cytoplasm may be regulated, as well as initiation of 
translation at the ribosome. An abundant set of nuclear proteins is associated with 
mRNA transcripts when it emerges from the RNA polymerase until transportation to the 
nucleus takes place (Lodish et al., 2000). 
 
The questions that need to be answered are how and where the AR regulator may 
stabilise the xyn2 reporter gene’s mRNA transcripts. A few mechanisms and sites of 
control that may be relevant for constitutive or low temperature induction will be 
discussed. 
 
Nuclear localization of mRNA and transport may assist in stabilizing transcripts: 
Does Mga2p compartmentalize transcripts to facilitate processing?  
Proteins involve in mRNA stabilizing may assist in both processing and transport of 
mRNAs. One of the most intriguing facts of mRNA processing is that most transcription 
and RNA processing occurs in certain domains (creating ‘rooms’ within the nucleus, 
(my description)) in mammalian nuclei. In higher eukaryotes cells, the cytoskeletal actin 
microfilaments participate in mRNA localization (Lodish et al., 2000). A nuclear matrix 
or skeleton formed by a fibrous protein network creates these ‘rooms’ or domains. The 
matrix is composed of actin and many other proteins. Mga2p has a putative link with 
actin and contains ankyrin regions, which are multifunctional adaptors that could link 
specific proteins to the membrane-associated spectrin-actin cytoskeleton. Mga2p was 
found in a protein-protein to complex with Tef4p (Cellzome®), known to interact with 
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cell membrane tubilin. However, involvement of Mga2p with the nucleus matrix still has 
to be indicated.  
Macromolecules larger than ~ 60kDa need active transportation across the nuclear 
membrane. Both import and export need participation of Ran, a GTPase (Lodish et al., 
2000). A Ran-binding protein was also present in the same protein complex as Mga2p 
(Cellzome®).  
 
mRNA stabilization through prevention of degradation 
Poly(A) polymerase (Pap) is responsible for the addition of the adenylate tail to the 3' 
ends of mRNA. Using the two-hybrid system Del Olmo et al. (1997) identified two 
proteins that interact specifically with the S. cerevisiae poly(A) polymerase, Pap1p, 
namely Uba2p and Ufd1p. Depletion of Uba2p from cells increased efficiency of Pap1p 
processing, while cells depleted of Ufd1p are defective in processing. These two 
proteins may have a role in regulating poly(A) polymerase activity, but are not 
components of polyadenylation factors. Uba2 is a homologue of ubiquitin-activating 
(E1) enzymes and Ufd1 is a protein whose function is probably also linked to the 
ubiquitin-mediated protein degradation pathway and may play a role in Mga2p 
proteasomal activation (for detail, see Chapter I). Udf1p play a role in the ER membrane 
associated complex with Nlp4 and Cdc48 to mediate proteasome-regulated cleavage of 
Mga2p and Spt23p. This proteolytic activation process of the ubiquitinated 
transactivators is affected by UFAs (Hitchcock et al., 2001.) Nlp4 protein could be 
component of the nuclear port given its localization and play a role in nuclear transport 
(DeHoratios and Silver, 1996). These proteins may play a role not only in Mga2p 
processing but also facilitate mRNA stability to mRNA transcripts of Mga2p target 
genes, if they are involved in adenylation and transport of mRNA. 
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Figure 3 A. An illustration and description of the putative destabilizing of the Mga2p proteolytic 
activation complex Npl4p/Cdc48/Udf1p by UFAs, Ski4 and other proteins or destabilization of Udf1p, 
effecting its role in polyadenylation of the Mga2 mRNA transcripts. B. The putative structure of complex 
formation at the OLE promoter, and/or OLE1mRNA transcripts to mediate gene transcription as well as 
mRNA stabilization by the active Mga2p90 form. C. The AR regulator is (probably) not under proteolytic 
processing control (described in A) since it does not contain the Mga2p C-terminal domain. AR regulator 
may facilitates a complex at the promoter of the reporter gene and stabilizes the reporter gene mRNA 
transcripts as indicated in this illustration. E. The RNA binding protein, Sbp1p may play a role in 
facilitating stability of the reporter gene transcripts. (See text for more detailed description of mechanisms 
suggested). 
 
It could be speculated that UFAs and the Ski4 protein repress the mRNA transcript 
adenylation mediated by poly(A) polymerase (Pap) by affecting Udf1p (Fig, 3A). As 
Ufdf1p is also involved in Mga2p processing, repression of this protein may prevent the 
“normal” proteolytic activation of Mga2p. Furthermore, it could also be speculated that 
instead of the active Mga2p90 form, a p100 form is produced. This form of Mga2p may 
interact with UFAs, Ski4 protein and other exosome proteins to degrade the OLE1 
mRNA transcripts in a 3’- 5’ process reported by Kandasamy et al, (2004) (Fig. 3B). 
Gonzalez and Martin (1996) indicated an effect of fatty acid / unsaturated fatty content 
on mRNA stability of OLE1 mRNA transcripts. They found the half-life of the OLE1 
mRNA transcripts was drastically reduce, following the addition of unsaturated fatty 
acids to the growth medium. A chimeric mRNA, produced by replacing the upstream 
activation and fatty acid-regulated regions of the OLE1 promoter with the GAL1 
promoter sequences, was destabilized by unsaturated fatty acids, indicating that 
regulation was mediated by mRNA destabilization and not at promoter level. 
 
The AR regulator may effect reporter gene transcription by means of both transcription 
and post-transcription mechanisms as illustrated in Fig.3B. The AR regulator does not 
contain the C-terminal domains of Mga2p and will therefore not be subjected to UFAs 
or Ski4p mediated degradation suggested for Mga2p in Fig.3A. The AR regulator 
protein may be in contact with the promoter DNA and move along to facilitate mRNA 
transcription, preventing degradation or simply increase efficiency by stabilizing 
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complexes. Kandasamy et al. (2004) studied the OLE1 induction in fatty acid free 
medium compared to medium with UFA. They found that mRNA stability (not 
chromosomal promoter modification or complex formation at the OLE1 promoter) 
to be the mechanism mediating transcription regulation. Kandasamy et al. (2004) found 
that Ski4p is involved in UFA-mediated instability in yeast. A strain with a mutated  
ski4-1 allele had a reduced ability to degrade OLE1mRNA. SKI4 encodes for one of the 
exosome subunits. The exosome consists of a multiprotein complex involved in mRNA 
degradation in yeast. The exosome complex is located both in the nucleus and in the 
cytoplasm and responsible for both 3’ – 5’ mRNA degradation and RNA processing 
reactions. The SKI genes were identified since mutations in them cause a "superkiller" 
phenotype when pathways of mRNA degradation are blocked (van Hoof et al., 2000).  
 
The expression of the xyn2 reporter gene under both aerobic and hypoxia conditions, as 
well as the futher low temperature induction, could be due to an increase in mRNA 
stability mediated by the ARp. This is a complex mechanism still ill defined. The Mga2p 
itself does not directly bind RNA (Kandasamy et al., 2004) or DNA (Jiang et al., 2001). 
Whether Mga2p (or ARp) is involved in a complex to stabilize mRNA transcripts under 
low temperatures, has not been determine. Mga2p was found in the same yeast protein 
complex as the Sbp1 protein (Cellzome®). This protein is a single stranded nucleic acid-
binding protein that associated with small nucleoar RNAs with two RNA recognition 
domains. A putative role that this protein may play in facilitating the binding of the AR 
regulator (and possibly Mga2p) to mRNA transcripts, is illustrated in Fig.3D.  
 
 
4. Conclusions: Induction mediated by the AR regulator 
 
The presence of the Mga2 a,b, and f domains provide to the AR regulator a 
sensing/signal transduction ability. The chimeric ARp senses low temperatures and also 
has the ability to mediate induction under aerobic conditions at 30°C (at a lower 
induction level as under low temperatures, but still 2-4 fold above basal levels). 
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Furthermore, pAR mediates induction under hypoxia conditions at both temperatures, 
comparable to levels of induction found under aerobic conditions at 30°C. It seems that 
Mga2p is a transcriptional activator responsible for gene activation, but also may protect 
transcripts or their translated products against degradation. The 3’-5’ exosome activity 
mediated by Mga2p in the presence of unsaturated fatty acids (Kandasamy et al., 2004) 
correlates with the mechanism of a mammalian Y box-binding protein-1 that binds 
preferentially to single-stranded nucleic acids and exhibits 3'→5' exonuclease activity 
(Izumi et al., 2001) ∞. Upregulation mediated by the AR regulator at low temperatures 
(17°C and 23°C) could be due to an increase in mRNA stability as well as the formation 
of an enhancesome at the target promoter to induce levels up to  
7-fold above levels found for the reference regulator. (Low temperature induction 
mediated by ARp of the reporter gene, was 2-3 fold above induction levels found at 
30°C). Reduced induction at 30°C could be due to either the lack of forming of an 
activation complex (enhancesome) at the promoter DNA or if only one of these 
mechanisms are involved in effecting AR mediated induction at 30. It may be speculated 
that a mechanism may exists where a transcription activator stays involved from 
transcription initiation to termination; possibly to play a role in facilitating in export of 
mRNA transcripts from the nucleus (Fig. 3E). 
 
Some factors are common to both transcriptional initiation and termination by RNA 
polymerase II processes. Proteins were recently identified that exist in a looped 
conformation, bringing together their promoter and terminator regions (O'Sullivan et al., 
2004).  
                                                 
∞ In higher eukaryotes, cold-shock domain (CSD)-containing proteins, also called Y-box proteins, is part 
of the RNA binding group of proteins. These proteins play an important role in transcriptional and 
translational regulation of a wide range of genes by controlling the recruitment of mRNA to the 
translational machinery (Raimondi et al., 2003). Low temperature signal sensors or transducers (also 
described as cold response proteins) that mediate upregulation of gene expression in response to a cold 
shock, have been identified and their respective promoter binding regions identified as the Y-box elements 
(Kohno et al., 2003). As identified by Kandasamy et al. (2004), they could play a role in low temperature 
induction mediate by the AR regulator (Chapter II). 
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It may be speculated that this form of gene regulation, in which transcription are defined 
before and during the transcription cycle, is the mechanism whereby Mga2p mediated 
induction and possibly other transcription regulators involved in mRNA transcript 
stability. In this study the Mga2p was divided in hypothetical domains, a-h. By inserting 
these regions one-by-one into the AR regulator, it should possible to identify their 
contribution to hypoxia induction or other signals such as unsaturated fatty acids and 
low temperatures. The AR regulation system could be adapted to ‘map’ functionality of 
other activator domains. Modifications and applications of this system will be discussed 
in Chapter V. 
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Improvements and applications of the pAR regulatory system 
 
The pAR system developed in this study can be improved by modification of the pAR 
system itself or changing the fermentation kinetics that will benefit the AR system. 
Modification of both target promoters and or composition of the AR regulator can improve 
control of targeted gene transcription. Examples of how such improvements can upregulate 
gene transcription or increase the ability to control gene transcription will be discussed. 
 
1. Improvements 
 
1.1 Regulation of enzyme ratios using different yeast selectable markers  
 
It will be possible to regulate enzyme production ratios by using different yeast selectable 
markers on the expression vectors. Ugolini et al. (2002) compared the effect of different 
marker genes on long-term growth rate and plasmid maintenance of 2µ-based shuttle-
plasmids. They found a plasmid provided with URA3 marker was maintained by host cells 
at the highest level in selective medium, HIS3 and TRP1 at intermediate and LEU2 at the 
lowest level. These differences could be exploited when implementing the double plasmid 
AR-based production system (described in Fig.1) to produce different protein levels. 
Ugoline et al. (2002) also showed that plasmid loss in synthetic complete and rich medium, 
were lower for the plasmid provided with marker genes URA3 and TRP1 than the HIS3 and 
LEU2 marker genes.  
 
1.2 Clone transactivator and target genes on separate plasmids and co-transform
 
The system could be evolved into a high expression system if the reporter and transactivator 
are cloned on separate plasmids and co-transformed to a receptor yeast strain. An example 
of such a system tested in a rat embryonic myocardial cell line showed induction levels of 
more than >100-fold mediated under hypoxia. Tang et al. (2002) showed that a hypoxia 
response element-mediated expression could quickly increase 2.08 +/- 0.75-fold within 6 h 
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of hypoxia and further augmented to 7.12 +/- 1.52-fold when the hypoxia condition was 
prolonged for 24 h in a single-plasmid system. A hypoxia-inducible double-plasmid system 
dramatically amplified the transgene expression under both hypoxia and normoxia by 
between 100-200 fold and between 20-30 fold at 6h and 24h respectively, relative to the 
single-plasmid system (Tang et al., 2002)Σ. The illustration in Fig. 1 indicates the system if 
the AR regulatory components are cloned on separated plasmids to be co-transformed into a 
host strain. The number of binding sites for the AR regulator will depend on the ratios of 
YFG – 1, 2 and 3 enzymes, needed to ensure metabolic flow of a 
fermentation/degradation/production process or combination of these processes.   
 
 
 
 
 
 
 
 
 
 
 
D ouble-p lasm id system co-transformed in host strain
-
pAR
URA3 2µ
YFG2
    3 x ‘GAl1/10 ’ prom oter fragm ents  (with each
fra gment containing  multiple G al4 p binding  elem ents)
YEp181
LEU2 2µ
AR gene
YFG3
YFG1
‘ GAl1/10 ’
promoter
fragment
ARp
ENO1
 prom oter
 
 
Figure 1 Putative double-plasmid system, with the AR regulatory components cloned on separated plasmids 
to be co-transformed into a S. cerevisiae host strain. The number of copies of the bi-directional ‘GAl1/10 ‘ 
target promoter fragment (bi-directional arrow) provided to the “your favorite gene” (YFG) in pAR and 
YEp181 are optional and can be varied. Replacing the 2µ with a CEN ARS replicon may reduce the copy 
number of the plasmids. When applied to other organisms (e.g. plant, other fungi, etc.) the appropriate 
selective marker genes and replication of origin need to be provided. 
 
 
 
                                                     
Σ The transactivator in this study was a Gal4pDBD-p65AD (p65 activation domain from NF-kappaB) chimeric 
protein, under control of a mammalian hypoxia response element / SV40 fusion promoter. The reporter gene, 
encoding luciferase, was provided with a target promoter [containing six Gal4p binding sites] fused to an 
adenovirus E1b TATA box on a separate plasmid (Tang et al., 2002).  
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1.3 Preparation of the pre-culture and the use of non-selective growth medium 
 
The AR regulatory system could be applied to industrial yeast strains using dominant 
selective markers or applied to laboratory strains using e.g. URA3 yeast marker and fur 
disruptive strains (la Grange et al., 1996) to allow growth of the recombinant strain on rich 
non-selective medium. Alternatively, the transactivator cassette can be integrated as a 
genomic copy or the target promoters may be inserted at the respective homologous genes 
that need to be up-regulated. The target promoters - YFG cassettes may also be integrated. 
  
Observations made in evaluating the pAR system and analyzing promoters induction under 
hypoxia (using the bi-directional cloning vector), showed that the key parameter that effects 
the recombinant protein production is cell vitality and viability of the pre-culture used. 
Preparation of the pre-culture in a rich meduim (YPD) without selective pressure was 
essential, as well as the cell density of the inoculum. Shi et al. (2002) found that increasing 
inoculum density gave rise to higher levels of heterologous protein production in Pichia 
pastoris. Parton and Willis (1990) showed the time of transfer (inoculum age) to be critical 
as the effect of the physiological state of the inoculum was marginal on biomass 
production, but critical for productivity of a streptomycete secondary metabolite.  
 
 
1.4 Application of the pAR regulatory system to other organisms for low temperature 
recombinant protein production 
 
Improvement of scFv production of a single-chain antibody against ς bertha armyworm in 
P. pastoris was attempted by Shi et al. (2002), by looking at the effect of several 
fermentation parameters. An interesting observation was that the cultivation at a lower 
temperature did not negatively effect cell yield for P. pastoris. In this study, similar results 
were obtained with S. cerevisiae cell yield at 23 °C and 30 °C being comparable (Chapter 
II, Fig. 7). Shi et al., (2002) also found that at an incubation temperature of 15 °C, intact 
scFv could be recovered from culture medium for periods in excess of seven days, probably 
due to reduced protease levels at the low temperature. Furthermore, Shi et al. (2002) found 
 
200
it was possible to induce the cell preparation biomass at 15 °C in an attempt to eliminate the 
need for continued renewal of pre-inoculum up to four times without compromising scFv 
production or integrity. Low temperature recombinant protein production could be a cost-
saving process. 
 
The AR regulation system can be modified by providing the appropriate marker gene (or 
integrating the AR cassette) for use in other organisms such as P. pastoris. Applying the 
low temperature inducible pAR system that mediated a 7-fold induction in S. cerevisiae at 
17˚C and 23˚ (Chapter II, Fig. 3), to P. pastoris could further upregulate recombinant 
protein production.  
 
 
1.5 Supply promoter of YFG with the appropriate number of “docking” cis elements 
to regulate gene expression 
 
Promoter elements may be incorporated and by inserting different number of elements in 
the different receptor promoters, control can be exerted. 
1. As indicated in Fig.1, the number of copies of ‘GAL1/10’ promoter fragments can be 
varied to increase the number of Gal4p DNA binding sites at the promoter.  
2. Signal transducer target elements: The insertion of elements targeted by a signal 
transducer can also be inserted as upstream activating sequences in multi-copies. If the 
LOR element and essential flanking regions (in addition with the GAL4DBD binding 
sites) are provided to target promoters, it may enhance formation of the hypoxia 
complex formation and mediate upregulation of your favorite gene under hypoxia. If the 
target promoter element for the Azfp present at the CLN3 promoter (Newcomb et al., 
2002) is inserted, glucose induction could be effected. The addition of response 
elements sensitive to specific metabolites (intermediates, e.g. glucose) to selective 
promoters will enhance the ability to control and up-regulate a recombinant pathway via 
the AR system.  
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2. Applications 
 
2.1. Apply the AR regulation system in a ‘mixed’ oxygen-level production system 
The AR regulatory system was designed with large-scale production systems in mind. The 
parameters that will induce recombinant protein production should also increase other 
fermentation kinetics, such as promoting cell growth induced under both aerobic and 
hypoxia conditions. Molecular oxygen has an immediate effect on the turnover of reducing 
equivalents, improving cell viability and therefore cell growth and division. It can be used 
to regulate heterologous protein production, as production is roughly proportional to cell 
biomass. When implementing the pAR system, targeted gene transcription will be 
upregulated under aerobic conditions as well as under hypoxia conditions. The pAR 
recombinant strains can therefore be used to produce recombinant proteins under both 
aerobic and hypoxia conditions.  
 
A possible application of a ‘mixed’ oxygen-level production system is a one–step biofuel 
production from complex carbon sources that requires simultaneous production of both 
heterologous enzymes and ethanol. A balance between essential aerobic processes  (cell 
growth and recombinant enzyme production) and hypoxic fermentation (ethanol 
production) could be reached by re-oxygenation during fermentation with oxygen pulses. 
The AR system, operational under both hypoxia and aerobic conditions, will be the ideal 
regulation system to implement.  
 
Pre-aeration of fermentation broth is standard practice in beer productions and in wineries 
where aeration is frequently applied during the fermentation process. An additional 
advantage of oxygen flushing will eliminate the need to add ergosterol (an essential but 
toxic substance not synthesized under anaerobic conditions in yeast cells, which the beer 
industry tries to avoid) (James et al., 2003). A putative layout of an industrial process using 
recombinant yeast with the AR regulatory system to degrade a complex carbon source (e.g. 
cellulose) to ethanol in a one-step fermentation system is illustrated in Fig.2. An increase in 
the production of enzymes with high specific activities under industrial conditions, as well 
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as efficient export of these enzymes out of the cell or uptake of substrates/intermediate by 
the  
recombinant cells, are critical factors. The temperature optimum of enzymes should also be 
manipulated to be compatible to the pH and temperature optimum of the host. However, the 
one-step fermentation could be feasible in the near future. An attempt has recently been 
made to illustrate simultaneous and synergistic saccharification and fermentation of 
lignocellulose to ethanol with the use of a recombinant yeast encoding three types of 
recombinant cellolulytic enzymes on laboratory scale (Fujita et al., 2004). 
 FED BATCH PROCESS
                                                                              Recombinant host cellCellulose degradation
  SUBSTRATE
Complex carbon source e.g. lignocellulose
Single fermentation
Need to produce engineered cellulose-
degradation enzymes adapted to host
(yeast)
Transform host cells with the plasmids
encoding:
i) Enzymes under control of optimized
target (for the AR regulator) promoter
for the AR regulator (see Fig.1)
ii) Plasmid encoding the AR regulator
Need to produce xylan-degrading enzymes
adapted to host (yeast)
Transform host cells (D) with an
additional plasmid encoding xylan
degrading enzymes under control of
optimized target (for the AR regulator)
promoter for the AR regulator (see Fig.1).
(Could integrate genes involved). Adjust
selective pressure (see text for detail)
based on pentoses or hexoses present in
fermentation tank.
30ºC
E.g. xylan degradation
B
23ºC -  25ºC
Ethanol production
C
30ºC
E.g. cellulose degradation
 A
Need ability to ferment both pentoses
and hexoses formed.
  D
E
 F
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 An illustration of a putative one-step enzymatic saccharification and fermentation of complex carbon 
source (e.g. lignocelluloses) to biofuel ethanol process. The AR regulator could mediate an up-regulation of 
all target genes at low temperatures (indicated by C). Enzymes levels will be induced and if the temperature is 
increased the degradation processes (as indicated in A and B) will enhance degradation of complex carbon 
source as well as biomass production. With the resultant increase in the levels of hexoses and pentoses, the 
temperature can be lowered to increase ethanol production (C). Detail of the relevant bioengineering steps 
reqiured to enable the recombinant host to process the carbon sources are describe in blocks D, E and F. 
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The fermentation process may be regulated by re-oxygenation during fermentation to 
increase biomass and recombinant protein production (D and E) or to benefit ethanol 
production (F).  
 
Enzyme production can be regulated by manipulation of the regulatory system incorporated 
in the recombinant host. For example, by adjusting the copy number of plasmids encoding 
the recombinant cellulose or xylan degradation enzymes and/or controlling the number of 
elements at target promoters (as is required) of the gene(s) of interest, optimum synergy 
between enzymes can be determined in the pAR system. The number of elements inserted 
at target promoters could also be increase (described in Fig. 1). Either more Gal4pDNA 
binding sites and/or other response elements such as LOR elements (Vasconcellus et al., 
2001, Jiang et al., 2001)) could be added to increase the ‘docking’ sites for the 
transactivator. Thus the pAR regulatory circuit provided a number of options to manipulate 
and it will be relative easily to make slight or drastic adjustments and re-evaluate the 
system.  
 
2.2 Use of the AR-system in determining protein domain function  
 
The catalytic site of any regulator can be located to a specific region, as was done for 
Mga2p in this work. The signal sensing “abilities” and/or transduction abilities of Mga2p 
domains were determined when Mga2p domains incorporated in the AR regulator, 
conferred these abilities to the chimeric transactivator. Similarly domain function mapping 
of uncharacterized activators can be determined by inserting domains in the AR regulator, 
replacing the Mga2p domains (or the GAL4DBD or TADIII activation domains) or adding 
domains and test the chimeric regulator under different conditions. 
 
One of the main problems in new drug discovery is to deliver the drugs to their respective 
targets. Transcription factors can be used as drugs to mediate changes at a molecular level. 
Firstly, targeting is needed to evaluate their effect and secondly, once validation is done, 
delivery needs to be maximized. Drug delivery to inactivate targets or simply identifying 
target (to validate their functions/roles in the cell) can be done by using monoclonal 
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antibodies, small, bioactive molecules that directly or indirectly inactivate effector proteins, 
gene knockouts, nucleic-acid-based agents and modular enzymes / engineered 
transcription factors (Hardy and Peet, 2004). Modular enzyme production may be not 
only be upregulated, but also be controlled, if delivered by the pAR regulatory system. 
Drug delivery to inactivate a target or determine the effect on a target can be done by 
modular enzymes and engineered transcription factors, as the function and folding of an 
enzyme are modular. Engineering strategies can take advantage of the modular nature of 
proteins and combining functions originating from different sources. Transcription factors 
can be delivered by a recombinant vector and is relatively stable. As expression of a 
transcription factor can be manipulated by external signals, application of the pAR 
regulator can have a wider application. Drug toxicity levels can be determined, as well as 
interference of the product with the transcriptor. Currently the evolutionary conserved 
pathways that preserve genetic stability in the yeast S. cerevisiae are utilized to screen for 
novel anti-cancer agents (Zhang and Siede, 2003). Yeast is established as a model system to 
characterize the cellular effects of inhibitors and anti-cancer agents. Further 
characterization of domains of these drugs (functional mapping) will be possible and 
interaction with other drugs could be determined if the agents under study are incorporated 
in a double pAR system and co-transformed.  
 
2.3. Use of the AR-system in determining signal transduction pathways or energy 
systems under hypoxia 
A cold-inducible RNA-binding protein that is also a highly conserved cold stress protein 
with RNA-binding properties, has recently been identified as a being expressed in response 
to hypoxia by a mechanism that involves neither HIF-1 nor mitochondria in human and 
murine leukemic cell lines (Wellmann et al., 2004). These two proteins were induced by 
moderate hypothermia (low temperatures). The low temperature and hypoxia induction of 
cold inducible RNA-binding protein suggests the possibility of an overlap of signal 
transduction pathways of the two signals. It is possible that this is a similar pathway 
response to both hypoxia and cold in higher eukaryotes comparable to the Mga2p system in 
yeast. This could be a system similar to the Mga2p for the following reasons: Mga2p is 
involved in the up-regulation of OLE1 transcription via mRNA stability (Kandasamy et al, 
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2004) and complex formation with a protein that binds single stranded RNA (or DNA) was 
shown by the Cellzome protein-protein complex studies. Mga2p mediates both hypoxia and 
low temperature induction of OLE1. This makes the work done in this study even more 
relevant for the discovery of new pathways. Protein-proteins interaction studies using the 
AR protein as bait will indicate the proteins/co-factors involve in mediating gene 
upregulation under cold or hypoxia conditions. Comparative studies of Mga2p and its 
homologue protein Spt23 (that does not mediated cold induction (Nakagawa et al., 2002)) 
using the AR system may provide information to determine low temperature signal 
response /signal transduction mechanisms in yeast.  
 
The AR protein will have a wider application in future due to its redox sensing abilities. It 
was speculated in the literature overview that the hypoxia-inducible Mga2p protein is 
involved in mediating upregulating of enzymes implicated in the redox shuffling in yeast 
cells under hypoxia. If these functions of Mga2p and the mechanisms by which it operate 
are characterized (inserting other domains of Mga2p in the AR regulator), it will give 
scientists the opportunity to manipulate native yeast metabolic pathways under hypoxia. It 
could also help to identify pathways that would shed more light on the cause of diseases in 
mammalian cells and the treatment thereof (Zhang and Siede, 2003) or determine the 
effected by hypoxia (caused by flooding) in plants (Ismond et al., 2003). 
 
 
THE FINAL WORD 
 
3. The AR regulator is a workhorse and prospector in one 
 
To conclude, it could be said that the hierarchy of signal transduction and processing 
determine a protein’s fate. All control mechanisms in the pathway upstream and 
downstream of the regulatory proteins' own production or its targets still have a great 
influence in the outcome of a regulatory system. Metabolic networks consist of many 
elements and regulatory loops (Kremling et al., 2000). 
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 A long journey was undertaken and some answers were obtained but far more options and 
possibilities were uncovered during this study of transcriptional engineering. This 
dissertation was started with the following quotation:  
 
“Genes are not puppet masters or blueprints, nor are they just the carriers of heredity. 
They are active during life; they switch one another on and off; they respond to the 
environment. To make grand changes in the bodyplan of animals, there is no need to 
invent new words to write an original novel. All you need to do is switch the same ones on 
and off in different patterns. Merely by adjusting the sequence of a promoter or adding a 
new one, you could alter the expression of a gene.” TIME (Matt Ridley June 2, 2003 What 
makes you who you are. p 41-47) 
 
An attempt was made to introduce “grand changes” to take control of hypoxia and 
temperature metabolic control. Regulating genes by a targeting mechanism, e.g. the 
Gal4pDBD – ‘GAL10/1’ cis element are used by other research groups (Tang et al., 2002). 
The uniqueness of this study lies in the addition of linker (adaptor) domains to this system, 
to establish the role of those domains and to either create signal sensitivity or relieve the 
regulator of the signal dependence. The unregulated expression qualities of the Mga2p 
were separated from the upregulated expression qualities. It opened the possibilities to not 
only see the “inside” of a relatively unknown regulatory protein, but also created an easy 
system for assessing other transactivators and their domains with unknown function – thus 
a workhorse and prospector in one. 
 
 “Using” of the natural patterns of “active life” enabled us to create unique recombinant 
organisms. However, this process is still rather more a rearrangement of things in existence. 
By controlling these patterns, humans will be able to produce metabolites of their choice 
even faster and cheaper in future, but something new it is not. It is only rewriting a book, 
creating a new novel with the words already in existence. New words are invented when 
single amino acids or motifs of proteins are targeted for change, but even these new words 
will need control to create a novel that make sense.  
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THE END 
 ‘Your thoughts are your own but the end of your thoughts you do not know’ 
William Shakespeare 
‘Your proteins are your own but the end of your proteins you do not know’ 
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APPENDIX 
SUPPLEMENT FILES INDEX 
A) CDART: Conserved Domain Architecture analysis – 
-List of proteins identified as an example   
-Motif ‘analysis’ of Mga2p 
B) CELLZOME: protein-protein interaction studies 
C) Draft for provisional Patent application  & sequences of pAR domain  
 
A) CDART: Conserved Domain Architecture analysis  
 
Some of the domains currently avialable to search for by the Cdart, it may change regularly as the list is updated with the discovery 
of new conserved protein domains. 
CG-domain 
Alpha amylase,C-terminal all-beta domain 
Protein present in Fab, YOTB,Vac,and EEA; Zi 
ATPases associated with a variety of cellular act 
Starch binding domain 
Oxysterol-bindingprotein ?  
DHHC zinc finger domain. 
Patatin-like phospho lipase 
Glycerophosphoryldiesterphosphodiesterase family 
SPXdomain 
Sterile alpha motif; Wide spread domain in signall 
In Between Ring fingers; the domains occurs between 
Suppressors of cytokine signalling  
Band.homologues; Also known as ezrin/radixin/... 
Ringfinger; E ubiquitin-protein ligase activity 
Domain present in PSD-,Dlg,andZO-/;Alsoc 
NUDIX domain  
LEMdomain long an 
GTPase-activator protein for Ras-like GTPases 
Rel homology domain (RHD)
Zincfinger 
Helical motif in the GIT family of ADP-ribosylati 
Domain in protein kinases,N-glycanases and other 
Worm-specific(usually)N-terminal domain 
N-terminal to some SET domains; A Cys-rich putati... 
CAP-Glydomain.CAP stands for cytoskeleton-assoc 
MYND finger 
Those underline of interest in this study  
 
E6-AP Carboxyl Terminus  
Ankyrin repeat. 
IPT/TIGdomain
Zinc binding domain seen in both chromatinic 
BTB/POZdomain 
Diacylglycerol kinase accessory domain 
Bacterial periplasmic substrate binding proteins 
Cyclic nucleotide-bindingdomain 
Protein kinase domain 
Ion transport protein 
Di acylglycerol kinase catalytic domain 
Yeast DNA-binding domain 
Ubiquitin homologues 
UvrD/REPhelicase 
AcylCoA binding protein 
Notch(DSL)domain 
Calcium-bindingEGF-likedomain 
F-boxdomain 
Asparaginase 
Ezrin/radixin/moesinfamily 
von Wille brand factor 
Extracellular domain helix loop helix domain  
DEATH domain 
Serine/ Threonine protein kinases, 
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Domains/motifs search for Mga2p – Examples of motifs searches and amino acid rich in  repeats 
regions 
 
gene 416121..419462 /gene="MGA2" /note="YIR033W" /translation= 
"MQQNSEFLTETPGSDPHISQLHANSVMESQLLDDFLLNGSPMYQDDSMAHINIDEGANFQNFIKTDEGDSPNLLSFEGIGNN
THVNQNVSTPLEEEMESNRALKEEEEDEHENKVFNEKNIGNPAHDEIVFGRKETIQSVYINPLDYLKVNAAQLPLDVEVSG
LPQVSRVENQLKLKVKITSETPLNQSMLYLPSDSISREKFYLKKNIEDFSEDFKKNLLYINAFVLCAVSNRTTNVCTKCVKR
EQRRAARRKSGIADNLLWCNNINRRLVVFNNKQVFPIMKTFDNVKEFELTTRLVCYCRHHKANNGFVILFTITDWQNRLL
GKFTTTPIMITDRKPANMDTTKFNNTTTSSRRQLTEEESTTEYYSTDNNQLSKDENMPFQYTYQHNPYDNDSQMNNIPLKD
KNVPFPYSISQQTDLLQNNNLSLNLSLPNQHIPSPTSMSEEGSESFNYHHRDNDNPVRTISLTNIEQQSQLNQRKRARNNLEN
DIGKPLFKHSFSNSISATNTMNPALHSMQDFSMKNNNNNLPSINRVIPSQGPINGGIEVTLLGCNFKDGLSVKFGSNLALS
TQCWSETTIVTYLPPAAYAGQVFVSITDTNNENNNDDLPQEIEINDNKKAIFTYVDDTDRQLIELALQIVGLKMNGKLED
ARNIAKRIVGNDSPDSGTNGNSCSKSTGPSPNQHSMNLNTSVLYSDEVLIQKVIKSLNINSNISICDSLGRTLLHLACLKNYSS
LVYTLIKKGARVNDIDSFGLTPLHFACISGDPKIIKMLLNCKVNYSLRSHNGLTAREVFIANHIHSKEIDKKQDNRDNHKFV
HNDTYISEVLSLFEEFQNGTKFTDSVETDSNYSISRKYSQSSFNSSLLDNESLNENLFESQSMINPTSMEIQHPTLQLFENSSYS
EYDQSDFEEDGDEDLFVTDEVEKPGVACREEQSELLDIGSSANEPEEDNGSTSLWNRVLHRINDDLPKYEDLFPLSWGKDD
KLKTTNQDSIVEQSASNIENSENSEEEDYEEEEEFLKKQFNRFFQNKQNFRNDKMLIFFWIPLTLLLLTWFIMYKFGNQDSSI
NHISELISEYLRIALAKFLLGNERMKTAFRSKLSNLQTTRMLNDLIVS 
PUTATIVE MOTIFS:  
 
1. NGS domain where glycolization could take place if system is similar as in humans 
2.  KCVKREQRRAARRK seq. rich in K & R amino acids - nucleus localization signal (NLS), needed for larger 
proteins to be transported into the nucleus 
3. LPKY motif that interact with Rsp5p to be ubiquinated and thus earmarked for degradation  
4. Asparagine (ASN,N) – rich region 5’- AAC or 5’-AAU 
5. Arginine-rich (ARG,R) – rich region found in RNA binding domain of HIV tat antitermination protein  
KCVKREQRRAARRK 
6. Glutamine (GLN,Q) 
7. Glutamic acid (GLU,E)  
 
  
Supplement B CELLZOME: protein-protein interaction studies 
 
PROTEIN PRODUCTION or PROCESSING COMPLEX PULLDOWN WITH Mga2p 
Sub-Units / Description / Localization / Putative function 
 
• ILV1 threonine deaminase  
ILV1 (yer086w) - L0000856 : Gene Product: threonine deaminase : Phenotype: Isoleucine-plus-valine requiring 
PUTATIVE FUNCTION: Facilitates Mga2p modification in the proteasome? Or proteins induced by Mga2p? 
CONNECTION: The eukaryotic, structural part of the proteasome, has six threonine protease active sites.  
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• CHA4 (ylr098c)  
Zinc-finger protein  (transcription activator) with Zn[2]-Cys[6] fungal-type binuclear cluster domain : Gene Product: DNA-
binding transcriptional activator or CHA1 : Phenotype: Unable to grow with serine or threonine as the sole nitrogen source, 
suppresses ilv1 mutant by causing inducer-independent, constitutive expression of CHA1 
PUTATIVE FUNCTION: Is this factor X that bind low oxygen response elements at promoters such at the OLE1 promoter – 
part of the hypoxia inducible complex mediate by Mga2p?  
CONNECTION: None other than being DNA-binding transcriptional activator and the fact that Mga2p does not bind the 
promoter DNA itself 
 
• Saccharomyces cerevisiae SGD NEW1 this gene encodes a protein with a Q/N-rich amino terminal domain that acts as a prion 
termed [NU]+. Function: None specified  
 PUTATIVE FUNCTION: Facilitates modification of Mga2p or Mga2p target proteins in the proteasome ? 
         CONNECTION  
Sterol regulatory element – binding proteins (SCREBP proteins), regulatory proteins in human cells the Alzheimer’s disease-
linked ameloid precursor protein, cell signaling protein Notch, and the unfolded protein response-signaling kinase, Ire1 are 
involve in an ubiquitin-independent activation mechanism (not found for Mga2p or Spt23).  Misfolding of these proteins 
caused the formation of prions that is the causative agent of Alzheimer disease. Interestingly, Mga2p was isolated in a protein-
protein complex with a protein encoded by NEW1 Prion Q/N-rich N-terminal domain that acts as a prion, termed [NU]+ 
(Brown et al., 2000). This association could implicate Mga2p in a chaperone role to get rid of prions formed ? 
My opinion / Speculation: NEW1 (Prion Q/N-rich N-terminal) simlar to Mga2p, may deliver short peptides as building blocks 
or chaperone misfolded proteins aided by Mga2p ? 
 
• Saccharomyces cerevisiae SGD EFB1 Translation elongation factor EF-1beta, GDP/GTP exchange factor for Tef1p/Tef2p 
Ribosome Product: Translation elongation factor EF-1beta, GDP/GTP exchange factor for Tef1p/Tef2p : Phenotype: Null 
mutant is inviable. 
PUTATIVE FUNCTION Could also be involve in the GDP/GTP exchange of the Ran-binding protein and teherby be involved 
in mRNA export. EFB1 Translation elongation factor located: Cytoplasm / ribosome / ER . Putative function in translation 
initiation or recycling of peptides? 
 
• Saccharomyces cerevisiae SGD YBR025C Hypothetical ORF Location: Cytoplasm  
 
• Saccharomyces cerevisiae SGD FAP1 FKBP12-associated protein, FKBP12-associated protein: Gene Product: Transcription 
factor homologue; similarity to Drosophila melanogaster shuttle craft protein; similarity to human NFX1 protein; similarity to 
human DNA-binding protein tenascin : Phenotype: Null mutant is viable and shows no phenotype; overexpression confers 
rapamycin resistance. 
PUTATIVE FUNCTION: Is this factor X that bind low oxygen response elements at promoters such at the OLE1 promoter – 
part of the hypoxia inducible complex mediate by Mga2p?  
CONNECTION: None other than being DNA-binding transcriptional activator and the fact that Mga2p does not bind the 
promoter DNA itself 
 
• Saccharomyces cerevisiae SGD SEC27. Involved in endoplasmic-to-Golgi protein trafficking Vesicle: Gene Product: encodes 
beta'-subunit of yeast coatomer: Phenotype: Null mutant is inviable. Sec27p function in the recycling of the yeast proteins. 
SEC27 yeast coatomer involved in early Golgi compartment to ER. 
Elevated mRNA levels (DNA array study) of SEC27after hypoxia induction of yeast cells, grown in a glucose-limited 
chemostat culture (ter Linde et al., 1999). 
PUTATIVE FUNCTION: Sec27p (coatomer protein) function in the recycling of the yeast proteins. 
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 • Saccharomyces cerevisiae SGD YGL245W Protein required for cell viability  
Elevated mRNA levels of YGL 245w (DNA array study) after hypoxia induction of yeast cells, grown in a glucose-limited 
chemostat culture (ter Linde 1999). 
YGL 245w encodes a ligase RNA binding tRNA synthetase also involved in a proteasome signaling protein complex.  
PUTATIVE FUNCTION/CONNECTION  
There, maybe a link between sterol and protein synthesis, important for pathway regulation. As the tRNA and sterol 
biosynthetic pathways was found to be in apparent competition for substrate, a delicate balance in protein levels to maintain 
proper functioning of translation and mevalonate metabolism is needed (Benko et al, 2000). The mevalonate pathway generates 
sterols, substrate for isopentenylation of tRNAs, ubiquinone, heme A and prenylated proteins. The link to hypoxia regulation 
via Mga2p - might be through the regulation of its association with proteins involves in the production of heme. Heme groups 
are essential oxygen carriers. This association is however not clear and highly  
 
• YIR033W MGA2, Chr IX from 416121 to 419462  
(1113 letters) Saccharomyces cerevisiae SGD MGA2 Endoplasmic reticulum  
Phenotype: Null mutant is viable, shows subtle effects on growth, UV sensitivity, and galactose utilization; mga2 spt23 
double deletion mutants are inviable. MGA2 (QN–rich) Mga2p induces OLE1 that encodes a desaturase that will determine 
structure of cell wall membrane, faciltates DNA binding. Involved in cell wall /membranes or tubilin biosynthesis, chaprone 
functions for mRNA, export of mRNA ? 
 
• Saccharomyces cerevisiae SGD KAP123 Karyopherin of predicted MW 122.524 Da. Similar to Kap95p (YLR347C) and 
Kap104p *YBR017C). Ran binding protein, Homolog of importin-beta Nucleus Nucleus Cytoplasm  
KAP123 (yer110c) - Karyopherin of predicted MW 122.524 Da. Similar to Kap95p (YLR347C) and Kap104p *YBR017C). 
Ran binding protein, Homolog of importin-beta : Gene Product: Karyopherin beta 4 : Phenotype: Null mutant is viable 
PUTATIVE FUNCTION: Transport of mRNA ? 
KAP123 Karyopherin Ran binding protein involve in mRNA export                              
 
• Saccharomyces cerevisiae SGD GFA1 catalyzes first step in hexosamine pathway required for biosynthesis of cell wall 
precursors None specified Gene Product: Glutamine_fructose-6-phosphate amidotransferase (glucoseamine-6-phosphate 
synthase) Function: None specified 
 
• Saccharomyces cerevisiae SGD TEF4 Translation elongation factor EF-1gamma Location: Ribosome 
Elevated mRNA levels of TEF4 (DNA array study) after hypoxia induction of yeast cells, grown in a glucose-limited 
chemostat culture (ter Linde et al., 1999). 
PUTATIVE FUNCTION/CONNECTION 
It possibly has translational proofreading abilities.  
As gamma-subunit of an elongation factor, deliver incoming tRNAs to the ribosome.  
Protein complex studies showed that it is also involved in a complex that function in proteosome signaling. TEF4 Translation 
elongation factor interacts with tubilin.                        
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 C. Draft for provisional Patent application  &  sequences of pAR   
 
Draft for Provisional Patent 
 
 
Title 
A modular transcription activating - gene regulatory, plasmid based system for 
controlled bio-production in fungi 
– A constitutive anaerobic and aerobic (/ [oxygen] insensitive) up-regulation of gene 
expression system 
– Up-regulation over and above constitutive levels by low temperatures = (low 
temperature inducible)  
 
Description of the field of invention 
1. Plasmid based regulatory system for controlled metabolic pathway control  
AIM: The controlled production of recombinant proteins/enzymes for substrate 
degradation, as well as converting the substrate to a desirable end product, 
simultaneously, in one-step fermentation. 
 
2. The plasmid design provides a protein domain mapping tool 
AIM: The modular nature of regulator cassette can be used to study the function of 
domains of other regulatory proteins, by inserting domains of unknown function in the 
chimeric regulator or by replacing domains in the regulator. 
 
By adding to, or by replacing/deleting domains in the activator protein cassette it 
could be used to study the effect of domain (/s) function on the synthetic activator’s 
ability to induce transcription in response to specific signals. A reference plasmid 
will also be provided for easy cloning purposes. 
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Claim 
If the chimeric AR regulatory system is incorporated on a wider scale in the yeast cell, 
upregulation in all the “connected” metabolic processes can be mediated via the AR 
regulator and a futher upregulated can be mediate in response to temperature. The 
Mga2p yeast transcription regulator mediates gene up-regulation under low 
temperatures. Mga2 domains responsible for the low temperature response were mapped 
by incorporating domains of this protein in a chimeric transcription activator. The 
chimeric transcription activator consisted of the GAL4 DNA binding domain, ADR1 
TAD III transactivation domain and two domains of Mga2p. A target fusion promoter 
consisting of GAL4 DNA binding domain and a Trichoderma reesei core xyn2 promoter 
was constructed as target for this transactivator and fused to a reporter gene. Both the 
chimeric transcriptor and reporter gene was expressed from the same episomal plasmid. 
The regulatory system induce transcription at constitutive levels under all oxygen 
conditions (aerobic and hypoxia). Furthermore the reporter gene expression was up-
regulated by the chimeric transcriptor at low temperatures 2 to 3 – fold over and above 
upregulated levels found under all oxygen conditions conditions at 30°C. 
 
 
 
CLAIMS IN RELATION TO BASIC RESEARCH –  
Mapping of functionality of activator domains of regulatory proteins by means 
pAR: 
Use plasmid AR for domain swopping to identify: 
 Domain functionality  
 Signal sensitive domains 
 Also to study the effect of response 
 If multicopies of domains are added 
 Domains are mutated before insertion 
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Claims in relation to implement the invention for commercial gain 
use plasmid AR and insert gene of choice  
 under control of  cis elements of  Gal 10/1 promoter, 
 transform to appropriate yeast strain 
Use low temperatures as induction signal to produce gene product of your choice 
either under aerobic or anaerobic conditions. Control expression levels by 
changing of growth temperatures. 
OR 
1. Add the cis element ‘GAL10/1’ promoter (cis GAL 10/1 –your favorite gene 
(YFG)) to gene(s) of choice (cis ‘GAL 10/1’ –YFG) 
2. Clone the promoter –gene construct on plasmid(s) with unique marker(s) / or 
integrate into the genome of other organisms  
3. Co-transformed plasmid or plasmids (p(cis ‘GAL 10/1’ –YFG)) and pAR to yeast 
OR transformed pAR to yeast with integrated (cis-‘GAL 10/1’ –YFGs)  
 
 
 
 
 
Sequence of pAR 
 
Domains regulatory cassette as well as target elements of promoter indicated 
 
 
1         GAATTCTTATAGGGTGGACGTCAAGACGAAAAGTGAAAAATTACATCCGTATAGAATTAT 
 
61        ATAACTTGATGAGATGAGATGAGTAAATGACAGAAGAATTACCGTTTCATCATTGAACTT 
 
121       CGATCATTTCAATGCTGGCATGCGAAGGAAAATGAGAAATATCGAGGGAGACGATTCAGA 
 
181       GGAGCAGGACAAACTATAACCGACTGTTTGTTGGAGGATGCCGTACATAACGAACACTGC 
 
241       TGAAGCTACCATGTCTACAGTTTAGAGGAATGGGTACAACTCACAGGCGAGGGATGGTGT 
 
301       TTACTCGTGCTAGCAAACGCGGTGGGAGCAAAAAGTAGAATATTATCTTTTATTCGTGAA 
 
361       ACTTCGAACACTGTCATCTAAAGATGCTATATACTAATATAGGCATGCTTGATAATGAAA 
 
421       ACTATAAATCGTAAAGACATAAGAGATCCGCTTATTTAGAAGTGTCAACAACGTATCTAC 
 
481       CAGCAATTTGGCCCTTCTCCATCTTTTCGTAAATTTCTGGTAAACTGGATAAGCCAACTA 
                                                             
541       CCTTTATTGGAGACTTGACTAGACCTCTGGCAAAGTCTGGATAGCAATCACTAGTGCGGC 
 
216
                                           < ADR1TADIII ◄ 
601       CGCGGGAATTCGATTCGCGATATCGTCGACTTAGTCAATCTCATTTGACGTGGCGGTAGC
 
661       ACTTACGCTATCATCATGTAAAAGTTCAAATTCTTTTAAAACGGCAGTGGTCTCTAACAA
                                                  ◄ ADR1TADIII ◄ 
721       ATCATTACCTAAAGTATCATTATCCAGCAGTTCTTGAAAATCGACGAAATCAGGCATTAC 
                         < MGA2 F domain ◄ 
781       GTAAGATCTAGGCCTCATCTTAATAATTTTAGGGTCACCACTTATGCAAGCAAAATGTAA 
 
841       TGGAGTTAGCCCAAAGGAATCAATATCGTTAACACGAGCACCCTTTTTAATCAATGTATA 
 
901       CACAAGGCTTGAGTAATTTTTCAAACAGGCAAGATGTAATAAAGTTCTCCCTAATGAATC 
 
961       ACATATGGAAATATTGGAATTTATGTTCAATGATTTTATAACTTTTTGTATCAAGACTTC 
 
1021      ATCGGAGTAAAGAACACTTGTGTTCAGATTCATACTGTGTTGGTTTGGAGAGGGACCTGT 
 
1081      GCTTTTTGAACAGCTGTTGCCATTTGTACCGCTATCAGGAGAATCATTGCCAACAATCCT 
 
1141      CTTCGCGATATTTCTTGCATCTTCTAACTTACCATTCATTTTTAATCCCACAATTTGCAA 
 
1201      AGCCAATTCAATCAGTTGCCTATCAGCATCATCAGCATAGGTAAATATGGCCTTTTTATT 
 
1261      GTCATTGATCTCAATTTCTTGGGGAAGGTCATCGTTATTATTTTCATTATTCGTATCAGT 
 
1321      AATAGAGACGAAAACTTGACCCGCGTAGGCAGCGGGAGGGAGATAAGTGACGATCGTGGT 
 
1381      CTCACTCCAGCATTGCGTAGAAAGGGCAAGATTAGAGCCGAACTTTACAGAAAGACCATC 
 
1441      TTTGAAGTTACAACCCAGTAATGTAACTTCGATACCACCATTGATTGGGCCTTGTGAAGG 
 
1501      TATAACGCGATTAATTGATGGCAAATTATTGTTGTTGTTTTTCATTGAGAAATCTTGCAT 
               ◄ MGA2 f domain ◄◄   < MGA2 ab  domain ◄ 
1561      TGAATGTAAAGCTGGATTCATCGTACGTCGCTTAACACACTTGGTACAAACATTTGTCGT 
 
1621      TCTGTTGCTGACCGCACATAGAACAAACGCATTGATGTACAGAAGATTTTTCTTGAAGTC 
 
1681      TTCTGAAAAATCCTCGATATTTTTTTTTAAATAAAACTTTTCTCTTGAAATGGAATCGCT 
 
1741      AGGCAAGTAAAGCATGCTTTGGTTTAGTGGTGTTTCAGACGTAATTTTCACTTTCAGTTT 
 
1801      CAGTTGATTTTCCACTCTAGATACTTGTGGCAAACCTGAGACCTCTACATCCAAAGGTAG 
 
1861      CTGCGCTGCGTTCACTTTAAGGTAATCTAAAGGATTTATGTAAACAGATTGAATCGTCTC 
 
1921      CTTTCTTCCAAATACAATCTCGTCATGAGCAGGGTTGCCTATATTTTTTTCATTAAAAAC 
 
1981      CTTATTTTCATGCTCGTCCTCTTCTTCCTCCTTCAAGGCTCTGTTACTTTCCATTTCCTC 
 
2041      CTCCAGTGGAGTGGACACGTTTTGGTTGACATGAGTATTGTTACCGATACCTTCGAAAGA 
 
2101      CAACAGGTTGGGCGAATCACCCTCATCTGTCTTGATAAAATTTTGGAAATTAGCACCCTC 
 
2161      ATCAATATTAATATGCGCCATGCTATCATCCTGGTACATGGGAGACCCGTTCAGGAGGAA 
 
2221      ATCGTCCAAGAGCTGTGATTCCATTACGCTATTCGCGTGCAATTGAGATATATGAGGGTC 
                         ◄ Mga2 ab domain◄◄     < GAL4DBD◄ 
2281      GCTTCCAGGTGTTTCCGTTAAGAACTCACTGTTCTGCTGCATTGGCCACGATACAGTCAA 
 
2341      CTGTCTTTGACCTTTGTTACTACTCTCTTCCGATGATGATGTCGCACTTATTCTATGCTG 
 
2401      TCTCAATGTTAGAGGCATATCAGTCTCCACTGAAGCCAATCTATCTGTGACGGCATCTTT 
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2461      ATTCACATTATCTTGTACAAATAATCCTGTTAACAATGCTTTTATATCCTGTAAAGAATC 
 
2521      CATTTTCAAAATCATGTCAAGGTCTTCTCGAGGAAAAATCAGTAGAAATAGCTGTTCCAG 
 
2581      TCTTTCTAGCCTTGATTCCACTTCTGTCAGATGTGCCCTAGTCAGCGGAGACCTTTTGGT 
 
2641      TTTGGGAGAGTAGCGACACTCCCAGTTGTTCTTCAGACACTTGGCGCACTTCGGTTTTTC 
 
2701      TTTGGAGCACTTGAGCTTTTTAAGTCGGCAAATATCGCATGCTTGTTCGATAGAAGACAG 
           ◄AR regulator◄                       ◄◄ ENO1 Promoter 
2761      TAGCTTCATGAATTCGGATCTCGGAATTCTTTGATTTAGTGTTTGTGTGTTGATAAGCAG 
 
2821      TTGCTTGGTTTTTTATGAAAAATAGCTAGAAGGAATAAGGGATTACAAGAGAGATGTTAC 
 
2881      AAGAAAGAAGTAAAATAAATTTGATTAATATTGCCATTATCAAAAGCTATTTATATGTTG 
 
2941      AAATCGTGGAGATCATGTGTGCCAGAAAAGGCCACAGTTTCCGGGGAGAGGCATACCTTG 
 
3001      AGGTGGCTAGGAATCACGGAGACCTCTTGACTTGCAGGGTAGGCTAGCTAGAATTAAGTG 
 
3061      AGGTGACAAGGTTTCCATACAGTTTTGACCTTGAGACGTTGCTACTTACGATTTGCAGTA 
 
3121      TGCAAGTCTCATGCTGCAAACAAAAGAGGACCGCTCAGGTAATCGCTCAATTAGTGGACG 
 
3181      TTATCAGGGGCGGGAGAGGCGAAAGTGGTTTTTGGTGGTGTAAGTAAAGGTCGTCCAAAT 
                                               ◄ ENO1 promoter ◄◄ 
3241      ATGCAGGTGTTTGGGTGCTATCCTAGTGGAAGCTCGGATCAGTAGATAACCCGCCTAGAA 
                       ►► GAL 10/1 promoter fragment ►             ▼ 
3301      GACTAGTGGATCCTGGAACTTTCAGTAATACGCTTAACTGCTCATTGCTATATTGAAGTA 
                ▼Gal4p binding sites ▼                 ▼ 
3361      CGGATTAGAAGCCGCCGAGCGGGCGACAGCCCTCCGACGGAAGACTCTCCTCCGTGCGTC 
                                                            ▼ 
3421      CTGGTCTTCACCGGTCGCGTTCCTGAAACGCAGATGTGCCTCGCGCCGCACTGCTCCGAA 
               ►►  xyn2 core promoter► 
3481      CAATGAATTCAGATCCGCCCGGGCATGCAAGCTTAAATAGAATTCGCCAAACCTGAACAA 
                 Putative lore site at xyn2 core promoter▼ 
3541      CCCCAGCACCTGAACAGTCATACAACCCCTCCAAGCCCAAAAGACACAACAACTCCTACT 
                                ► xyn2 Reporter gene   
3601      AGCCGAAGCAAGAAGACATCAACATGGTCTCCTTCACCTCCCTCCTCGCCGGCGTCGCCG 
 
3661      CCATCTCGGGCGTCTTGGCCGCTCCCGCCGCCGAGGTCGAACCCGTGGCTGTGGAGAAGC 
 
3721      GCCAGACGATTCAGCCCGGCACGGGCTACAACAACGGCTACTTCCACTCGTACTGGAACG 
 
3781      ATGGCCACGGCGGCGTGACGTACACCAATGGTCCCGGCGGGCAGTTCTCCGTCAACTGGT 
 
3841      CCAACTCGGGCAACTTTGTCGGCGGCAAGGGATGGCAGCCCGGCACCAAGAACAAGGTCA 
 
3901      TCAACTTCTCGGGCAGCTACAACCCCAACGGCAACAGCTACCTCTCCGTGTACGGCTGGT 
 
3961      CCCGCAACCCCCTGATCGAGTACTACATCGTCGGGAACTTTGGCACCTACAACCCGTCCA 
 
4021      CGGGCGCCACCAAGCTGGGCGAGGTCACCTCCGACGGCAGCGTCTACGACATTTACCGCA 
 
4081      CGCAGCGCGTCAACCAGCCGTCCATCATCGGCACCGCCACCTTTTACCAGTACTGGTCCG 
 
4141      TCCGCCGCAACCACCGCGGCTCCGTCAACACGGCGAACCACTTCAACGCGTGGGCTCAGC 
 
4201      AAGGCCTGACGCTCGGGACGATCTCGAGGGATTACCAGATTGTTGCCGTGGAGGGTTACT 
 
4261      TTAGCTCTGGCTCTGCTTCCATCACCGTCAGCTAAAGGGAGATCTCCTCGAGGGATCTGC 
 
4321      GATAGATCAATTTTTTTCTTTTCTCTTTCCCCATCCTTTACGCTAAAATAATAGTTTATT 
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4381      TTATTTTTTGAATATTTTTTATTTATATACGTATATATAGACTATTATTTATCTTTTAAT 
 
4441      GATTATTAAGATTTTTATTAAAAAAAAATTCGCTCCTCTTTTAATGCCTTTATGCAGTTT 
 
4501      TTTTTTCCCATTCGATATTTCTATGTTCGGGGATATCGTACGTACGTCTTCCCGAGCGAA 
 
4561      AACGGTCTGCGCTGCGGGACGCGCGAATTGAATTATGGCCCACACCAGTGGCGCGGCGAC 
 
4621      TTCCAGTTCAACATCAGCCGCTACAGTCAACAGCAACTGATGGAAACCAGCCATCGCCAT 
 
4681      CTGCTGCACGCGGAAGAAGGCACATGGCTGAATATCGACGGTTTCCATATGGGGATTGGT 
 
4741      GGCGACGACTCCTGGAGCCCGTCAGTATCGGCGGAATTCCAGCTGAGCGCCGGTCGCTAC 
 
4801      CATTACCAGTTGGTCTGGTGTCAAAAATAATAATAACCGGGCAGGCCATGTCTGCCCGTA 
 
4861      TTTCGCGTAAGGAAATCCATTATGTACTATTTGCCTGATGCGGTATTTTCTCCTTACGCA 
 
4921      TCTGTGCGGTATTTCACACCGCATAGGGTAATAACTGATATAATTAAATTGAAGCTCTAA 
 
4981      TTTGTGAGTTTAGTATACATGCATTTACTTATAATACAGTTTTTTAGTTTTGCTGGCCGC 
 
5041      ATCTTCTCAAATATGCTTCCCAGCCTGCTTTTCTGTAACGTTCACCCTCTACCTTAGCAT 
 
5101      CCCTTCCCTTTGCAAATAGTCCTCTTCCAACAATAATAATGTCAGATCCTGTAGAGACCA 
 
5161      CATCATCCACGGTTCTATACTGTTGACCCAATGCGTCTCCCTTGTCATCTAAACCCACAC 
 
5221      CGGGTGTCATAATCAACCAATCGTAACCTTCATCTCTTCCACCCATGTCTCTTTGAGCAA 
 
5281      TAAAGCCGATAACAAAATCTTTGTCGCTCTTCGCAATGTCAACAGTACCCTTAGTATATT 
 
5341      CTCCAGTAGATAGGGAGCCCTTGCATGACAATTCTGCTAACATCAAAAGGCCTCTAGGTT 
 
5401      CCTTTGTTACTTCTTCTGCCGCCTGCTTCAAACCGCTAACAATACCTGGGCCCACCACAC 
 
5461      CGTGTGCATTCGTAATGTCTGCCCATTCTGCTATTCTGTATACACCCGCAGAGTACTGCA 
 
5521      ATTTGACTGTATTACCAATGTCAGCAAATTTTCTGTCTTCGAAGAGTAAAAAATTGTACT 
 
5581      TGGCGGATAATGCCTTTAGCGGCTTAACTGTGCCCTCCATGGAAAAATCAGTCAAGATAT 
 
5641      CCACATGTGTTTTTAGTAAACAAATTTTGGGACCTAATGCTTCAACTAACTCCAGTAATT 
 
5701      CCTTGGTGGTACGAACATCCAATGAAGCACACAAGTTTGTTTGCTTTTCGTGCATGATAT 
 
5761      TAAATAGCTTGGCAGCAACAGGACTAGGATGAGTAGCAGCACGTTCCTTATATGTAGCTT 
 
5821      TCGACATGATTTATCTTCGTTTCGGTTTTTGTTCTGTGCAGTTGGGTTAAGAATACTGGG 
 
5881      CAATTTCATGTTTCTTCAACACTACATATGCGTATATATACCAATCTAAGTCTGTGCTCC 
 
5941      TTCCTTCGTTCTTCCTTCTGTTCGGAGATTACCGAATCAAAAAAATTTCAAAGAAACCGA 
 
6001      AATCAAAAAAAAGAATAAAAAAAAAATGATGAATTGAATTGAAAAGCTCTTGTTACCCAT 
 
6061      CATTGAATTTTGAACATCCGAACCTGGGAGTTTTCCCTGAAACAGATAGTATATTTGAAC 
 
6121      CTGTATAATAATATATAGTCTAGCGCTTTACGGAAGACAATGTATGTATTTCGGTTCCTG 
 
6181      GAGAAACTATTGCATCTATTGCATAGGTAATCTTGCACGTCGCATCCCCGGTTCATTTTC 
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6241      TGCGTTTCCATCTTGCACTTCAATAGCATATCTTTGTTAACGAAGCATCTGTGCTTCATT 
 
6301      TTGTAGAACAAAAATGCAACGCGAGAGCGCTAATTTTTCAAACAAAGAATCTGAGCTGCA 
 
6361      TTTTTACAGAACAGAAATGCAACGCGAAAGCGCTATTTTACCAACGAAGAATCTGTGCTT 
 
6421      CATTTTTGTAAAACAAAAATGCAACGCGAGAGCGCTAATTTTTCAAACAAAGAATCTGAG 
 
6481      CTGCATTTTTACAGAACAGAAATGCAACGCGAGAGCGCTATTTTACCAACAAAGAATCTA 
 
6541      TACTTCTTTTTTGTTCTACAAAAATGCATCCCGAGAGCGCTATTTTTCTAACAAAGCATC 
 
6601      TTAGATTACTTTTTTTCTCCTTTGTGCGCTCTATAATGCAGTCTCTTGATAACTTTTTGC 
 
6661      ACTGTAGGTCCGTTAAGGTTAGAAGAAGGCTACTTTGGTGTCTATTTTCTCTTCCATAAA 
 
6721      AAAAGCCTGACTCCACTTCCCGCGTTTACTGATTACTAGCGAAGCTGCGGGTGCATTTTT 
 
6781      TCAAGATAAAGGCATCCCCGATTATATTCTATACCGATGTGGATTGCGCATACTTTGTGA 
 
6841      ACAGAAAGTGATAGCGTTGATGATTCTTCATTGGTCAGAAAATTATGAACGGTTTCTTCT 
 
6901      ATTTTGTCTCTATATACTACGTATAGGAAATGTTTACATTTTCGTATTGTTTTCGATTCA 
 
6961      CTCTATGAATAGTTCTTACTACAATTTTTTTGTCTAAAGAGTAATACTAGAGATAAACAT 
 
7021      AAAAAATGTAGAGGTCGAGTTTAGATGCAAGTTCAAGGAGCGAAAGGTGGATGGGTAGGT 
 
7081      TATATAGGGATATAGCACAGAGATATATAGCAAAGAGATACTTTTGAGCAATGTTTGTGG 
 
7141      AAGCGGTATTCGCAATATTTTAGTAGCTCGTTACAGTCCGGTGCGTTTTTGGTTTTTTGA 
 
7201      AAGTGCGTCTTCAGAGCGCTTTTGGTTTTCAAAAGCGCTCTGAAGTTCCTATACTTTCTA 
 
7261      GCTAGAGAATAGGAACTTCGGAATAGGAACTTCAAAGCGTTTCCGAAAACGAGCGCTTCC 
 
7321      GAAAATGCAACGCGAGCTGCGCACATACAGCTCACTGTTCACGTCGCACCTATATCTGCG 
 
7381      TGTTGCCTGTATATATATATACATGAGAAGAACGGCATAGTGCGTGTTTATGCTTAAATG 
 
7441      CGTTATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGCCCCGAC 
 
7501      ACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACA 
 
7561      GACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGA 
 
7621      AACGCGCGAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCATGATAA 
 
7681      TAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTT 
 
7741      GTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAA 
 
7801      TGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTA 
 
7861      TTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAG 
 
7921      TAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACA 
 
7981      GCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTA 
 
8041      AAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTC 
 
8101      GCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATC 
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8161      TTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACA 
 
8221      CTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGC 
 
8281      ACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCA 
 
8341      TACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTTGCGCAAAC 
 
8401      TATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGG 
 
8461      CGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTG 
 
8521      ATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATG 
 
8581      GTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAAC 
 
8641      GAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACC 
 
8701      AAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCT 
 
8761      AGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCC 
 
8821      ACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGC 
 
8881      GCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGG 
 
8941      ATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAA 
 
9001      ATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGC 
 
9061      CTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGT 
 
9121      GTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAA 
 
9181      CGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACC 
 
9241      TACAGCGTGAGCATTGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATC 
 
9301      CGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCT 
 
9361      GGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGAT 
 
9421      GCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCC 
 
9481      TGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGG 
 
9541      ATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGC 
 
9601      GCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCCAATACGCAAACCGCCTCTCCCCG 
 
9661      CGCGTTGGCCGATTCATTCCC 
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